<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0076)http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51 -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <title>The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020</title>
    <title>The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020</title>

	<meta name="keywords" content="2019 Novel Coronavirus, Outbreak, Epidemiological characteristics">
	<meta name="hw.ad-path" content="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51">
	<meta name="hw.identifier" content="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51">
	<meta name="dc.format" content="text/html">
	<meta name="dc.title" content="The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020">
	<meta name="dc.identifier" content="">
	<meta name="dc.contributor" content="The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team">
	<meta name="dc.creator" content="The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team">
	<meta name="dc.date" content="2020-02-01">
	<meta name="dc.keywords" content="2019 Novel Coronavirus, Outbreak, Epidemiological characteristics">
	
	<meta name="citation_journal_title" content="China CDC Weekly">
	<meta name="citation_publisher" content="China CDC Weekly">
	<meta name="citation_journal_abbrev" content="CCDCW">
	<meta name="citation_issn" content="2096-7071">
	<meta name="citation_date" content="2020-02-01">
	<meta name="citation_authors" content="The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team">
	<meta name="citation_online_date" content="2020-02-01">
	
	<meta name="citation_abstract_html_url" content="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51?viewType=HTML">
	<meta name="citation_pdf_url" content="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51">
	<meta name="citation_public_url" content="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51">
	<meta name="robots" content="noarchive">
	
	<meta name="dc.type" content="Vital Surveillances">
	<meta name="dc.source" content="China CDC Weekly, 2020, Vol. 2, Issue 8, Pages: 113-122">
	<meta name="dc.publisher" content="China CDC Weekly">
	<meta name="dc.rights" content="http://creativecommons.org/licenses/by/3.0/">
	<meta name="dc.format" content="application/pdf">
	<meta name="dc.language" content="en">
	<meta name="dc.description" content="">
	<meta name="dc.subject" content="2019 Novel Coronavirus">
	<meta name="dc.subject" content="Outbreak">
	<meta name="dc.subject" content="Epidemiological characteristics">
	<!-- SoWise SEO 2019-9-6 -->
	<meta name="citation_title" content="The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020">
	<meta name="citation_author" content="The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team">
	<meta name="citation_keywords" content="2019 Novel Coronavirus, Outbreak, Epidemiological characteristics">
	<meta name="citation_year" content="2020">
	<meta name="citation_volume" content="2"> 
	<meta name="citation_issue" content="8">
	<meta name="citation_firstpage" content="113">
	<meta name="citation_lastpage" content="122">
	<meta name="citation_doi" content="">
	<meta name="citation_id" content="e53946e2-c6c4-41e9-9a9b-fea8db1a8f51">
	<meta name="citation_state" content="">
<meta name="renderer" content="webkit">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">

<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1.0,minimum-scale=1.0,user-scalable=no">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/favicon.ico" rel="shortcut icon">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/bootstrap.min.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/font-awesome.min.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/swiper.min.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/iconfont.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/owl.carousel.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/base.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/media.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/style.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery.mCustomScrollbar.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/articleFont.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/article_en.css" rel="stylesheet">
<link type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/imgShow.css" rel="stylesheet">
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery-1.11.2.min.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/bootstrap.min.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery.validate.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/swiperd.min.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery.nicescroll.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/owl.carousel.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery.colorbox.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/user_validate.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/rhhz.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/base.js.download"></script> 
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/better-scroll.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/index.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/respond.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/main.js.download"></script> 
<!--[if lt IE 9]>
<script type="text/javascript" src="http://weekly.chinacdc.cn:80/style/web/js/public/html5.js"></script>
<![endif]--><script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery.mCustomScrollbar.concat.min.js.download"></script>

<!-- <script type="text/javascript" src="http://120.27.31.57/platformTools/js/MathJax-master/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script> -->
<!-- CND -->
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/MathJax.js.download"></script>
<script type="text/x-mathjax-config;executed=true">
			MathJax.Hub.Config({
				tex2jax: {inlineMath: [['$','$'], ['\\(','\\)']]},
				"HTML-CSS": {
					scale: 100,
					minScaleAdjust: 100,
					mtextFontInherit: true,
				 }
			});
</script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/search_en.js.download"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 2px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: 1em}
.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}
.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: Highlight; color: HighlightText}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MathJax_Preview .MJXf-math {color: inherit!important}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/article_en.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/articleDetails_en.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/imgShow_en.js.download"></script>
<script type="text/javascript" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/embed.js.download"></script><script id="altmetric-embed-js" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/altmetric_badges-75bc9437b4bcd96622a3f013e4e9519d1b65ea847ab601ad6158cf84b9291df9.js.download"></script>
<script type="text/javascript">
/**
 * 网站访问统计jsonp回调
 * @param data
 * @return
 */
//全局变量存储访问总数
var totalPv = 1;
function visitCountjsonpCallback(data){
	if(!isNull(data)){
		totalPv = data.history.pv;
	}
}
</script>
<link rel="stylesheet" type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/jquery.qtip.min.css"><link rel="stylesheet" type="text/css" href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/sowise-plugin.css"><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}
</style></head>
<body data-spy="scroll" data-target="#myScrollspy" class="articleBody">
<input type="hidden" value="China CDC Weekly" id="journalName">
<input type="hidden" value="browseJournal" id="pageViewId">
<input type="hidden" value="e53946e2-c6c4-41e9-9a9b-fea8db1a8f51" id="articleId">
<input type="hidden" value="en" id="articlelanguage">
<input hidden="" type="checkbox" checked="" id="reference">
<!--头部 开始-->
<div id="common-top">
    
 
<div class="top">
	<div class="header">
        <div class="container">
	    	<div class="clear">
		    	<div class="logo fl">
			        <a href="http://weekly.chinacdc.cn/index.htm" class="logocon fl">
			            <img class="img-responsive" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/logo.png" alt="">
			        </a>
		        </div>
		        <div class="fr logor">
		        	<a class="gjssbtn fr" href="http://weekly.chinacdc.cn/en/to_advance_search">Advanced Search</a>
		        	<div class="searchwrap clear">
			        	<form action="http://weekly.chinacdc.cn/search" method="POST" onsubmit="return checkSearch(this);" class="fl">
				            <div class="search-form-checkbox" style="display: block;">
								<label class="subset"><input type="checkbox" name="subset" checked="checked" value="MMWR" disabled="true">Search</label>
							</div>						           
							<div class="form-group fl  gjcfield">
								<input type="hidden" name="pageType" value="en">
				                <input name="q" type="text" placeholder="Search" class="form-control">
				            	<input type="submit" value="" class="fr tj">
				            </div>
				            
				        </form>
			        </div>
			        <div class="alphtit pull-right" style="display:none;">CCDC Weekly A-Z INDEX <span></span> </div>
		        </div>
	        </div>
       		<div class="alphwrap">
	        	<div class="alphcon">
	        		<ul>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#">A</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#b.html">B</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#c.html">C</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#d.html">D</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#e.html">E</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#f.html">F</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#g.html">G</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#h.html">H</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#i.html">I</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#j.html">J</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#k.html">K</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#l.html">L</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#m.html">M</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#n.html">N</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#o.html">O</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#p.html">P</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#q.html">Q</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#r.html">R</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#s.html">S</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#t.html">T</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#u.html">U</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#v.html">V</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#w.html">W</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#x.html">X</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#y.html">Y</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#z.html">Z</a></li>
						<li><a href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51#0.html">#</a></li>
					</ul>
	        	</div>
	        </div>
        </div>
    </div>
 
	<div class="top-nav nav header-nav header-nav-en">
        <div class="nav-inner clearfix container">
        	<div class="pull-left welcome"></div>
            <ul class="pull-left nav-con">
				<li><a href="http://weekly.chinacdc.cn/index.htm"><span></span>Home</a></li>
				<!--<li><a href="/indexcn.htm">中文 </a> </li>-->
			</ul>
        </div>
    </div>
 
	<div class="phone-nav" style="">
	    <div class="container clearfix">
	        <div class="navList fl">
	            <span class="span1"></span>
	            <span class="span2"></span>
	            <span class="span3"></span>
	        </div>
	        <a href="http://weekly.chinacdc.cn/" class="logo fl">
	            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/logo1.png" alt="">
	        </a>
	        <div class="search-app fr"></div>
	    </div>
	   
	    <div class="search-app-wrap">
	    	<form action="http://weekly.chinacdc.cn/search" method="POST" id="appTopSearchForm" onsubmit="return checkSearchNew(this);" class="clear ">
	            <div class="container clear">
	            	<!--手机搜索可能用到的id：appSearchType-->
	                <select name="searchField" class="fl">
	                    	                		<option value="" selected="">All</option><option value="titleEn">Title</option><option value="authorNameEn">Author</option><option value="abstractinfoEn">Abstract</option><option value="doi">DOI</option><option value="categoryNameEn">Category</option><option value="addressEn">Address</option><option value="fundsInfoEn">Fund</option>
	                		                </select>
	                <input type="hidden" name="pageType" value="en">
	                <input type="text" name="q" placeholder="Search" class="fl text">
	                <input type="submit" class="sub fl" value="">
	            </div>
	        </form>
	    </div>
	    <!--<ul class="smallUl">
	       	<li><a href="/index.htm"><span></span>Home</a></li>
				<li><a href="/indexcn.htm">中文 </a> </li>
	    </ul>-->
	    <ul class="smallUl">
				<div class="columnscon">
				 <div class="columns-list"><div class="columns-tit"><a href="http://weekly.chinacdc.cn/">Home</a></div></div>
                                                           <div class="columns-list">
              
                		                <div class="columns-tit" data="publications"><a href="http://weekly.chinacdc.cn/news/publications.htm" target="_top">Publications</a> 
	                	                </div>
                 
                
                              	<div class="columns-detail" style="display: block;">
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="WeeklyReports">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/en/zcustom/currentVolume/1" target="_top" data-category="Weekly Reports">Weekly Reports</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		     						                    							                     	<div class="columns-three" data="PastVolumes1">
							                    								                        <a href="http://weekly.chinacdc.cn/en/zcustom/volumeList/1" target="_top">Past Volumes(2019-2019)</a>
							                        							                 		</div>					                 	 
						                    						                           		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="Recommendations">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/en/zcustom/currentVolume/2" target="_top" data-category="Recommendations">Recommendations</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		     						                    							                     	<div class="columns-three" data="PastVolumes2">
							                    								                        <a href="http://weekly.chinacdc.cn/en/zcustom/volumeList/2" target="_top">Past Volumes()</a>
							                        							                 		</div>					                 	 
						                    						                           		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="SurveillanceSummaries">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/en/zcustom/currentVolume/3" target="_top" data-category="Surveillance Summaries">Surveillance Summaries</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		     						                    							                     	<div class="columns-three" data="PastVolumes3">
							                    								                        <a href="http://weekly.chinacdc.cn/en/zcustom/volumeList/3" target="_top">Past Volumes()</a>
							                        							                 		</div>					                 	 
						                    						                           		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="Supplements">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/en/zcustom/currentVolume/4" target="_top" data-category="Supplements">Supplements</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		     						                    							                     	<div class="columns-three" data="PastVolumes4">
							                    								                        <a href="http://weekly.chinacdc.cn/en/zcustom/volumeList/4" target="_top">Past Volumes()</a>
							                        							                 		</div>					                 	 
						                    						                           		</div>
                                     </div>
                            </div>
                                                                        <div class="columns-list">
              
                		                <div class="columns-tit" data="submission"><a href="http://weekly.chinacdc.cn/news/submission.htm" target="_top">Manuscript Submission</a> 
	                	                </div>
                 
                
                              	<div class="columns-detail">
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="WeeklyPublications">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/WeeklyPublications.htm" target="_top" data-category="Weekly Publications">Weekly Publications</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="SerialPublication">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/SerialPublication.htm" target="_top" data-category="Serial Publication">Serial Publication</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                     </div>
                            </div>
                                                                        <div class="columns-list">
              
                		                <div class="columns-tit" data="instructions"><a href="http://weekly.chinacdc.cn/news/instructions.htm" target="_top">Instructions for Authors</a> 
	                	                </div>
                 
                
                              	<div class="columns-detail">
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="WeeklyPublicationssauthor">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/WeeklyPublicationssauthor.htm" target="_top" data-category="Weekly Publications">Weekly Publications</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="SerialPublicationssauthor">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/SerialPublicationssauthor.htm" target="_top" data-category="Serial Publications">Serial Publications</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                     </div>
                            </div>
                                                <div class="columns-list">
              
                		                <div class="columns-tit" data="ccdcw"><a href="http://weekly.chinacdc.cn/news/ccdcw.htm" target="_top">About CCDC Weekly</a> 
	                	                </div>
                 
                
                              	<div class="columns-detail">
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="Staff">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/Staff.htm" target="_top" data-category="Editorial Office">Editorial Office</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="EditorialBoard">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/EditorialBoard.htm" target="_top" data-category="Editorial Board">Editorial Board</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="expert_eng">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/expert_eng.htm" target="_top" data-category="Advisory Committee">Advisory Committee</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                     </div>
                            </div>
                                                                        <div class="columns-list">
              
                		                <div class="columns-tit" data="subscriptions"><a href="http://weekly.chinacdc.cn/news/subscriptions.htm" target="_top">Subscriptions</a> 
	                	                </div>
                 
                
                              	<div class="columns-detail">
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="CCDCWFreeSubscription">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/email_alert_en.htm" target="_top">CCDCW Free Subscription </a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                                       
	                     	<div class="columns-body">
	                 			<div class="columns-two" data="CCDCWPaperSubscriptions">	                 			
			                    				                        <a href="http://weekly.chinacdc.cn/news/CCDCWPaperSubscriptions.htm" target="_top" data-category="CCDCW Paper Subscriptions">CCDCW Paper Subscriptions</a>
			                        			                         
		                 		</div>
	                 		                 		
		             		                      		</div>
                                     </div>
                            </div>
                                                                                                                                                <div class="columns-list">
              
                		                <div class="columns-tit" data="contactus"><a href="http://weekly.chinacdc.cn/news/contactus.htm" target="_top">Contact Us</a> 
	                	                </div>
                 
                
                            </div>
                                  
	</div>
           
            </ul>
	</div>
</div></div>
<!--头部 结束-->
<!--电脑端 开始-->
<div class="article-pc">
	<div class="article-header-new active">
    <div class="inner clear">
        <ul class="fl">
            <li>
                <a href="javascript:void(0);" onclick="downloadpdf(&#39;e53946e2-c6c4-41e9-9a9b-fea8db1a8f51&#39;);"><i class="fa fa-file-pdf-o"></i><span>PDF</span></a>
            </li>
            <li>
                <a href="javascript:void(0);" data-target="#exportCitationModal" data-toggle="modal"><i class="fa fa-quote-left"></i><span>Cite</span></a>
            </li>
            <li>
                <a><i class="fa fa-share-alt"></i><span>Share</span></a>
                <dl>
                    <dd>
                        <a href="javascript:void(0);" onclick="shareTools(&#39;facebook&#39;);" title="share to facebook">facebook</a>
                    </dd>
                    <dd>
                        <a href="javascript:void(0);" onclick="shareTools(&#39;twitter&#39;);" title="share to twitter">twitter</a>
                    </dd>
                    <dd>
                        <a href="javascript:void(0);" onclick="shareTools(&#39;google+&#39;);" title="share to google">google</a>
                    </dd>
                    <dd>
                        <a href="javascript:void(0);" onclick="shareTools(&#39;linkedin&#39;);" title="share to linkedin">linkedin</a>
                    </dd>
                </dl>
            </li>
        </ul>
        <div class="article-search fr clear">
            <form class="topSearchForm" id="searchFormTop" action="http://weekly.chinacdc.cn/search" method="POST" onsubmit="return checkSearchNew(this);" role="form">
                <select class="fl" name="searchField">
                    <option value="" selected="">All</option><option value="titleEn">Title</option><option value="authorNameEn">Author</option><option value="abstractinfoEn">Abstract</option><option value="doi">DOI</option><option value="categoryNameEn">Category</option><option value="addressEn">Address</option><option value="fundsInfoEn">Fund</option></select>
                <input type="text" name="q" placeholder="Search" class="fl text input">
                <input name="pageType" type="hidden" value="en">
                <input type="submit" class="sub fl" value="">
            </form>
        </div>
    </div>
</div>
<div class="article-main">
	<div class="inner clear content active" style="position:relative;">
       
        <div class="article-main-mid fl active">
        	<div class="articleNav">
        	<strong>Article Navigation</strong>&nbsp;&gt;&nbsp;
        	<span class="jounralName"><a class="mainColor" href="http://weekly.chinacdc.cn/">China CDC Weekly</a></span>	
        		
					&nbsp;&gt;
					<span class="aIssue"><a class="mainColor" href="http://weekly.chinacdc.cn/en/zcustom/volume/1/2020">2020,&nbsp;2(8):&nbsp;113-122</a></span>
				 </div>
            <div class="article-left">
                <div class="articleEn">
                    <div class="article-title" style="text-align:center;">
                        <h1>Vital Surveillances:&nbsp;The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020</h1>
                    </div>
                    <ul class="article-author clear">
                        <li>
	                                <a href="javascript:void(0);" class="mainColor" data-relate="zhangyp@chinacdc.cn" onclick="">The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team</a><sup class="authorTag"><a href="javascript:void(0);" class="com-user" title="Corresponding author: The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, zhangyp@chinacdc.cn"></a>,&nbsp;<a href="mailto:zhangyp@chinacdc.cn" class="com-mail" title="zhangyp@chinacdc.cn"></a></sup></li>	                         
                            </ul>
                    
                      </div>
            </div>
                    <ul class="article-tab-box tab-content" id="myTabContent">
                 <li id="Abstract" class="articleListBox">
                    <!--<ul class="article-keyword article-info-en">
                            <b>Keywords:</b>
                            <li><a class="underHigh mainColor" href="javascript:void(0);" onclick="searchLike('keywordEn','2019 Novel Coronavirus')">
                                        2019 Novel Coronavirus</a>,</li>
                                <li><a class="underHigh mainColor" href="javascript:void(0);" onclick="searchLike('keywordEn','Outbreak')">
                                        Outbreak</a>,</li>
                                <li><a class="underHigh mainColor" href="javascript:void(0);" onclick="searchLike('keywordEn','Epidemiological characteristics')">
                                        Epidemiological characteristics</a></li>
                                </ul>
                    --> 
                </li>
                <li id="FullText" class="articleListBox FullText-all">	<input id="basePath" type="hidden" value="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/">
	<!-- 遍历章节列表 -->
			<!-- 输出章节标题 start -->
									<h3 class="navTitle navTitle2">
					<span id="ea477446-85f5-4d7e-b018-df0d0f1af127" level="1" sort="1" class="sec-title">
												Abstract
					</span>
				</h3>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="90afd8bf-1ded-4f42-a378-d5834a4036f2"><b>Background:</b> An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, Hubei Province, China has spread quickly nationwide. Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="4c053d95-9380-482b-9abe-4eb92c6a9b4e"><b>Methods:</b> All COVID-19 cases reported through February 11, 2020 were extracted from China’s Infectious Disease Information System. Analyses included the following: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality and mortality rates; 4) geo-temporal analysis of viral spread; 5) epidemiological curve construction; and 6) subgroup analysis.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="04b3e991-c0a1-4aea-8919-0dd707810f8d"><b>Results:</b> A total of 72,314 patient records—44,672 (61.8%) confirmed cases, 16,186 (22.4%) suspected cases, 10,567 (14.6%) clinically diagnosed cases (Hubei Province only), and 889 asymptomatic cases (1.2%)—contributed data for the analysis. Among confirmed cases, most were aged 30–79 years (86.6%), diagnosed in Hubei (74.7%), and considered mild (80.9%). A total of 1,023 deaths occurred among confirmed cases for an overall case fatality rate of 2.3%. The COVID-19 spread outward from Hubei Province sometime after December 2019, and by February 11, 2020, 1,386 counties across all 31 provinces were affected. The epidemic curve of onset of symptoms peaked around January 23–26, then began to decline leading up to February 11. A total of 1,716 health workers have become infected and 5 have died (0.3%).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="ef99e70d-3146-45ef-bcaf-526b3d00c686"><b>Conclusions: </b> COVID-19 epidemic has spread very quickly taking only 30 days to expand from Hubei to the rest of Mainland China. With many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h3 class="navTitle navTitle2">
					<span id="a1954dfa-b1e8-43bb-9927-ba268658fba9" level="1" sort="2" class="sec-title">
												Introduction
					</span>
				</h3>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="7c953e6b-b627-4984-ae62-7810f579d94f">A cluster of pneumonia cases of unknown origin in Wuhan, China caused concern among health officials in late December 2019. On December 31, an alert was issued by the Wuhan Municipal Health Commission, a rapid response team was sent to Wuhan by the Chinese Center for Disease Control and Prevention (China CDC), and a notification was made to the World Health Organization (WHO) (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b1">1</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b4">4</a></span>). Likely potential causes including influenza, avian influenza, adenovirus, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) were ruled out. Epidemiological investigation implicated Wuhan’s Huanan Seafood Wholesale Market, which was shut down and disinfected, and active case finding was initiated and vigorously pursued (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b2">2</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b4">4</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b5">5</a></span>).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="c09adf89-4ae9-4180-a439-4a979b8510e0">On January 7, 2020, the causative pathogen was identified as a novel coronavirus, and genomic characterization and test method development ensued (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b2">2</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b6">6</a></span>). Now named 2019-nCoV, the virus is distinct from both SARS-CoV and MERS-CoV, yet closely related (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b5">5</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b7">7</a></span>). Early cases suggested that COVID-19 (i.e. the new name for disease caused by the novel coronavirus) may be less severe than SARS and MERS. However, illness onset among rapidly increasing numbers of people and mounting evidence of human-to-human transmission suggests that 2019-nCoV is more contagious than both SARS-CoV and MERS-CoV (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>-<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b11">11</a></span>).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="664a053e-8c1e-4940-ae12-202f09f90870">On January 20, China’s “<i>National Infectious Diseases Law</i>” was amended to make 2019-novel coronavirus diseases (COVID-19) a Class B notifiable disease and its “<i>Frontier Health and Quarantine Law</i>” was amended to support the COVID-19 outbreak response effort. Then, on January 23, the Chinese Government began to limit movement of people in and out of Wuhan, and two days later, it announced its highest-level commitment and mobilized all sectors to respond to the epidemic and prevent further spread of COVID-19. Characterization of the epidemiological features of COVID-19 is crucial for the development and implementation of effective control strategies. Here, we report the results of a descriptive, exploratory analysis of all cases found through February 11, 2020.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h3 class="navTitle navTitle2">
					<span id="2f8af81c-faf0-41e7-bc83-5ab5d3201b95" level="1" sort="3" class="sec-title">
												Method
					</span>
				</h3>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
				<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="900485b0-ec56-416e-b7c7-3f0eb8826a11" level="2" sort="4" class="sec-title">
												Study Design
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="bbb8c2fb-eb02-49e6-99c4-911159a28a2f">This study was a descriptive, exploratory analysis of all cases of COVID-19 diagnosed nationwide in China as of the end of February 11, 2020. As such, it in some respects uses a cross-sectional study design and hence, we have used the STROBE Guidelines (<a href="http://weekly.chinacdc.cn/en/article/id/www.equator-network.org" target="_blank">www.equator-network.org</a>) to aid our thorough reporting of this observational study.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="bf0fe962-b8f4-4490-88c6-6be90c0f7d2e">A public health emergency was declared, and a formal investigation began on December 31, 2019, supported by city (Wuhan Municipal Health Commission and Wuhan CDC), provincial (Health Commission of Hubei Province and Hubei Provincial CDC), and national (National Health Commission and China CDC) authorities and resources. This study was reviewed by the China CDC Institutional Review Board via a fast-track mechanism. Although individual informed consent was not required for this study, all data were handled as a deidentified set to protect patient privacy and confidentiality.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="75352e41-70cb-4398-9548-aa8b2e41b41c" level="2" sort="5" class="sec-title">
												Data Source
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="d278b4a7-68aa-4eff-9636-c334e215de5b">By categorizing COVID-19 as a Class B notifiable disease, Chinese law required all cases to be immediately reported to China’s Infectious Disease Information System. Entry of each case into the system was performed by local epidemiologists and public health workers who investigated and collected information on possible exposures. All case records contain national identification numbers, and therefore, all cases have records in the system and no records are duplicated. All data contained in all COVID-19 case records in the Infectious Disease Information System through the end of February 11, 2020 were extracted from the system as a single dataset and were then stripped of all personal identifying information. No sampling was done to achieve a predetermined study size and no eligibility criteria were used—all cases were included.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="0d42d769-4cf5-4f29-9637-4cbe12796afd" level="2" sort="6" class="sec-title">
												Variables
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="63c34c11-ef04-4bc1-813c-2ec7e5f8d902">Patient characteristics were collected at baseline, meaning the time of diagnosis, epidemiological investigation, and entry into the Infectious Disease Information System. Patients were categorized as health workers for the occupation variable if they had active employment of any kind in a health facility (i.e. this category did not just include physicians and nurses). Patients were categorized as having a Wuhan-related exposure if they had recently resided in or visited Wuhan or if they had close contact with someone who had. The comorbid conditions variable was determined upon epidemiological investigation by patient self-reported medical history, which was not independently verified using medical records for all cases. The severity of symptoms variable was categorized as mild, severe, or critical. Mild included non-pneumonia and mild pneumonia cases. Severe was characterized by dyspnea, respiratory frequency ≥30/minute, blood oxygen saturation ≤93%, PaO<sub>2</sub>/FiO<sub>2</sub> ratio &lt;300, and/or lung infiltrates &gt;50% within 24–48 hours. Critical cases were those that exhibited respiratory failure, septic shock, and/or multiple organ dysfunction/failure.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="6a9210c3-c7da-4981-8e80-9b17b424bf8a">As some variables of interest (i.e., Wuhan-related exposure, comorbid condition, and case severity) are not required fields when creating records in the Infectious Disease Information System, some records have missing data for these variables.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="b3b0029a-b78b-458c-9556-f5974870fa55">For construction of epidemiological curves, date of onset was defined as the date on which patients self-reported the start of either fever or cough during epidemiological investigation. Cases were categorized as confirmed, suspected, clinically diagnosed (Hubei Province only), or asymptomatic. Confirmed cases were diagnosed based on positive viral nucleic acid test results on throat swab samples (some samples were tested retrospectively). Suspected cases were diagnosed clinically based on symptoms and exposures. Clinically diagnosed cases were suspected cases with lung imaging features consistent with coronavirus pneumonia. Asymptomatic cases were diagnosed based on positive viral nucleic acid test results but without any COVID-19 symptoms (e.g., fever, dry cough). The date of positive viral nucleic acid test result is used as onset date for asymptomatic cases</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="81205290-f847-4966-b23a-aa05c9762ccd" level="2" sort="7" class="sec-title">
												Analysis
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="3f3d3579-ffd3-4386-afd6-add6fdad137f">For confirmed cases, demographic and clinical characteristics were summarized using descriptive statistics. Age distribution graphs were constructed using patient age at baseline for confirmed cases diagnosed in Wuhan, Hubei Province (including Wuhan), and China (including Hubei Province). Sex ratio (i.e., male:female [M:F] ratio) was also calculated. Case fatality rates were calculated as the total number of deaths (numerator) divided by the total number of cases (denominator), expressed as a percent. Observed time was summarized using person-days (PD) and mortality was calculated as the number of deaths (numerator) divided by the total observed time (denominator), expressed per 10 PD.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="f05a1e04-5871-462c-9eba-112d699491fa">For geo-temporal analysis, the county-level location of each case at time of diagnosis was used to build color-coded maps of China to indicate the numbers of cases in each province on December 31, 2019; January 10, 2020; January 31, 2020; and February 11, 2020. This analysis was performed using ArcGIS Desktop software (version 10.6; Esri; Redlands, California, USA).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="30f74db4-8499-4249-aed7-4e26390fe8af">The epidemiological curve for all cases was constructed by plotting the number of cases (y-axis) versus self-reported date of symptom onset (x-axis). Date of symptom onset for confirmed, suspected, clinically diagnosed, and asymptomatic cases were stacked to show total cases over time. The epidemiological curve for confirmed cases was also overlaid with the number of cases versus date of diagnosis to show the delay between onset of symptoms and diagnosis of disease.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="06ef0567-6954-4b28-a128-e5dea19e2c79">Two subgroups were also analyzed separately using epidemiological curves: confirmed cases diagnosed outside of Hubei Province (with and without Wuhan-related exposure) and all cases diagnosed among health workers (confirmed, suspected, clinically diagnosed, and asymptomatic).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h3 class="navTitle navTitle2">
					<span id="111f31f2-28d6-4d28-b463-cac06ea5db89" level="1" sort="8" class="sec-title">
												Results
					</span>
				</h3>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
				<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="44719c7b-c83a-4fe4-885b-6c40859b15ec" level="2" sort="9" class="sec-title">
												Patients
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="47099661-afea-4332-a8e1-329bc8bdf71f">A total of 72,314 unique records were extracted and data from all records were included in the analysis. Thus, all 72,314 individuals diagnosed with COVID-19 as of February 11, 2020, were included in the analysis. Among them, 44,672 cases (61.8%) were confirmed, 16,186 cases (22.4%) were suspected, 10,567 cases (14.6%) were clinically diagnosed, and 889 cases (1.2%) were asymptomatic.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="6c67d4f2-e0a1-428b-85e6-c61e11c58560">Baseline characteristics of confirmed cases (n=44,672) are presented in <span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table1">Table 1</a></span>. A majority were aged 30–69 years (77.8%), male (51.4%), farmers or laborers (22.0%), and diagnosed in Hubei Province (74.7%). Most patients reported Wuhan-related exposures (85.8%) and were classified as mild cases (80.9%).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
									<!-- 图段落 -->
						<!-- 表段落 -->
							
				<div class="figure table_new" style="display: none;">
				<span id="44719c7b-c83a-4fe4-885b-6c40859b15ec" level="2" sort="9" class="sec-title">&nbsp;</span>
					<div class="article_table_fullText clearfix" ref="Table1">
																		<!--<a class="group4" href="#Table1_content" title="TABLE&nbsp;1.&nbsp;Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020." id="Table1">
							<img src="http://weekly.chinacdc.cn:80/style/web/images/table-icon.gif"/>
						</a> -->
						<div class="table_caption">
						 	<!-- 英文图题 -->
						 									<div>
									<span class="TableText">
										<b>TABLE&nbsp;1.</b>&nbsp;
									</span>
					    			Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020.
					       		</div>
				       								</div>
						<div id="Table1_content" class="table table_content">
							<div class="table-body 									                       table_type2	                        						    ">
								<table>
<thead>  <tr><td class="table_top_border" align="center" valign="middle"><b>Baseline characteristics</b></td><td class="table_top_border" align="center" valign="middle"><b>Confirmed cases,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Deaths,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Case fatality </b><br><b>rate, %</b></td><td class="table_top_border" align="center" valign="middle"><b>Observed time,</b><br><b> PD</b></td><td class="table_top_border" align="center" valign="middle"><b>Mortality,</b><br><b> per 10 PD</b> </td></tr></thead>
<tbody><tr><td class="table_top_border2" align="left" valign="middle">Overall</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:20pt" align="center" valign="middle">  44,672</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:30pt" align="center" valign="middle">1,023</td><td class="table_top_border2" align="center" valign="middle">  2.3</td><td class="table_top_border2" align="center" valign="middle">661,609</td><td class="table_top_border2" align="center" valign="middle">0.015</td></tr><tr><td align="left" valign="middle">Age, years</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　0–9</td><td align="center" valign="middle">416 (0.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">    4,383</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　10–19</td><td align="center" valign="middle">549 (1.2)</td><td align="center" valign="middle">1 (0.1)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">    6,625</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　20–29</td><td align="center" valign="middle">3,619 (8.1)</td><td align="center" valign="middle">7 (0.7)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">  53,953</td><td align="center" valign="middle">0.001</td></tr><tr><td align="left" valign="middle">　30–39</td><td align="center" valign="middle">7,600 (17.0)</td><td align="center" valign="middle">18 (1.8)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">114,550</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　40–49</td><td align="center" valign="middle">8,571 (19.2)</td><td align="center" valign="middle">38 (3.7)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">128,448</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">　50–59</td><td align="center" valign="middle">10,008 (22.4)</td><td align="center" valign="middle">130 (12.7)</td><td align="center" valign="middle">  1.3</td><td align="center" valign="middle">151,059</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　60–69</td><td align="center" valign="middle">8,583 (19.2)</td><td align="center" valign="middle">309 (30.2)</td><td align="center" valign="middle">  3.6</td><td align="center" valign="middle">128,088</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　70–79</td><td align="center" valign="middle">3,918 (8.8)</td><td align="center" valign="middle">312 (30.5)</td><td align="center" valign="middle">  8.0</td><td align="center" valign="middle">  55,832</td><td align="center" valign="middle">0.056</td></tr><tr><td align="left" valign="middle">　≥80</td><td align="center" valign="middle">1,408 (3.2)</td><td align="center" valign="middle">208 (20.3)</td><td align="center" valign="middle">14.8</td><td align="center" valign="middle">  18,671</td><td align="center" valign="middle">0.111</td></tr><tr><td align="left" valign="middle">Sex</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Male</td><td align="center" valign="middle">22,981 (51.4)</td><td align="center" valign="middle">653 (63.8)</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">342,063</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">　Female</td><td align="center" valign="middle">21,691 (48.6)</td><td align="center" valign="middle">370 (36.2)</td><td align="center" valign="middle">  1.7</td><td align="center" valign="middle">319,546</td><td align="center" valign="middle">0.012</td></tr><tr><td align="left" valign="middle">Occupation</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Service industry</td><td align="center" valign="middle">3,449 (7.7)</td><td align="center" valign="middle">23 (2.2)</td><td align="center" valign="middle">  0.7</td><td align="center" valign="middle">  54,484</td><td align="center" valign="middle">0.004</td></tr>   <tr><td align="left" valign="middle">　Farmer/laborer</td><td align="center" valign="middle">9,811 (22.0)</td><td align="center" valign="middle">139 (13.6)</td><td align="center" valign="middle">  1.4</td><td align="center" valign="middle">137,992</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">　Health worker </td><td align="center" valign="middle">1,716 (3.8)</td><td align="center" valign="middle">5 (0.5)</td><td align="center" valign="middle">  0.3</td><td align="center" valign="middle">  28,069</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　Retiree</td><td align="center" valign="middle">9,193 (20.6)</td><td align="center" valign="middle">472 (46.1)</td><td align="center" valign="middle">  5.1</td><td align="center" valign="middle">137,118</td><td align="center" valign="middle">0.034</td></tr><tr><td align="left" valign="middle">　Other/none</td><td align="center" valign="middle">20,503 (45.9)</td><td align="center" valign="middle">384 (37.5)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">303,946</td><td align="center" valign="middle">0.013</td></tr>     <tr><td align="left" valign="middle">Province</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hubei</td><td align="center" valign="middle">33,367 (74.7)</td><td align="center" valign="middle">979 (95.7)</td><td align="center" valign="middle">  2.9</td><td align="center" valign="middle">496,523</td><td align="center" valign="middle">0.020</td></tr><tr><td align="left" valign="middle">　Other</td><td align="center" valign="middle">11,305 (25.3)</td><td align="center" valign="middle">44 (4.3)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">165,086</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">Wuhan-related exposure*</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Yes</td><td align="center" valign="middle">31,974 (85.8)</td><td align="center" valign="middle">853 (92.8)</td><td align="center" valign="middle">  2.7</td><td align="center" valign="middle">486,612</td><td align="center" valign="middle">0.018</td></tr><tr><td align="left" valign="middle">　No</td><td align="center" valign="middle">5,295 (14.2)</td><td align="center" valign="middle">66 (7.2)</td><td align="center" valign="middle">  1.2</td><td align="center" valign="middle">  71,201</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">    7,403</td><td align="center" valign="middle">104</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">103,796</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">Comorbid condition<sup>†</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hypertension</td><td align="center" valign="middle">2,683 (12.8)</td><td align="center" valign="middle">161 (39.7)</td><td align="center" valign="middle">  6.0</td><td align="center" valign="middle">  42,603</td><td align="center" valign="middle">0.038</td></tr><tr><td align="left" valign="middle">　Diabetes</td><td align="center" valign="middle">1,102 (5.3)</td><td align="center" valign="middle">80 (19.7)</td><td align="center" valign="middle">  7.3</td><td align="center" valign="middle">  17,940</td><td align="center" valign="middle">0.045</td></tr><tr><td align="left" valign="middle">　Cardiovascular disease</td><td align="center" valign="middle">873 (4.2)</td><td align="center" valign="middle">92 (22.7)</td><td align="center" valign="middle">10.5</td><td align="center" valign="middle">  13,533</td><td align="center" valign="middle">0.068</td></tr><tr><td align="left" valign="middle">　Chronic respiratory disease</td><td align="center" valign="middle">511 (2.4)</td><td align="center" valign="middle">32 (7.9)</td><td align="center" valign="middle">  6.3</td><td align="center" valign="middle">    8,083</td><td align="center" valign="middle">0.040</td></tr><tr><td align="left" valign="middle">　Cancer (any)</td><td align="center" valign="middle">107 (0.5)</td><td align="center" valign="middle">6 (1.5)</td><td align="center" valign="middle">  5.6</td><td align="center" valign="middle">    1,690</td><td align="center" valign="middle">0.036</td></tr><tr><td align="left" valign="middle">　None</td><td align="center" valign="middle">15,536 (74.0)</td><td align="center" valign="middle">133 (32.8)</td><td align="center" valign="middle">  0.9</td><td align="center" valign="middle">242,948</td><td align="center" valign="middle">0.005</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">23,690 (53.0)</td><td align="center" valign="middle">617 (60.3)</td><td align="center" valign="middle">  2.6</td><td align="center" valign="middle">331,843</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">Case severity<sup>§</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Mild</td><td align="center" valign="middle">36,160 (80.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Severe</td><td align="center" valign="middle">6,168 (13.8)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Critical</td><td align="center" valign="middle">2,087 (4.7)</td><td align="center" valign="middle">1,023 (100)</td><td align="center" valign="middle">49.0</td><td align="center" valign="middle">  31,456</td><td align="center" valign="middle">0.325</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">257 (0.6)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">Period (by date of onset)</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Before Dec 31, 2019</td><td align="center" valign="middle">104 (0.2)</td><td align="center" valign="middle">15 (1.5)</td><td align="center" valign="middle">14.4</td><td align="center" valign="middle">    5,142</td><td align="center" valign="middle">0.029</td></tr><tr><td align="left" valign="middle">　Jan 1–10, 2020</td><td align="center" valign="middle">653 (1.5)</td><td align="center" valign="middle">102 (10.0)</td><td align="center" valign="middle">15.6</td><td align="center" valign="middle">  21,687</td><td align="center" valign="middle">0.047</td></tr><tr><td align="left" valign="middle">　Jan 11–20, 2020</td><td align="center" valign="middle">5,417 (12.1)</td><td align="center" valign="middle">310 (30.3)</td><td align="center" valign="middle">  5.7</td><td align="center" valign="middle">130,972</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　Jan 21–31, 2020</td><td align="center" valign="middle">26,468 (59.2)</td><td align="center" valign="middle">494 (48.3)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">416,009</td><td align="center" valign="middle">0.012</td></tr><tr><td class="table_bottom_border" align="left" valign="middle">　After Feb 1, 2020</td><td class="table_bottom_border" align="center" valign="middle">12,030 (26.9)</td><td class="table_bottom_border" align="center" valign="middle">102 (10.0)</td><td class="table_bottom_border" align="center" valign="middle">  0.8</td><td class="table_bottom_border" align="center" valign="middle">  87,799</td><td class="table_bottom_border" align="center" valign="middle">0.012</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="6">Abreviation: PD, person-days. -, not applicable.<br>* The Wuhan-related exposure variable, only includes a total of 37,269 patients and 919 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>†</sup> The comorbid condition variable, only includes a total of 20,812 patients and 504 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>§</sup> The case severity variable, only includes a total of 44,415 patients and 1,023 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.</td></tr></tfoot>
</table>
							</div>
						</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button clear">
						<div class="table-csv-right fr" data-href="Table1">&nbsp;|&nbsp;Show Table</div>
						<div class="table-csv-left fr">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
							<a href="javascript:void(0);" onclick="downloadCsv(&#39;929d84bd-d6a0-42dd-b1ca-2fd716173a30&#39;,&#39;para&#39;)">CSV</a>
						</div>
					</div>
				</div>
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="1704154e-2a1a-4cc4-9a7d-41210ab1dd5f" level="2" sort="10" class="sec-title">
												Deaths, Case Fatality Rates, and Mortality
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="ad0909b4-d417-4b98-86ec-dbf829f96f4d">As shown in <span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table1">Table 1</a></span>, a total of 1,023 deaths have occurred among 44,672 confirmed cases for an overall case fatality rate of 2.3%. Additionally, these 1,023 deaths occurred during 661,609 PD of observed time, for a mortality rate of 0.015/10 PD.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="0b7c3c13-befb-4992-8218-f08a7756d773">The ≥80 age group had the highest case fatality rate of all age groups at 14.8%. Case fatality rate for males was 2.8% and for females was 1.7%. By occupation, patients who reported being retirees had the highest case fatality rate at 5.1%, and patients in Hubei Province had a &gt;7-fold higher case fatality rate at 2.9% compared to patients in other provinces (0.4%). While patients who reported no comorbid conditions had a case fatality rate of 0.9%, patients with comorbid conditions had much higher rates—10.5% for those with cardiovascular disease, 7.3% for diabetes, 6.3% for chronic respiratory disease, 6.0% for hypertension, and 5.6% for cancer. Case fatality rate was also very high for cases categorized as critical at 49.0%.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="1861d75a-3ed5-4b54-918b-e92d9eee972f" level="2" sort="11" class="sec-title">
												Age Distribution and Sex Ratio
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="c24d0bfe-b222-4a29-81f1-85ddc12ee407">The age distribution of cases in Wuhan only, in Hubei Province overall, and in China overall are presented in <span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure1">Figure 1</a></span>. The proportion of confirmed cases 30–79 years of age at baseline (i.e., date of diagnosis) was 89.8% for cases in Wuhan city versus 88.6% in Hubei overall (which includes Wuhan) and 86.6% in China overall (which includes Hubei Province and all 30 other provincial-level administrative divisions, or PLADs). The male-to-female ratio was 0.99:1 in Wuhan, 1.04:1 in Hubei, and 1.06:1 in China overall.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
									<!-- 图段落 -->
							
				<div class="_figclass figure" style="display:none;">
				 <span id="362ce21f-297b-4c44-b6ff-e03313f656ad" level="2" sort="11" class="sec-title"></span>
					<div class="figure_title figure_fulltext clearfix">
																		<a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg" title="FIGURE 1. Age distribution and sex ratio of all confirmed COVID-19 cases in China through February 11, 2020. (A) patients diagnosed in the city of Wuhan only; (B) patients diagnosed in Hubei Province, which includes Wuhan as its capital city; and (C) patients diagnosed in China overall, including Hubei Province and all 30 other provincial-level administrative divisions (PLADs). Dashed red line highlights the proportion of patients in the 30–79 years age range. Sex ratio (i.e. male-to-female [M:F] ratio) is shown below each graph." img_id="Fig-Figure1" img_ref="#Fig-Figure1">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1_mini.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-1.jpg&#39;" class="figure_img 
																	 figure_type2 								 " id="Figure1">
						</a>
						<div class="figure_caption">
							<!-- 英文图题 -->
															<div>
									<span class="FigText" id="Figure1">
										<b>FIGURE&nbsp;1.</b>&nbsp;
									</span>
									Age distribution and sex ratio of all confirmed COVID-19 cases in China through February 11, 2020. (A) patients diagnosed in the city of Wuhan only; (B) patients diagnosed in Hubei Province, which includes Wuhan as its capital city; and (C) patients diagnosed in China overall, including Hubei Province and all 30 other provincial-level administrative divisions (PLADs). Dashed red line highlights the proportion of patients in the 30–79 years age range. Sex ratio (i.e. male-to-female [M:F] ratio) is shown below each graph.
								</div>
														<!-- 图注释 -->
													</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button">
						<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
						<a href="javascript:void(0);" onclick="downloadImg(&#39;362ce21f-297b-4c44-b6ff-e03313f656ad&#39;,&#39;para&#39;)">Full-Size Img</a>
						<a href="javascript:void(0);" onclick="downloadPPT(&#39;362ce21f-297b-4c44-b6ff-e03313f656ad&#39;,&#39;para&#39;)" style="border-left: 1px solid #ccc;
    padding-left: 5px;">PowerPoint</a>
					</div>
					<!-- 下拉显示 -->
				</div>
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="a134c178-8595-4906-9501-eb75d0e38144" level="2" sort="12" class="sec-title">
												Geo-Temporal Findings
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="4ccdb8ed-b69f-4b0d-9673-02d1d437f498">On January 19, 2020, National Health Commission of the People’s Republic of China confirmed that Guangdong Provincial CDC reported first imported cases of COVID-19, via the Chinese Infectious Diseases Reporting System. This was the first time COVID-19 had been reported outside of Hubei Province via the System. As of January 22, 2020, a total of 301 confirmed COVID-19 cases were reported from 83 counties in 23 provinces. On January 30, 2020, Xizang Autonomous Region (Tibet) reported its first confirmed COVID-19 case coming from Hubei Province. Thus, COVID-19 cases have been reported from all 31 PLADs (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2</a></span>).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
									<!-- 图段落 -->
							
				<div class="_figclass figure" style="display:none;">
				 <span id="148a3fa4-3d7d-450c-a3ff-5c7bc2857d97" level="2" sort="12" class="sec-title"></span>
					<div class="figure_title figure_fulltext clearfix">
																		<a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg" title="FIGURE 2. Geo-temporal spread of COVID-19 in China through February 11, 2020. (A) a total of 14 county-level administrative areas (hereafter counties) in Hubei Province only (inset) had reported cases as of December 31, 2019; (B) by January 10, 2020, 113 counties in 20 PLADs had reported cases with the highest prevalence still in Hubei Province; (C) nine days later, on January 20, 627 counties in 30 PLADs had reported cases and PLADs neighboring Hubei Province observed increasing prevalence; (D) by the end of January 31, 1,310 counties across all 31 PLADs were affected and prevalence in the central, south, and south-central regions had risen dramatically; (E) by the end of February 11, 1,386 counties nationwide were affected and prevalence in the south-central PLADs had risen to the level of Hubei." img_id="Fig-Figure2" img_ref="#Fig-Figure2">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2_mini.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-2.jpg&#39;" class="figure_img 
																	 figure_type2 								 " id="Figure2">
						</a>
						<div class="figure_caption">
							<!-- 英文图题 -->
															<div>
									<span class="FigText" id="Figure2">
										<b>FIGURE&nbsp;2.</b>&nbsp;
									</span>
									Geo-temporal spread of COVID-19 in China through February 11, 2020. (A) a total of 14 county-level administrative areas (hereafter counties) in Hubei Province only (inset) had reported cases as of December 31, 2019; (B) by January 10, 2020, 113 counties in 20 PLADs had reported cases with the highest prevalence still in Hubei Province; (C) nine days later, on January 20, 627 counties in 30 PLADs had reported cases and PLADs neighboring Hubei Province observed increasing prevalence; (D) by the end of January 31, 1,310 counties across all 31 PLADs were affected and prevalence in the central, south, and south-central regions had risen dramatically; (E) by the end of February 11, 1,386 counties nationwide were affected and prevalence in the south-central PLADs had risen to the level of Hubei.
								</div>
														<!-- 图注释 -->
													</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button">
						<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
						<a href="javascript:void(0);" onclick="downloadImg(&#39;148a3fa4-3d7d-450c-a3ff-5c7bc2857d97&#39;,&#39;para&#39;)">Full-Size Img</a>
						<a href="javascript:void(0);" onclick="downloadPPT(&#39;148a3fa4-3d7d-450c-a3ff-5c7bc2857d97&#39;,&#39;para&#39;)" style="border-left: 1px solid #ccc;
    padding-left: 5px;">PowerPoint</a>
					</div>
					<!-- 下拉显示 -->
				</div>
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="12a67433-2eb2-4548-81a4-62b0ea09a211">As of February 11, 2020, a total 44,672 confirmed cases were reported from 1,386 counties of 31 provinces, autonomous regions, and municipalities and Hubei Province accounted for 74.7% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2E</a></span>). Among them, 0.2% of cases had onset of illness before December 31, 2019 and all were from Hubei Province (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2A</a></span>); 1.7% had onset of illness during January 1–10, 2020, distributed in 113 counties of 22 PLADs and Hubei Province accounted for 88.5% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2B</a></span>); 13.8% had onset of illness during January 11–20, 2020, distributed in 627 counties of 30 PLADs and Hubei Province accounted for 77.6% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2C</a></span>); 73.1% had onset of illness during January 21–31, 2020, distributed in 1310 counties of 31 PLADs and Hubei Province accounted for 74.7% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2D</a></span>).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="fb23820e-9aff-4637-92eb-8391d126ea30" level="2" sort="13" class="sec-title">
												Epidemiological Curve
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="8649763b-f4b9-472e-a53a-bf1be10dd4c7"><span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure3">Figure 3A</a></span> shows the COVID-19 epidemic curve with number of cases plotted by date of patient onset of symptoms from December 8, 2019 to February 11, 2020. Confirmed, suspected, clinically diagnosed, and asymptomatic cases are stacked to show total daily cases by date of symptom onset. The inset shows that in December 2019 only 0–22 cases/day began to experience symptoms. The peak onset of symptoms for all cases overall occurred on February 1, 2020. Since then, onset of illness has declined.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
									<!-- 图段落 -->
							
				<div class="_figclass figure" style="display:none;">
				 <span id="00a54dec-c9fd-4f29-8686-e8bcfd63ee9e" level="2" sort="13" class="sec-title"></span>
					<div class="figure_title figure_fulltext clearfix">
																		<a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg" title="FIGURE 3. Epidemiological curves of COVID-19 in China through February 11, 2020. (A) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020. A total of 72,314 cases are shown and confirmed cases (blue) are compared to suspected cases (green), clinically diagnosed cases (yellow), and asymptomatic cases (red). The inset shows a zoomed-in view of all days in December, when total daily count remained below 24 cases; (B) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020 for confirmed cases only (blue). The number of cases diagnosed each day is also shown for confirmed cases only (orange). The inset shows a zoomed-in view of all days in December, when total daily count remained below 15 cases." img_id="Fig-Figure3" img_ref="#Fig-Figure3">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3_mini.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-3.jpg&#39;" class="figure_img 
																	 figure_type2 								 " id="Figure3">
						</a>
						<div class="figure_caption">
							<!-- 英文图题 -->
															<div>
									<span class="FigText" id="Figure3">
										<b>FIGURE&nbsp;3.</b>&nbsp;
									</span>
									Epidemiological curves of COVID-19 in China through February 11, 2020. (A) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020. A total of 72,314 cases are shown and confirmed cases (blue) are compared to suspected cases (green), clinically diagnosed cases (yellow), and asymptomatic cases (red). The inset shows a zoomed-in view of all days in December, when total daily count remained below 24 cases; (B) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020 for confirmed cases only (blue). The number of cases diagnosed each day is also shown for confirmed cases only (orange). The inset shows a zoomed-in view of all days in December, when total daily count remained below 15 cases.
								</div>
														<!-- 图注释 -->
													</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button">
						<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
						<a href="javascript:void(0);" onclick="downloadImg(&#39;00a54dec-c9fd-4f29-8686-e8bcfd63ee9e&#39;,&#39;para&#39;)">Full-Size Img</a>
						<a href="javascript:void(0);" onclick="downloadPPT(&#39;00a54dec-c9fd-4f29-8686-e8bcfd63ee9e&#39;,&#39;para&#39;)" style="border-left: 1px solid #ccc;
    padding-left: 5px;">PowerPoint</a>
					</div>
					<!-- 下拉显示 -->
				</div>
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="fa705e88-ab79-45dd-bbd0-7b4d55b73db2"><span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure3">Figure 3B</a></span> shows the same COVID-19 epidemic curve for confirmed cases only with number of cases plotted by date of patients’ onset of symptoms from December 8, 2019 to February 11, 2020. These data are overlaid with confirmed cases plotted by date of diagnosis to show the lag between the time patients fall ill and the time they actually are diagnosed and are reported to the Infectious Disease Information System. Although for confirmed cases onset of illness peaked around January 23–27, diagnosis of infection by nucleic acid testing of throat swabs did not peak until February 4.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h4 class="navTitle navTitle2">
					<span id="08c69da6-cf6d-4f6d-a693-799b231ab229" level="2" sort="14" class="sec-title">
												Subgroup Findings
					</span>
				</h4>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="6bc22324-ed72-413f-8f8f-174144e22944"><span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure4">Figure 4</a></span> shows the COVID-19 epidemic curve with the number of cases plotted by date of onset of symptoms from December 18, 2019 to February 11, 2020 for two subgroups—confirmed cases found outside of Hubei Province (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure4">Figure 4A</a></span>) and all cases among health workers nationwide (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure4">Figure 4B</a></span>). Peak timing of onset of symptoms among cases outside of Hubei Province occurred on January 27. Most of these cases (85.8%) reported having recently resided in or visited Wuhan or having had close contact with an infected individual from Wuhan. Peak timing of onset of symptoms among health worker cases occurred on February 1. In the 422 medical facilities serving COVID-19 patients, a total of 3,019 health workers have been infected (1,716 confirmed cases), and 5 have died.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
									<!-- 图段落 -->
							
				<div class="_figclass figure" style="display:none;">
				 <span id="f0cc1a97-9ad7-4acb-8440-c542dea268aa" level="2" sort="14" class="sec-title"></span>
					<div class="figure_title figure_fulltext clearfix">
																		<a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg" title="FIGURE 4. Subgroup epidemiological curves of COVID-19 in China through February 11, 2020. (A) subgroup analysis of confirmed cases discovered outside of Hubei Province only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first case outside Hubei Province on December 18, 2019 through the end of February 11, 2020. Total confirmed cases outside Hubei Province, and Wuhan-related exposure (dark purple) versus Wuhan-unrelated exposure (light purple), are shown; (B) subgroup analysis of all cases among health workers only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first health worker case on December 27, 2019 through the end of February 11, 2020. Total cases among health workers and confirmed (blue) versus suspected (green), clinically diagnosed (yellow), and asymptomatic (red) cases are shown." img_id="Fig-Figure4" img_ref="#Fig-Figure4">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4_mini.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-4.jpg&#39;" class="figure_img 
																	 figure_type2 								 " id="Figure4">
						</a>
						<div class="figure_caption">
							<!-- 英文图题 -->
															<div>
									<span class="FigText" id="Figure4">
										<b>FIGURE&nbsp;4.</b>&nbsp;
									</span>
									Subgroup epidemiological curves of COVID-19 in China through February 11, 2020. (A) subgroup analysis of confirmed cases discovered outside of Hubei Province only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first case outside Hubei Province on December 18, 2019 through the end of February 11, 2020. Total confirmed cases outside Hubei Province, and Wuhan-related exposure (dark purple) versus Wuhan-unrelated exposure (light purple), are shown; (B) subgroup analysis of all cases among health workers only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first health worker case on December 27, 2019 through the end of February 11, 2020. Total cases among health workers and confirmed (blue) versus suspected (green), clinically diagnosed (yellow), and asymptomatic (red) cases are shown.
								</div>
														<!-- 图注释 -->
													</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button">
						<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
						<a href="javascript:void(0);" onclick="downloadImg(&#39;f0cc1a97-9ad7-4acb-8440-c542dea268aa&#39;,&#39;para&#39;)">Full-Size Img</a>
						<a href="javascript:void(0);" onclick="downloadPPT(&#39;f0cc1a97-9ad7-4acb-8440-c542dea268aa&#39;,&#39;para&#39;)" style="border-left: 1px solid #ccc;
    padding-left: 5px;">PowerPoint</a>
					</div>
					<!-- 下拉显示 -->
				</div>
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="d6e8f169-460a-416c-bdb4-57cd30b31974">Confirmed cases, case severity, and case fatality rates among health workers in different areas of China and different time periods are presented in <span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table2">Table 2</a></span>. A total of 1,080 confirmed cases among health workers have been found in Wuhan, accounting for 64.0% of national total. An additional 394 health worker cases (23.3%) were found in Hubei Province (excluding Wuhan), and 214 cases (12.7%) were found in the other 30 PLADs. The proportion of health worker cases that were severe or critical was 17.7% in Wuhan, 10.4% in Hubei Province, 7.0% in the remaining 30 PLADs, and 14.6% overall. The proportion of health worker cases in Wuhan classified as severe or critical declined from 38.9% in early January to 12.7% in early February. In China overall, the severe or critical cases among health workers also declined—from 45.0% in early January to 8.7% in early February.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
									<!-- 图段落 -->
						<!-- 表段落 -->
							
				<div class="figure table_new" style="display: none;">
				<span id="08c69da6-cf6d-4f6d-a693-799b231ab229" level="2" sort="14" class="sec-title">&nbsp;</span>
					<div class="article_table_fullText clearfix" ref="Table2">
																		<!--<a class="group4" href="#Table2_content" title="TABLE&nbsp;2.&nbsp;Confirmed cases, case severity, and case fatality rates among health workers in different areas of China by time period." id="Table2">
							<img src="http://weekly.chinacdc.cn:80/style/web/images/table-icon.gif"/>
						</a> -->
						<div class="table_caption">
						 	<!-- 英文图题 -->
						 									<div>
									<span class="TableText">
										<b>TABLE&nbsp;2.</b>&nbsp;
									</span>
					    			Confirmed cases, case severity, and case fatality rates among health workers in different areas of China by time period.
					       		</div>
				       								</div>
						<div id="Table2_content" class="table table_content">
							<div class="table-body 									                       table_type2	                        						    ">
								<table>
<thead><tr><td rowspan="2" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Period </b><br><b>(by date of onset)</b></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Wuhan</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Hubei (outside Wuhan)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (outside Hubei)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (overall)</b></td></tr><tr><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td></tr></thead>
<tbody><tr><td class="table_top_border2" style="font-size:7pt" align="left" valign="middle">Before Dec 31, 2019</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 1–10, 2020</td><td align="center" valign="middle" style="font-size:7pt">     18</td><td align="center" valign="middle" style="font-size:7pt">7 (38.9)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     20</td><td align="center" valign="middle" style="font-size:7pt">9 (45.0)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.0)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 11–20, 2020</td><td align="center" valign="middle" style="font-size:7pt">   233</td><td align="center" valign="middle" style="font-size:7pt">52 (22.3)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.4)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     48</td><td align="center" valign="middle" style="font-size:7pt">8 (16.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     29</td><td align="center" valign="middle" style="font-size:7pt">1 (3.4)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   310</td><td align="center" valign="middle" style="font-size:7pt">61 (19.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 21–31, 2020</td><td align="center" valign="middle" style="font-size:7pt">   656</td><td align="center" valign="middle" style="font-size:7pt">110 (16.8)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   250</td><td align="center" valign="middle" style="font-size:7pt">29 (11.6)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.8)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   130</td><td align="center" valign="middle" style="font-size:7pt">10 (7.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">1,036</td><td align="center" valign="middle" style="font-size:7pt">149 (14.4)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.2)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">After Feb 1, 2020</td><td align="center" valign="middle" style="font-size:7pt">   173</td><td align="center" valign="middle" style="font-size:7pt">22 (12.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     95</td><td align="center" valign="middle" style="font-size:7pt">3 (3.2)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     54</td><td align="center" valign="middle" style="font-size:7pt">3 (5.6)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   322</td><td align="center" valign="middle" style="font-size:7pt">28 (8.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr>  <tr><td class="table_bottom_border" style="font-size:7pt" align="left" valign="middle">Total</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,080</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">191 (17.7)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">3 (0.3)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   394</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">41 (10.4)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">2 (0.5)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   214</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">15 (7.0)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,688</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">247 (14.6)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">5 (0.3)</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="16">Abreviation: CFR, case-fatality rate.<br>* CFR presented here was calculated as number of deaths (numerator) divided by total number of confirmed cases in the row (denominator), expressed as a percent.</td></tr></tfoot>
</table>
							</div>
						</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button clear">
						<div class="table-csv-right fr" data-href="Table2">&nbsp;|&nbsp;Show Table</div>
						<div class="table-csv-left fr">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
							<a href="javascript:void(0);" onclick="downloadCsv(&#39;1e2a6c9c-4405-4fe6-9c73-8644b984f555&#39;,&#39;para&#39;)">CSV</a>
						</div>
					</div>
				</div>
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h3 class="navTitle navTitle2">
					<span id="154b2cb1-fa51-44f8-9bb4-a11cdda06b33" level="1" sort="15" class="sec-title">
												Discussion
					</span>
				</h3>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="ec91a14c-d80f-45ee-9176-e32e5ecb7c89">A main finding of this characterization and exploratory analysis of the first 72,314 cases of COVID-19 found in China in the 40 days between first recognition of the outbreak of pneumonia with unknown etiology on December 31, 2019 to the end of the study period on February 11, 2020 is that this novel coronavirus is highly contagious. It has spread extremely rapidly from a single city to the entire country within only about 30 days. Moreover, it has achieved such far-reaching effects even in the face of extreme response measures including the complete shutdown and isolation of whole cities, cancellation of Chinese New Year celebrations, prohibition of attendance at school and work, massive mobilization of health and public health personnel as well as military medical units, and rapid construction of entire hospitals.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="0fc8cac6-2a48-4d83-869b-da0d50084bcf">In light of this rapid spread, it is fortunate that COVID-19 has been mild for 81% of patients and has a very low overall case fatality rate of 2.3%. Among the 1,023 deaths, a majority have been ≥60 years of age and/or have had pre-existing, comorbid conditions such as hypertension, cardiovascular disease, and diabetes. Moreover, the case fatality rate is unsurprisingly highest among critical cases at 49%, and no deaths have occurred among those with mild or even severe symptoms (<span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table1">Table 1</a></span>).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="f0cd995a-7a11-4091-a0e3-c412f651d7d3">A major contribution of our study is a first description of the COVID-19 epidemic curves. We interpret the overall curve (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure3">Figure 3A</a></span>) as having a mixed outbreak pattern—the data appear to indicate a continuous common source pattern of spread in December and then from early January through February 11, 2020, the data appear to have a propagated source pattern. This mixed outbreak time trend is consistent with the working theory that perhaps several zoonotic events occurred at Huanan Seafood Wholesale Market in Wuhan allowed 2019-nCoV to be transmitted from a still-unknown animal into humans and, due to its high mutation and recombination rates, it adapted to become capable of and then increasingly efficient at human-to-human transmission (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>).</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="b6e31f56-5e0c-4bcf-a584-35daa92c1a0c">The early days of the outbreak have been reminiscent of SARS and MERS, and indeed, the discovery that the causative agent was a closely-related, never-before-described coronavirus predicted potential for nosocomial transmission and so-called “super-spreader” events (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>). Unfortunately, 2019-nCoV did indeed infect health workers in China via nosocomial transmission. Here we offer a first description of the 1,716 confirmed cases among health workers. Overall, they also display a likely mixed outbreak pattern—perhaps the data are characterized by a point source curve beginning in late December 2019, which was eclipsed by a higher magnitude continuous source curve beginning on January 20, 2020. To date, there is no evidence of a super-spreader event occurring in any of the Chinese health facilities serving COVID-19 patients. However, we do not know whether this is due to the nature of the virus itself or whether these events have been successfully prevented.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="81b3a955-a722-4a07-b226-0b7eb3077019">It is these authors’ sincere hope and intent that this new analysis, on what has become a “public health emergency of international concern,” (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b12">12</a></span>) helps to inform health and public health workers preparing for or perhaps already experiencing COVID-19 in their populations. This study provides important insight into several crucial open questions on this epidemic and how to design strategies to effectively control it (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>). For instance, the downward trend in the overall epidemic curve suggests that perhaps isolation of whole cities, broadcast of critical information (e.g., promoting hand washing, mask wearing, and care seeking) with high frequency through multiple channels, and mobilization of a multi-sector rapid response teams is helping to curb the epidemic.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="7a5421f4-6289-4617-bbcb-29a99f65a8c5">China’s response is certainly an echo of lessons learned during SARS and is a tribute to the work China and other low- and middle-income countries have been doing, with the much-needed help of international partners, over the past few decades to build infectious disease surveillance systems and public health infrastructure capable of catching outbreaks early and responding swiftly using evidence-based best practices. The 2019-nCoV and other coronaviruses may continue to adapt over time to become more virulent (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>), and zoonosis is not going to stop. We must remain vigilant, hone our skills, fund our defenses, and practice our responses, and we must help our neighbors to do the same.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="1d6d9bb3-7e78-4287-b58c-332e1acfeab4">The very large number of cases included in our study was a major strength. Nevertheless, our study did have some important limitations. Firstly, a large proportion of cases included in our analysis (37%) were not confirmed by nucleic acid testing since this process is slow, labor intensive, and requires specialized equipment and skilled technicians. Yet all 72,314 cases were at least diagnosed clinically and investigated by trained epidemiologists. Secondly, some records did have missing data for a few important variables of interest—Wuhan-related exposure, comorbid conditions, and case severity—which limits our ability to draw conclusions from the data.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="568ad511-04d1-401c-bb08-9ddc914e5474">In conclusion, the present descriptive, exploratory analysis of the first 72,314 cases of COVID-19 reported through February 11, 2020 offers important new information to the international community on the epidemic in China. In particular, this analysis chronicles the extremely rapid spread of the novel coronavirus despite extreme efforts to contain it. However, important questions remain including identification of the animal reservoir, determination of infectiousness period, identification of transmission routes, and effective treatment and prevention methods including further test development, drug development, and vaccine development (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b4">4</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b9">9</a></span>). As an international community, we must all be responsible partners in surveillance, communication, response, research, and implementation of evidence-based public health and clinical practice. The massive vigorous actions taken by the Chinese government have slowed down the epidemic in China and curbed spread to the rest of the world. Although the epidemic appears to be in decline in the lead up to February 11, 2020, we may yet face more challenges. Huge numbers of people will soon be returning to work and school after the extended New Year holiday. We need to prepare for a possible rebound of the COVID-19 epidemic in the coming weeks and months.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
			<!-- 输出章节标题 start -->
									<h3 class="navTitle navTitle2">
					<span id="65e75123-979e-4ca4-a265-b2598d1c602e" level="1" sort="16" class="sec-title">
												Acknowledgements
					</span>
				</h3>
							<!-- 输出章节标题 end -->
		<!-- 输出章节下的段落内容start -->
					<!-- 普通段落 -->
							<p id="8b04e711-4d44-4a12-a6f5-57e025cf8db3">This work was supported by National Science and Technology Foundation of China (2018ZX10201002-008-002), and by National Nature Science Foundation of China (NSFC, 71934002). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="4a7d70c9-7c68-42cc-ad88-8e7a14232aca">The team thanks all local health workers for their contributions in providing testing, treatment, and care to COVID-19 patients in China.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="fc68e203-a575-4937-9545-b2c1d756c9df"><b>Disclaimer: </b> The opinions expressed herein reflect the collective views of the co-authors and do not necessarily represent the official position of the National Center for AIDS/STD Control and Prevention of the Chinese Center for Disease Control and Prevention.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="d9431f33-430f-4cc1-9eda-2731e458a29e">In order to share the results of epidemiological characteristics of COVID-19 domestically and internationally, the Chinese Versionis jointly published on the <i>Chinese Journal of Epidemiology</i>.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
								<!-- 普通段落 -->
							<p id="26aa36f9-abb6-4cf8-ac4c-8543cb0bf77c"><b>Author Group &amp; Contributions:</b> The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team includes Zijian Feng, Qun Li, Yanping Zhang<sup>#</sup>, Zunyou Wu, Xiaoping Dong, Huilai Ma, Dapeng Yin, Ke Lyu, Dayan Wang, Lei Zhou, Ruiqi Ren, Chao Li, Yali Wang, Dan Ni, Jing Zhao, Bin Li, Rui Wang, Yan Niu, Xiaohua Wang, Lijie Zhang, Jingfang Sun, Boxi Liu, Zhiqiang Deng, Zhitao Ma, Yang Yang, Hui Liu, Ge Shao, Huan Li, Yuan Liu, Hangjie Zhang, Shuquan Qu, Wei Lou, Dou Shan, Yuehua Hu, Lei Hou, Zhenping Zhao, Jiangmei Liu, Hongyuan Wang, Yuanjie Pang, Yuting Han, Qiuyue Ma, Yujia Ma, Shi Chen, Wei Li, Routong Yang, Zhewu Li, Yingnan Guo, Xinran Liu, Bahabaike Jiangtulu, Zhaoxue Yin, Juan Xu, Shuo Wang, Lin Xiao, Tao Xu, Limin Wang, Xiao Qi, Guoqing Shi, Wenxiao Tu, Xiaomin Shi, Xuemei Su, Zhongjie Li, Huiming Luo, Jiaqi Ma, Jennifer M. McGoogan. All Team members jointly conceptualized the study, analyzed and interpreted the data, wrote and revised the manuscript, and decided to submit for publication.</p>
									<!-- 图段落 -->
						<!-- 表段落 -->
						<!-- box段落 -->
							<!-- 输出章节下的段落内容end -->
		<!-- 致谢 -->
		</li>
                <!-- Reported by: -->
                <!-- Reported by: -->              
                 <ul class="about-author" id="affiliations">                     
                        </ul>
                    <ul class="about-article">
                        <li>
                                 <b>Corresponding author:</b>
                                    <!--The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team,&nbsp;<a class="" href="mailto:zhangyp@chinacdc.cn">zhangyp@chinacdc.cn</a>-->Yanping Zhang, <a href="mailto:zhangyp@chinacdc.cn">zhangyp@chinacdc.cn</a></li>
                            <li class="com-author-info">  
                       		 <b>Online Date: </b>February 17 2020</li>
                       <li class="com-author-info">                      
                            </li>
                    </ul>
                 <li id="References" class="articleListBox">
	                    <h3 class="navTitle" id="References-list">References</h3>
	                    <div class="References-wrap" style="word-break:break-all;">
	<table class="reference-tab">
		<tbody><tr class="document-box" id="b1">
				<td valign="top" class="td1" style="width:28px;">
	                    [1]
	                </td>
				<td class="td2">
					Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan, China: Wuhan Municipal Health Commission. <a href="http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989" target="_blank">http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989</a>. [2019-12-31]. (In Chinese).<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989">http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989</a> </span></td>
			</tr>
		<tr class="document-box" id="b2">
				<td valign="top" class="td1" style="width:28px;">
	                    [2]
	                </td>
				<td class="td2">
					World Health Organization. Novel coronavirus – China. Geneva, Switzerland: World Health Organization. <a href="https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/" target="_blank">https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/</a>. [2020-01-12].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/">https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/</a> </span></td>
			</tr>
		<tr class="document-box" id="b3">
				<td valign="top" class="td1" style="width:28px;">
	                    [3]
	                </td>
				<td class="td2">
					Wang C, Hornby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. <a href="http://dx.doi.org/10.1016/S0140-6736(20)30185-9" target="_blank">http://dx.doi.org/10.1016/S0140-6736(20)30185-9</a>. [2020-01-24].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1016/S0140-6736(20)30185-9">http://dx.doi.org/10.1016/S0140-6736(20)30185-9</a> </span></td>
			</tr>
		<tr class="document-box" id="b4">
				<td valign="top" class="td1" style="width:28px;">
	                    [4]
	                </td>
				<td class="td2">
					Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91(2020):264 − 6. <a href="http://dx.doi.org/10.1016/j.ijid.2020.01.009" target="_blank" class="referenceDoi">http://dx.doi.org/10.1016/j.ijid.2020.01.009</a><a href="https://doi.org/10.1016/j.ijid.2020.01.009" target="blank" class="crossRefA"><span class="crossRefText">CrossRef</span><span class="crossRefImg"><img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/icoreference.png"></span></a>
					  </td>
			</tr>
		<tr class="document-box" id="b5">
				<td valign="top" class="td1" style="width:28px;">
	                    [5]
	                </td>
				<td class="td2">
					Zhu N, Zhang D, Wang W, Li XW, Yang B, Song JD, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. <a href="http://dx.doi.org/10.1056/NEJMoa2001017" target="_blank">http://dx.doi.org/10.1056/NEJMoa2001017</a>. [2020-01-24].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1056/NEJMoa2001017">http://dx.doi.org/10.1056/NEJMoa2001017</a> </span></td>
			</tr>
		<tr class="document-box" id="b6">
				<td valign="top" class="td1" style="width:28px;">
	                    [6]
	                </td>
				<td class="td2">
					Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan SF, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbs Infect. <a href="http://dx.doi.org/10.1080/22221751.2020.1719902" target="_blank">http://dx.doi.org/10.1080/22221751.2020.1719902</a>. [2020-01-24].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1080/22221751.2020.1719902">http://dx.doi.org/10.1080/22221751.2020.1719902</a> </span></td>
			</tr>
		<tr class="document-box" id="b7">
				<td valign="top" class="td1" style="width:28px;">
	                    [7]
	                </td>
				<td class="td2">
					Tan WJ, Zhao X, Ma XJ, Wang WL, Niu PH, Xu WB, et al. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019−2020. China CDC Weekly 2020;2(4): 61-2. <a href="http://weekly.chinacdc.cn/en/article/ccdcw/2020/4/61" target="_blank">http://weekly.chinacdc.cn/en/article/ccdcw/2020/4/61</a>.<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://weekly.chinacdc.cn/en/article/ccdcw/2020/4/61">http://weekly.chinacdc.cn/en/article/ccdcw/2020/4/61</a> </span></td>
			</tr>
		<tr class="document-box" id="b8">
				<td valign="top" class="td1" style="width:28px;">
	                    [8]
	                </td>
				<td class="td2">
					Paules CI, Marston HD, Fauci AS. Coronavirus infection—more than just the common cold. JAMA. <a href="http://dx.doi.org/10.1001/jama.2020.0757" target="_blank">http://dx.doi.org/10.1001/jama.2020.0757</a>. [2020-01-23].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1001/jama.2020.0757">http://dx.doi.org/10.1001/jama.2020.0757</a> </span></td>
			</tr>
		<tr class="document-box" id="b9">
				<td valign="top" class="td1" style="width:28px;">
	                    [9]
	                </td>
				<td class="td2">
					Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China – key questions for impact assessment. N Engl J Med. <a href="http://dx.doi.org/10.1056/NEJMp2000929" target="_blank">http://dx.doi.org/10.1056/NEJMp2000929</a>.[2020-01-24].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1056/NEJMp2000929">http://dx.doi.org/10.1056/NEJMp2000929</a> </span></td>
			</tr>
		<tr class="document-box" id="b10">
				<td valign="top" class="td1" style="width:28px;">
	                    [10]
	                </td>
				<td class="td2">
					Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. <a href="http://dx.doi.org/10.1016/S0140-6736(20)30183-5" target="_blank">http://dx.doi.org/10.1016/S0140-6736(20)30183-5</a>. [2020-01-24]<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1016/S0140-6736(20)30183-5">http://dx.doi.org/10.1016/S0140-6736(20)30183-5</a> </span></td>
			</tr>
		<tr class="document-box" id="b11">
				<td valign="top" class="td1" style="width:28px;">
	                    [11]
	                </td>
				<td class="td2">
					Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. <a href="http://dx.doi.org/10.1016/S0140-6736(20)30154-9" target="_blank">http://dx.doi.org/10.1016/S0140-6736(20)30154-9</a>. [2020-01-24].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="http://dx.doi.org/10.1016/S0140-6736(20)30154-9">http://dx.doi.org/10.1016/S0140-6736(20)30154-9</a> </span></td>
			</tr>
		<tr class="document-box" id="b12">
				<td valign="top" class="td1" style="width:28px;">
	                    [12]
	                </td>
				<td class="td2">
					World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, Switzerland: World Health Organization. <a href="https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)" target="_blank">https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</a>. [2020-01-30].<span class="referenceOldSpan"><a class="referenceOldA" target="_blank" href="https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)">https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</a> </span></td>
			</tr>
		</tbody></table>
</div></li>
	                <!--Figure/Table-->
					 <li class="article-box article-chart" id="figTab">
							


    <meta name="renderer" content="webkit">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">


<div class="_figclass figure">
            <div class="figureTextBox">
                <div>
                    <a class="" title="FIGURE 1. Age distribution and sex ratio of all confirmed COVID-19 cases in China through February 11, 2020. (A) patients diagnosed in the city of Wuhan only; (B) patients diagnosed in Hubei Province, which includes Wuhan as its capital city; and (C) patients diagnosed in China overall, including Hubei Province and all 30 other provincial-level administrative divisions (PLADs). Dashed red line highlights the proportion of patients in the 30–79 years age range. Sex ratio (i.e. male-to-female [M:F] ratio) is shown below each graph." href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg">
								<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-1.jpg&#39;" class="figure_img  figure_type2 " id="Fig-Figure1" ref="#Fig-Figure1">
							</a>
						</div>
                <div class="figureTitle">
                    <!-- 英文图题 -->
                    <p class="figTabSpan">
							<span class="FigText" id="Figure1">
								<b>FIGURE&nbsp;1.</b>&nbsp;
							</span>
							Age distribution and sex ratio of all confirmed COVID-19 cases in China through February 11, 2020. (A) patients diagnosed in the city of Wuhan only; (B) patients diagnosed in Hubei Province, which includes Wuhan as its capital city; and (C) patients diagnosed in China overall, including Hubei Province and all 30 other provincial-level administrative divisions (PLADs). Dashed red line highlights the proportion of patients in the 30–79 years age range. Sex ratio (i.e. male-to-female [M:F] ratio) is shown below each graph.</p>
						
                    </div>
            </div>
            <!-- 下拉显示 -->
			<div class="figure_button">
				<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">Download: 
				<a href="javascript:void(0);" onclick="downloadImg(&#39;ce156d55-4c32-44ba-82fa-81c56589ee58&#39;,&#39;figure&#39;)">Full-Size Img</a>
				<a href="javascript:void(0);" onclick="downloadPPT(&#39;ce156d55-4c32-44ba-82fa-81c56589ee58&#39;,&#39;figure&#39;)" style="border-left: 1px solid #ccc;padding-left: 5px;">PowerPoint</a>						
			</div>
			<!-- 下拉显示 -->		
        </div>
       	<div class="_figclass figure">
            <div class="figureTextBox">
                <div>
                    <a class="" title="FIGURE 2. Geo-temporal spread of COVID-19 in China through February 11, 2020. (A) a total of 14 county-level administrative areas (hereafter counties) in Hubei Province only (inset) had reported cases as of December 31, 2019; (B) by January 10, 2020, 113 counties in 20 PLADs had reported cases with the highest prevalence still in Hubei Province; (C) nine days later, on January 20, 627 counties in 30 PLADs had reported cases and PLADs neighboring Hubei Province observed increasing prevalence; (D) by the end of January 31, 1,310 counties across all 31 PLADs were affected and prevalence in the central, south, and south-central regions had risen dramatically; (E) by the end of February 11, 1,386 counties nationwide were affected and prevalence in the south-central PLADs had risen to the level of Hubei." href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg">
								<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-2.jpg&#39;" class="figure_img  figure_type2 " id="Fig-Figure2" ref="#Fig-Figure2">
							</a>
						</div>
                <div class="figureTitle">
                    <!-- 英文图题 -->
                    <p class="figTabSpan">
							<span class="FigText" id="Figure2">
								<b>FIGURE&nbsp;2.</b>&nbsp;
							</span>
							Geo-temporal spread of COVID-19 in China through February 11, 2020. (A) a total of 14 county-level administrative areas (hereafter counties) in Hubei Province only (inset) had reported cases as of December 31, 2019; (B) by January 10, 2020, 113 counties in 20 PLADs had reported cases with the highest prevalence still in Hubei Province; (C) nine days later, on January 20, 627 counties in 30 PLADs had reported cases and PLADs neighboring Hubei Province observed increasing prevalence; (D) by the end of January 31, 1,310 counties across all 31 PLADs were affected and prevalence in the central, south, and south-central regions had risen dramatically; (E) by the end of February 11, 1,386 counties nationwide were affected and prevalence in the south-central PLADs had risen to the level of Hubei.</p>
						
                    </div>
            </div>
            <!-- 下拉显示 -->
			<div class="figure_button">
				<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">Download: 
				<a href="javascript:void(0);" onclick="downloadImg(&#39;dbe4612b-45f3-4a3a-93a3-223ba653d2bd&#39;,&#39;figure&#39;)">Full-Size Img</a>
				<a href="javascript:void(0);" onclick="downloadPPT(&#39;dbe4612b-45f3-4a3a-93a3-223ba653d2bd&#39;,&#39;figure&#39;)" style="border-left: 1px solid #ccc;padding-left: 5px;">PowerPoint</a>						
			</div>
			<!-- 下拉显示 -->		
        </div>
       	<div class="_figclass figure">
            <div class="figureTextBox">
                <div>
                    <a class="" title="FIGURE 3. Epidemiological curves of COVID-19 in China through February 11, 2020. (A) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020. A total of 72,314 cases are shown and confirmed cases (blue) are compared to suspected cases (green), clinically diagnosed cases (yellow), and asymptomatic cases (red). The inset shows a zoomed-in view of all days in December, when total daily count remained below 24 cases; (B) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020 for confirmed cases only (blue). The number of cases diagnosed each day is also shown for confirmed cases only (orange). The inset shows a zoomed-in view of all days in December, when total daily count remained below 15 cases." href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg">
								<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-3.jpg&#39;" class="figure_img  figure_type2 " id="Fig-Figure3" ref="#Fig-Figure3">
							</a>
						</div>
                <div class="figureTitle">
                    <!-- 英文图题 -->
                    <p class="figTabSpan">
							<span class="FigText" id="Figure3">
								<b>FIGURE&nbsp;3.</b>&nbsp;
							</span>
							Epidemiological curves of COVID-19 in China through February 11, 2020. (A) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020. A total of 72,314 cases are shown and confirmed cases (blue) are compared to suspected cases (green), clinically diagnosed cases (yellow), and asymptomatic cases (red). The inset shows a zoomed-in view of all days in December, when total daily count remained below 24 cases; (B) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020 for confirmed cases only (blue). The number of cases diagnosed each day is also shown for confirmed cases only (orange). The inset shows a zoomed-in view of all days in December, when total daily count remained below 15 cases.</p>
						
                    </div>
            </div>
            <!-- 下拉显示 -->
			<div class="figure_button">
				<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">Download: 
				<a href="javascript:void(0);" onclick="downloadImg(&#39;6f1f49a5-7d61-4d1e-a234-8e1fe1434e55&#39;,&#39;figure&#39;)">Full-Size Img</a>
				<a href="javascript:void(0);" onclick="downloadPPT(&#39;6f1f49a5-7d61-4d1e-a234-8e1fe1434e55&#39;,&#39;figure&#39;)" style="border-left: 1px solid #ccc;padding-left: 5px;">PowerPoint</a>						
			</div>
			<!-- 下拉显示 -->		
        </div>
       	<div class="_figclass figure">
            <div class="figureTextBox">
                <div>
                    <a class="" title="FIGURE 4. Subgroup epidemiological curves of COVID-19 in China through February 11, 2020. (A) subgroup analysis of confirmed cases discovered outside of Hubei Province only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first case outside Hubei Province on December 18, 2019 through the end of February 11, 2020. Total confirmed cases outside Hubei Province, and Wuhan-related exposure (dark purple) versus Wuhan-unrelated exposure (light purple), are shown; (B) subgroup analysis of all cases among health workers only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first health worker case on December 27, 2019 through the end of February 11, 2020. Total cases among health workers and confirmed (blue) versus suspected (green), clinically diagnosed (yellow), and asymptomatic (red) cases are shown." href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg">
								<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-4.jpg&#39;" class="figure_img  figure_type2 " id="Fig-Figure4" ref="#Fig-Figure4">
							</a>
						</div>
                <div class="figureTitle">
                    <!-- 英文图题 -->
                    <p class="figTabSpan">
							<span class="FigText" id="Figure4">
								<b>FIGURE&nbsp;4.</b>&nbsp;
							</span>
							Subgroup epidemiological curves of COVID-19 in China through February 11, 2020. (A) subgroup analysis of confirmed cases discovered outside of Hubei Province only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first case outside Hubei Province on December 18, 2019 through the end of February 11, 2020. Total confirmed cases outside Hubei Province, and Wuhan-related exposure (dark purple) versus Wuhan-unrelated exposure (light purple), are shown; (B) subgroup analysis of all cases among health workers only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first health worker case on December 27, 2019 through the end of February 11, 2020. Total cases among health workers and confirmed (blue) versus suspected (green), clinically diagnosed (yellow), and asymptomatic (red) cases are shown.</p>
						
                    </div>
            </div>
            <!-- 下拉显示 -->
			<div class="figure_button">
				<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">Download: 
				<a href="javascript:void(0);" onclick="downloadImg(&#39;0a807ce1-3669-445d-ba1a-f8c62d7622ee&#39;,&#39;figure&#39;)">Full-Size Img</a>
				<a href="javascript:void(0);" onclick="downloadPPT(&#39;0a807ce1-3669-445d-ba1a-f8c62d7622ee&#39;,&#39;figure&#39;)" style="border-left: 1px solid #ccc;padding-left: 5px;">PowerPoint</a>						
			</div>
			<!-- 下拉显示 -->		
        </div>
       	<div class="figure table">
        	<div class="figureTitle" style="margin-top:0;">
				<!-- 中文表题 -->
				<!-- 英文表题 -->
				<p class="figTabSpan">
						<span class="TableText  figure_type2 " id="Table1">
							<b>TABLE&nbsp;1.</b>&nbsp;
						</span>
						Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020.</p>
				</div>
			<div class="article_table_fullText clearfix tableTextBox" id="Fig-Table1" ref="#Fig-Table1">
				<input id="basePath" type="hidden" value="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/">	
					<div class="table-body table_content">
					<table>
<thead>  <tr><td class="table_top_border" align="center" valign="middle"><b>Baseline characteristics</b></td><td class="table_top_border" align="center" valign="middle"><b>Confirmed cases,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Deaths,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Case fatality </b><br><b>rate, %</b></td><td class="table_top_border" align="center" valign="middle"><b>Observed time,</b><br><b> PD</b></td><td class="table_top_border" align="center" valign="middle"><b>Mortality,</b><br><b> per 10 PD</b> </td></tr></thead>
<tbody><tr><td class="table_top_border2" align="left" valign="middle">Overall</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:20pt" align="center" valign="middle">  44,672</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:30pt" align="center" valign="middle">1,023</td><td class="table_top_border2" align="center" valign="middle">  2.3</td><td class="table_top_border2" align="center" valign="middle">661,609</td><td class="table_top_border2" align="center" valign="middle">0.015</td></tr><tr><td align="left" valign="middle">Age, years</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　0–9</td><td align="center" valign="middle">416 (0.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">    4,383</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　10–19</td><td align="center" valign="middle">549 (1.2)</td><td align="center" valign="middle">1 (0.1)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">    6,625</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　20–29</td><td align="center" valign="middle">3,619 (8.1)</td><td align="center" valign="middle">7 (0.7)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">  53,953</td><td align="center" valign="middle">0.001</td></tr><tr><td align="left" valign="middle">　30–39</td><td align="center" valign="middle">7,600 (17.0)</td><td align="center" valign="middle">18 (1.8)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">114,550</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　40–49</td><td align="center" valign="middle">8,571 (19.2)</td><td align="center" valign="middle">38 (3.7)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">128,448</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">　50–59</td><td align="center" valign="middle">10,008 (22.4)</td><td align="center" valign="middle">130 (12.7)</td><td align="center" valign="middle">  1.3</td><td align="center" valign="middle">151,059</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　60–69</td><td align="center" valign="middle">8,583 (19.2)</td><td align="center" valign="middle">309 (30.2)</td><td align="center" valign="middle">  3.6</td><td align="center" valign="middle">128,088</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　70–79</td><td align="center" valign="middle">3,918 (8.8)</td><td align="center" valign="middle">312 (30.5)</td><td align="center" valign="middle">  8.0</td><td align="center" valign="middle">  55,832</td><td align="center" valign="middle">0.056</td></tr><tr><td align="left" valign="middle">　≥80</td><td align="center" valign="middle">1,408 (3.2)</td><td align="center" valign="middle">208 (20.3)</td><td align="center" valign="middle">14.8</td><td align="center" valign="middle">  18,671</td><td align="center" valign="middle">0.111</td></tr><tr><td align="left" valign="middle">Sex</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Male</td><td align="center" valign="middle">22,981 (51.4)</td><td align="center" valign="middle">653 (63.8)</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">342,063</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">　Female</td><td align="center" valign="middle">21,691 (48.6)</td><td align="center" valign="middle">370 (36.2)</td><td align="center" valign="middle">  1.7</td><td align="center" valign="middle">319,546</td><td align="center" valign="middle">0.012</td></tr><tr><td align="left" valign="middle">Occupation</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Service industry</td><td align="center" valign="middle">3,449 (7.7)</td><td align="center" valign="middle">23 (2.2)</td><td align="center" valign="middle">  0.7</td><td align="center" valign="middle">  54,484</td><td align="center" valign="middle">0.004</td></tr>   <tr><td align="left" valign="middle">　Farmer/laborer</td><td align="center" valign="middle">9,811 (22.0)</td><td align="center" valign="middle">139 (13.6)</td><td align="center" valign="middle">  1.4</td><td align="center" valign="middle">137,992</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">　Health worker </td><td align="center" valign="middle">1,716 (3.8)</td><td align="center" valign="middle">5 (0.5)</td><td align="center" valign="middle">  0.3</td><td align="center" valign="middle">  28,069</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　Retiree</td><td align="center" valign="middle">9,193 (20.6)</td><td align="center" valign="middle">472 (46.1)</td><td align="center" valign="middle">  5.1</td><td align="center" valign="middle">137,118</td><td align="center" valign="middle">0.034</td></tr><tr><td align="left" valign="middle">　Other/none</td><td align="center" valign="middle">20,503 (45.9)</td><td align="center" valign="middle">384 (37.5)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">303,946</td><td align="center" valign="middle">0.013</td></tr>     <tr><td align="left" valign="middle">Province</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hubei</td><td align="center" valign="middle">33,367 (74.7)</td><td align="center" valign="middle">979 (95.7)</td><td align="center" valign="middle">  2.9</td><td align="center" valign="middle">496,523</td><td align="center" valign="middle">0.020</td></tr><tr><td align="left" valign="middle">　Other</td><td align="center" valign="middle">11,305 (25.3)</td><td align="center" valign="middle">44 (4.3)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">165,086</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">Wuhan-related exposure*</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Yes</td><td align="center" valign="middle">31,974 (85.8)</td><td align="center" valign="middle">853 (92.8)</td><td align="center" valign="middle">  2.7</td><td align="center" valign="middle">486,612</td><td align="center" valign="middle">0.018</td></tr><tr><td align="left" valign="middle">　No</td><td align="center" valign="middle">5,295 (14.2)</td><td align="center" valign="middle">66 (7.2)</td><td align="center" valign="middle">  1.2</td><td align="center" valign="middle">  71,201</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">    7,403</td><td align="center" valign="middle">104</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">103,796</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">Comorbid condition<sup>†</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hypertension</td><td align="center" valign="middle">2,683 (12.8)</td><td align="center" valign="middle">161 (39.7)</td><td align="center" valign="middle">  6.0</td><td align="center" valign="middle">  42,603</td><td align="center" valign="middle">0.038</td></tr><tr><td align="left" valign="middle">　Diabetes</td><td align="center" valign="middle">1,102 (5.3)</td><td align="center" valign="middle">80 (19.7)</td><td align="center" valign="middle">  7.3</td><td align="center" valign="middle">  17,940</td><td align="center" valign="middle">0.045</td></tr><tr><td align="left" valign="middle">　Cardiovascular disease</td><td align="center" valign="middle">873 (4.2)</td><td align="center" valign="middle">92 (22.7)</td><td align="center" valign="middle">10.5</td><td align="center" valign="middle">  13,533</td><td align="center" valign="middle">0.068</td></tr><tr><td align="left" valign="middle">　Chronic respiratory disease</td><td align="center" valign="middle">511 (2.4)</td><td align="center" valign="middle">32 (7.9)</td><td align="center" valign="middle">  6.3</td><td align="center" valign="middle">    8,083</td><td align="center" valign="middle">0.040</td></tr><tr><td align="left" valign="middle">　Cancer (any)</td><td align="center" valign="middle">107 (0.5)</td><td align="center" valign="middle">6 (1.5)</td><td align="center" valign="middle">  5.6</td><td align="center" valign="middle">    1,690</td><td align="center" valign="middle">0.036</td></tr><tr><td align="left" valign="middle">　None</td><td align="center" valign="middle">15,536 (74.0)</td><td align="center" valign="middle">133 (32.8)</td><td align="center" valign="middle">  0.9</td><td align="center" valign="middle">242,948</td><td align="center" valign="middle">0.005</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">23,690 (53.0)</td><td align="center" valign="middle">617 (60.3)</td><td align="center" valign="middle">  2.6</td><td align="center" valign="middle">331,843</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">Case severity<sup>§</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Mild</td><td align="center" valign="middle">36,160 (80.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Severe</td><td align="center" valign="middle">6,168 (13.8)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Critical</td><td align="center" valign="middle">2,087 (4.7)</td><td align="center" valign="middle">1,023 (100)</td><td align="center" valign="middle">49.0</td><td align="center" valign="middle">  31,456</td><td align="center" valign="middle">0.325</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">257 (0.6)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">Period (by date of onset)</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Before Dec 31, 2019</td><td align="center" valign="middle">104 (0.2)</td><td align="center" valign="middle">15 (1.5)</td><td align="center" valign="middle">14.4</td><td align="center" valign="middle">    5,142</td><td align="center" valign="middle">0.029</td></tr><tr><td align="left" valign="middle">　Jan 1–10, 2020</td><td align="center" valign="middle">653 (1.5)</td><td align="center" valign="middle">102 (10.0)</td><td align="center" valign="middle">15.6</td><td align="center" valign="middle">  21,687</td><td align="center" valign="middle">0.047</td></tr><tr><td align="left" valign="middle">　Jan 11–20, 2020</td><td align="center" valign="middle">5,417 (12.1)</td><td align="center" valign="middle">310 (30.3)</td><td align="center" valign="middle">  5.7</td><td align="center" valign="middle">130,972</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　Jan 21–31, 2020</td><td align="center" valign="middle">26,468 (59.2)</td><td align="center" valign="middle">494 (48.3)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">416,009</td><td align="center" valign="middle">0.012</td></tr><tr><td class="table_bottom_border" align="left" valign="middle">　After Feb 1, 2020</td><td class="table_bottom_border" align="center" valign="middle">12,030 (26.9)</td><td class="table_bottom_border" align="center" valign="middle">102 (10.0)</td><td class="table_bottom_border" align="center" valign="middle">  0.8</td><td class="table_bottom_border" align="center" valign="middle">  87,799</td><td class="table_bottom_border" align="center" valign="middle">0.012</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="6">Abreviation: PD, person-days. -, not applicable.<br>* The Wuhan-related exposure variable, only includes a total of 37,269 patients and 919 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>†</sup> The comorbid condition variable, only includes a total of 20,812 patients and 504 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>§</sup> The case severity variable, only includes a total of 44,415 patients and 1,023 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.</td></tr></tfoot>
</table></div>
			</div>
			<!-- 下拉显示 -->
			<div class="figure_button">
				<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">
				Download: <a onclick="downloadCsv(&#39;d91ab65a-695c-4f49-9add-55b074abc361&#39;,&#39;table&#39;)">CSV</a>
			</div>
		</div>
    <div class="figure table">
        	<div class="figureTitle" style="margin-top:0;">
				<!-- 中文表题 -->
				<!-- 英文表题 -->
				<p class="figTabSpan">
						<span class="TableText  figure_type2 " id="Table2">
							<b>TABLE&nbsp;2.</b>&nbsp;
						</span>
						Confirmed cases, case severity, and case fatality rates among health workers in different areas of China by time period.</p>
				</div>
			<div class="article_table_fullText clearfix tableTextBox" id="Fig-Table2" ref="#Fig-Table2">
				<input id="basePath" type="hidden" value="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/">	
					<div class="table-body table_content">
					<table>
<thead><tr><td rowspan="2" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Period </b><br><b>(by date of onset)</b></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Wuhan</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Hubei (outside Wuhan)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (outside Hubei)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (overall)</b></td></tr><tr><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td></tr></thead>
<tbody><tr><td class="table_top_border2" style="font-size:7pt" align="left" valign="middle">Before Dec 31, 2019</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 1–10, 2020</td><td align="center" valign="middle" style="font-size:7pt">     18</td><td align="center" valign="middle" style="font-size:7pt">7 (38.9)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     20</td><td align="center" valign="middle" style="font-size:7pt">9 (45.0)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.0)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 11–20, 2020</td><td align="center" valign="middle" style="font-size:7pt">   233</td><td align="center" valign="middle" style="font-size:7pt">52 (22.3)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.4)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     48</td><td align="center" valign="middle" style="font-size:7pt">8 (16.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     29</td><td align="center" valign="middle" style="font-size:7pt">1 (3.4)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   310</td><td align="center" valign="middle" style="font-size:7pt">61 (19.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 21–31, 2020</td><td align="center" valign="middle" style="font-size:7pt">   656</td><td align="center" valign="middle" style="font-size:7pt">110 (16.8)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   250</td><td align="center" valign="middle" style="font-size:7pt">29 (11.6)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.8)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   130</td><td align="center" valign="middle" style="font-size:7pt">10 (7.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">1,036</td><td align="center" valign="middle" style="font-size:7pt">149 (14.4)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.2)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">After Feb 1, 2020</td><td align="center" valign="middle" style="font-size:7pt">   173</td><td align="center" valign="middle" style="font-size:7pt">22 (12.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     95</td><td align="center" valign="middle" style="font-size:7pt">3 (3.2)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     54</td><td align="center" valign="middle" style="font-size:7pt">3 (5.6)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   322</td><td align="center" valign="middle" style="font-size:7pt">28 (8.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr>  <tr><td class="table_bottom_border" style="font-size:7pt" align="left" valign="middle">Total</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,080</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">191 (17.7)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">3 (0.3)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   394</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">41 (10.4)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">2 (0.5)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   214</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">15 (7.0)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,688</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">247 (14.6)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">5 (0.3)</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="16">Abreviation: CFR, case-fatality rate.<br>* CFR presented here was calculated as number of deaths (numerator) divided by total number of confirmed cases in the row (denominator), expressed as a percent.</td></tr></tfoot>
</table></div>
			</div>
			<!-- 下拉显示 -->
			<div class="figure_button">
				<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">
				Download: <a onclick="downloadCsv(&#39;4a8e373a-95e7-4cae-890b-a0297e67bde4&#39;,&#39;table&#39;)">CSV</a>
			</div>
		</div>
    

</li>
                    <li id="Supplements" class="articleListBox">

                    </li>
        <!-- 访问统计 -->
        <!--  <li id="metric_count" class="articleListBox">
            <h3 class="navTitle" id="Access-list">Proportional views</h3>             
            <img id="downLoading" style="display:block;margin:10px auto;" src="http://weekly.chinacdc.cn:80/style/web/images/public/1.gif" alt="加载中" />
            <div class="hichart_box" id="article_visit_count_column"></div>
            <div class="hichart_box" id="article_visit_type_pie"></div>
            <div class="hichart_box" id="article_visit_area_pie"></div>
        </li>
        -->
        <li>
	        <script defer="" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/trendmd.min.js.download" data-trendmdconfig="{&quot;journal_id&quot;:&quot;59917&quot;,&quot;element&quot;:&quot;#trendmd-suggestions&quot;}"></script></li>
        <li id="citedby-info" class="articleListBox"></li>
        </ul>
        
        
       
        <div class="article-header">
                <p class="quot">
                </p><div class="copyCitationInfo" style="width: 0px;height: 0px;opacity:0;overflow: hidden;">The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020[J]. China CDC Weekly, 2020, 2(8): 113-122.</div>
                <table class="article-tab">
                    <tbody><tr>
                        <td valign="top" width="70"><span class=""><b>Citation:</b></span></td>
                        <td>
                            <span class="info" id="infoEn">										The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020[J]. <i>China CDC Weekly</i>, 2020, 2(8): 113-122. 								</span>
                            <div class="modal-footer">
									<span class="copy-citation" onclick="copyArticle2(this)" title="copy to clipboard">
										<img class="shu" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/shu.png" alt="shu">
									</span>
                            </div>
                        </td>
                    </tr>
                </tbody></table>


                <p></p>
            </div>
        
        
        <div class=" contentArea-left-bg">
        <div class="article-footer"></div>
        <!--鼠标点击悬浮框-->
        <div class="box box-top box-tan">
            <div class="box-tan-con">
				<table class="box-content reference-tab"></table>
			</div>
            <div class="triangle">
                <div class="triangle-bg"></div>
                <div class="triangle-content"></div>
            </div>
            <i class="close-box articleFont icon-cuo"></i>
        </div>
        <!--鼠标点击author悬浮框-->
        <div class="author-box">
            <div class="author-content">
                <h6>
                    <span>通讯作者: </span>陈斌, bchen63@163.com
                </h6>
                <ul>
                    <li><span class="">1.&nbsp;</span>
                        <p class="">沈阳化工大学材料科学与工程学院 沈阳 110142</p></li>
                </ul>
                <p></p>
                <ol>
                    <li><a href="http://weekly.chinacdc.cn/en/article/id/search?q=">本站搜索</a>
                    </li>
                    <li><a href="http://xueshu.baidu.com/s?wd=author:(%E5%8F%B6%E7%A4%BA%E8%88%9F)&amp;tn=SE_baiduxueshu_c1gjeupa&amp;bs=&amp;ie=utf-8&amp;sc_f_para=sc_tasktype%3D%7BfirstAdvancedSearch%7D" "="">百度学术搜索</a>
                    </li>
                    <li><a href="http://s.wanfangdata.com.cn/Paper.aspx?q=%E4%BD%9C%E8%80%85%3A%E5%8F%B6%E7%A4%BA%E8%88%9F&amp;f=top">万方数据库搜索</a>
                    </li>
                    <li><a href="http://scholar.cnki.net/result.aspx?q=%E4%BD%9C%E8%80%85%3A%28%E5%8F%B6%E7%A4%BA%E8%88%9F%29&amp;rt=Journal&amp;rl=&amp;udb=">CNKI搜索</a>
                    </li>
                </ol>
            </div>
            <div class="triangle">
                <div class="triangle-bg"></div>
                <div class="triangle-content"></div>
            </div>
            <i class="close-box articleFont icon-cuo"></i>
        </div>
    </div>
        
        
        
    </div>
    <div class="article-main-right fr active" style="right: 366.5px; height: 833px;">
        <!-- 图集 -->
        <div class="article-right">
        	<!--<div class="article-right-pic">
                    <ul class="article-imgs">
                        <li class="first"></li>
                        <li class="second"></li>
                        <li class="atlas">
                            <a href="javascript:void(0);">
                                <img src="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-1.jpg"
                                                     onerror="this.onerror=null;this.src='/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-1.jpg'"/>
                                            </a>
                        </li>
                    </ul>
                    <p>
                        <span class="articleFont icon-tuce"></span>
                        <span class="show-tu">Figures(<span class="mainColor">4</span>)</span>&nbsp;/&nbsp;<span class="show-biao">Tables(<span class="mainColor">2</span>)</span></p>
                </div>
            
            -->
            <div class="content-nav">
             	    <a class="switchFormula" href="javascript:;" onclick="switchFormula();" style="display: none;">Turn off MathJax</a>
                    <div class="contents-title">Article Contents</div>
                  
                    <div class="Abstract-left-list">
                        <a href="javascript:;"></a>
                    </div>
                    <div class="jumplink-list">
                    	
                    		
                    	
                    <div class="div1 textHidden"><a href="javascript:;">Abstract</a></div><div class="div1 textHidden"><a href="javascript:;">Introduction</a></div><div class="div1 textHidden"><a href="javascript:;">Method</a><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Study Design</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Data Source</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Variables</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Analysis</a></div></div><div class="div1 textHidden"><a href="javascript:;">Results</a><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Patients</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Deaths, Case Fatality Rates, and Mortality</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Age Distribution and Sex Ratio</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Geo-Temporal Findings</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Epidemiological Curve</a></div><div class="div2 textHidden" style="display: none;"><a href="javascript:;">Subgroup Findings</a></div></div><div class="div1 textHidden"><a href="javascript:;">Discussion</a></div><div class="div1 textHidden"><a href="javascript:;">Acknowledgements</a></div></div>
                         <div class="References-left-list active">
                        <a href="javascript:;">References</a>
                    </div>
                    <div class="Supplements-left-list">
                        <a href="javascript:;"></a>
                    </div>
					<div class="FigureOrTable"><div class="div1 textHidden"><a href="javascript:;">FIGURE1</a></div><div class="div1 textHidden"><a href="javascript:;">FIGURE2</a></div><div class="div1 textHidden"><a href="javascript:;">FIGURE3</a></div><div class="div1 textHidden"><a href="javascript:;">FIGURE4</a></div><div class="div1 textHidden"><a href="javascript:;">TABLE1</a></div><div class="div1 textHidden"><a href="javascript:;">TABLE2</a></div></div>
                </div>
           		 <div class="article-detail-right">
                	
                <br>
                <div class="download-btns clear-size">
                     <!--  <div class="download-btn"><a href="javascript:void(0);" data-target="#exportCitationModal" data-toggle="modal">
                        Get Citation</a></div>
                     <div class="pdf-xml clearfix">
                         <div class="download-pdf fl"><a href="javascript:void(0);" onclick="downloadpdf('e53946e2-c6c4-41e9-9a9b-fea8db1a8f51');">
                        PDF</a></div>
                        <div class="download-xml fr"><a href="javascript:void(0);" onclick="toExportXML('e53946e2-c6c4-41e9-9a9b-fea8db1a8f51');">
                        XML</a></div>
                     </div>
                     -->
                      <div class="pdf-xml clearfix">
                         <div class="download-pdf fl"><a href="javascript:void(0);" data-target="#exportCitationModal" data-toggle="modal">
                        Get Citation</a></div>
                        <div class="download-xml fr"><a href="javascript:void(0);" onclick="downloadpdf(&#39;e53946e2-c6c4-41e9-9a9b-fea8db1a8f51&#39;);">
                        PDF</a></div>
                     </div>
                     <div class="all-pdf">
                    </div>
                   
                </div>

                <div class="metrics">
                	<h2>Article Metrics</h2>
                    <div style="padding:10px 0;display:none;" data-badge-type="donut" data-doi="" data-hide-no-mentions="false" class="altmetric-embed" data-uuid="d80a2251-5e50-6732-9c34-b7df474b3e3b"></div>
                    <div style="padding:5px 0;" class="altmetric-embed" data-badge-popover="left" data-doi="" data-uuid="eccb549c-bb38-df14-ebb0-9f6f707a49ab"></div>
                    <p class="all-message">
                        <span style="display: block;" href="javascript:void(0);">Article views(<span class="mainColor">508089</span>)</span>
                        <!--
                        <span style="display: block;" href="javascript:void(0);">HTML views(<span class="mainColor">250</span>)</span>
                          -->
                        <span style="display: block;" href="javascript:void(0);">PDF downloads(<span class="mainColor">22566</span>)</span>
                        <span style="display: none;" href="javascript:void(0);">Cited by(<span class="mainColor" id="citedByCount"></span>)</span>


                        <!--
                         
                        -->
                        <!--
                        <a href="#">Received: 14 February 2020</a>
                        <a href="#">Revised manuscript received: </a>
                        <a href="#">Published in print: 01 February 2020</a>
                         -->
                    </p>
                </div>
                <!-- <div class="article-metrics">
                    <h6>Metrics</h6>
                    <ul class="browse-count">
                         <li>PDF Downloads(<span class="mainColor">22566</span>)</li>
                        <li>Abstract views(<span class="mainColor">508089</span>)</li>

                        <li>HTML views(<span class="mainColor">250</span>)</li>
                    </ul>


                      <div class="ijac-tab">
                        <ol></ol>
                        <ol></ol>
                        <ol></ol>
                    </div>
                </div>-->
                <div class="article-metrics">
                	<h6>Related</h6>
	                    <div class="trend-right-list">
	                        <a href="javascript:;">
	                            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/trend_03.jpg">
	                        </a>
	                    </div>
                    </div>
                
                <!--  <div class="article-metrics Access-right-list">
                    <a href="#Access-list">
                        <h6>Proportional views</h6>
                        <div class="img">
                            <img src="http://weekly.chinacdc.cn:80/style/web/images/public/Access-list_03.jpg"/>
                        </div>
                    </a>
                </div>-->
                
            </div>
        </div>
    </div>
    
    
    
</div>
</div>




</div>
<!--电脑端 结束-->
<!--手机端 开始-->
<div class="article-app">
	<div id="panel" class="main">
    <!--英文摘要-->
    <section class="articleEn">
        <h2>The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020</h2><!--作者-->
        <ul class="article-author clear">            
                <li>
			                <a onclick="searchLike(&quot;authorNameEn&quot;,&quot;The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team&quot;);" href="javascript:void(0);">The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team</a><sup class="authorTag"><a href="javascript:void(0);" class="com-user" title="Corresponding author: The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, zhangyp@chinacdc.cn"></a>,&nbsp;<a href="mailto:zhangyp@chinacdc.cn" class="com-mail" title="mailto: zhangyp@chinacdc.cn"></a></sup></li>
		           </ul>
        
         <!--摘要-->
        <div class="summary">
          <!--  -->
          
              
			
        </div>        
                      
			<!--通讯作者-->
        
        <h6 class="navTitle" id="about-articletit-app" style="padding-top:15px;"><b>Author Affiliation</b></h6>
        <ul class="about-author" id="articleAffiliations">
      
           
            <h6><b>Corresponding author: </b>
            <p style="margin-bottom:2px;display:inline-block;">Yanping Zhang, <a href="mailto:zhangyp@chinacdc.cn">zhangyp@chinacdc.cn</a><!--The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team,&nbsp;<a class="mainColor" href="mailto:zhangyp@chinacdc.cn">zhangyp@chinacdc.cn</a>--></p>
                    
                </h6>
               <h6> 
                       		 <b>Online Date: </b>February 17 2020</h6>
                       <h6 style="margin:8px 0 3px;">
         
            
            
             </h6>
        </ul>
        <!-- 稿件日期 -->
        <!--  <ul class="article-date">
            <li><b>Accepted:</b>
                    2020-02-14</li>
            <li><b>Available Online:</b>
                    2020-02-01</li>
            </ul>-->
        <!-- 英文基金项目 -->
        </section>

    <!--主页内容-->
    <section class="article-content FullText-all">
        <ul id="htmlContent2" class="current">
            <!--鼠标点击悬浮框-->
            <div class="box box-top box-tan">
                <table class="box-content reference-tab"></table>
                <div class="triangle">
                    <div class="triangle-bg"></div>
                    <div class="triangle-content"></div>
                </div>
                <i class="close-box articleFont icon-cuo"></i>
            </div>
            <h3 class="full-text navTitle">HTML</h3>
            <!--<details>-->
            <!--<summary></summary>-->
            <!--</details>-->
            <!-- 遍历章节列表 -->
            <!-- 输出章节标题 start -->
                <figure vid="s01">
                                <figcaption class="mainColor navTitle">
                                    Abstract</figcaption>
                                <ul class="group">

                        <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s01">
                    <!-- 普通段落 -->
                        <p id="90afd8bf-1ded-4f42-a378-d5834a4036f2">
                            <b>Background:</b> An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, Hubei Province, China has spread quickly nationwide. Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="4c053d95-9380-482b-9abe-4eb92c6a9b4e">
                            <b>Methods:</b> All COVID-19 cases reported through February 11, 2020 were extracted from China’s Infectious Disease Information System. Analyses included the following: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality and mortality rates; 4) geo-temporal analysis of viral spread; 5) epidemiological curve construction; and 6) subgroup analysis.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="04b3e991-c0a1-4aea-8919-0dd707810f8d">
                            <b>Results:</b> A total of 72,314 patient records—44,672 (61.8%) confirmed cases, 16,186 (22.4%) suspected cases, 10,567 (14.6%) clinically diagnosed cases (Hubei Province only), and 889 asymptomatic cases (1.2%)—contributed data for the analysis. Among confirmed cases, most were aged 30–79 years (86.6%), diagnosed in Hubei (74.7%), and considered mild (80.9%). A total of 1,023 deaths occurred among confirmed cases for an overall case fatality rate of 2.3%. The COVID-19 spread outward from Hubei Province sometime after December 2019, and by February 11, 2020, 1,386 counties across all 31 provinces were affected. The epidemic curve of onset of symptoms peaked around January 23–26, then began to decline leading up to February 11. A total of 1,716 health workers have become infected and 5 have died (0.3%).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="ef99e70d-3146-45ef-bcaf-526b3d00c686">
                            <b>Conclusions: </b> COVID-19 epidemic has spread very quickly taking only 30 days to expand from Hubei to the rest of Mainland China. With many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                </ul>
        </figure>
        <figure vid="s01_1">
            <figcaption class="mainColor navTitle">
                Introduction</figcaption>
            <ul class="group">
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s01_1">
                    <!-- 普通段落 -->
                        <p id="7c953e6b-b627-4984-ae62-7810f579d94f">
                            A cluster of pneumonia cases of unknown origin in Wuhan, China caused concern among health officials in late December 2019. On December 31, an alert was issued by the Wuhan Municipal Health Commission, a rapid response team was sent to Wuhan by the Chinese Center for Disease Control and Prevention (China CDC), and a notification was made to the World Health Organization (WHO) (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b1">1</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b4">4</a></span>). Likely potential causes including influenza, avian influenza, adenovirus, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) were ruled out. Epidemiological investigation implicated Wuhan’s Huanan Seafood Wholesale Market, which was shut down and disinfected, and active case finding was initiated and vigorously pursued (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b2">2</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b4">4</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b5">5</a></span>).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="c09adf89-4ae9-4180-a439-4a979b8510e0">
                            On January 7, 2020, the causative pathogen was identified as a novel coronavirus, and genomic characterization and test method development ensued (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b2">2</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b6">6</a></span>). Now named 2019-nCoV, the virus is distinct from both SARS-CoV and MERS-CoV, yet closely related (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b5">5</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b7">7</a></span>). Early cases suggested that COVID-19 (i.e. the new name for disease caused by the novel coronavirus) may be less severe than SARS and MERS. However, illness onset among rapidly increasing numbers of people and mounting evidence of human-to-human transmission suggests that 2019-nCoV is more contagious than both SARS-CoV and MERS-CoV (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>-<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b11">11</a></span>).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="664a053e-8c1e-4940-ae12-202f09f90870">
                            On January 20, China’s “<i>National Infectious Diseases Law</i>” was amended to make 2019-novel coronavirus diseases (COVID-19) a Class B notifiable disease and its “<i>Frontier Health and Quarantine Law</i>” was amended to support the COVID-19 outbreak response effort. Then, on January 23, the Chinese Government began to limit movement of people in and out of Wuhan, and two days later, it announced its highest-level commitment and mobilized all sectors to respond to the epidemic and prevent further spread of COVID-19. Characterization of the epidemiological features of COVID-19 is crucial for the development and implementation of effective control strategies. Here, we report the results of a descriptive, exploratory analysis of all cases found through February 11, 2020.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                </ul>
        </figure>
        <figure vid="s02">
            <figcaption class="mainColor navTitle">
                Method</figcaption>
            <ul class="group">
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <!-- 输出章节标题 start -->
                <!-- <figure vid="s02">2
                        <figcaption class="mainColor">
                            Study Design</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s02">
                        Study Design</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s02">
                    <!-- 普通段落 -->
                        <p id="bbb8c2fb-eb02-49e6-99c4-911159a28a2f">
                            This study was a descriptive, exploratory analysis of all cases of COVID-19 diagnosed nationwide in China as of the end of February 11, 2020. As such, it in some respects uses a cross-sectional study design and hence, we have used the STROBE Guidelines (<a href="http://weekly.chinacdc.cn/en/article/id/www.equator-network.org" target="_blank">www.equator-network.org</a>) to aid our thorough reporting of this observational study.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="bf0fe962-b8f4-4490-88c6-6be90c0f7d2e">
                            A public health emergency was declared, and a formal investigation began on December 31, 2019, supported by city (Wuhan Municipal Health Commission and Wuhan CDC), provincial (Health Commission of Hubei Province and Hubei Provincial CDC), and national (National Health Commission and China CDC) authorities and resources. This study was reviewed by the China CDC Institutional Review Board via a fast-track mechanism. Although individual informed consent was not required for this study, all data were handled as a deidentified set to protect patient privacy and confidentiality.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s02">2
                        <figcaption class="mainColor">
                            Data Source</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s02">
                        Data Source</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s02">
                    <!-- 普通段落 -->
                        <p id="d278b4a7-68aa-4eff-9636-c334e215de5b">
                            By categorizing COVID-19 as a Class B notifiable disease, Chinese law required all cases to be immediately reported to China’s Infectious Disease Information System. Entry of each case into the system was performed by local epidemiologists and public health workers who investigated and collected information on possible exposures. All case records contain national identification numbers, and therefore, all cases have records in the system and no records are duplicated. All data contained in all COVID-19 case records in the Infectious Disease Information System through the end of February 11, 2020 were extracted from the system as a single dataset and were then stripped of all personal identifying information. No sampling was done to achieve a predetermined study size and no eligibility criteria were used—all cases were included.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s02">2
                        <figcaption class="mainColor">
                            Variables</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s02">
                        Variables</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s02">
                    <!-- 普通段落 -->
                        <p id="63c34c11-ef04-4bc1-813c-2ec7e5f8d902">
                            Patient characteristics were collected at baseline, meaning the time of diagnosis, epidemiological investigation, and entry into the Infectious Disease Information System. Patients were categorized as health workers for the occupation variable if they had active employment of any kind in a health facility (i.e. this category did not just include physicians and nurses). Patients were categorized as having a Wuhan-related exposure if they had recently resided in or visited Wuhan or if they had close contact with someone who had. The comorbid conditions variable was determined upon epidemiological investigation by patient self-reported medical history, which was not independently verified using medical records for all cases. The severity of symptoms variable was categorized as mild, severe, or critical. Mild included non-pneumonia and mild pneumonia cases. Severe was characterized by dyspnea, respiratory frequency ≥30/minute, blood oxygen saturation ≤93%, PaO<sub>2</sub>/FiO<sub>2</sub> ratio &lt;300, and/or lung infiltrates &gt;50% within 24–48 hours. Critical cases were those that exhibited respiratory failure, septic shock, and/or multiple organ dysfunction/failure.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="6a9210c3-c7da-4981-8e80-9b17b424bf8a">
                            As some variables of interest (i.e., Wuhan-related exposure, comorbid condition, and case severity) are not required fields when creating records in the Infectious Disease Information System, some records have missing data for these variables.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="b3b0029a-b78b-458c-9556-f5974870fa55">
                            For construction of epidemiological curves, date of onset was defined as the date on which patients self-reported the start of either fever or cough during epidemiological investigation. Cases were categorized as confirmed, suspected, clinically diagnosed (Hubei Province only), or asymptomatic. Confirmed cases were diagnosed based on positive viral nucleic acid test results on throat swab samples (some samples were tested retrospectively). Suspected cases were diagnosed clinically based on symptoms and exposures. Clinically diagnosed cases were suspected cases with lung imaging features consistent with coronavirus pneumonia. Asymptomatic cases were diagnosed based on positive viral nucleic acid test results but without any COVID-19 symptoms (e.g., fever, dry cough). The date of positive viral nucleic acid test result is used as onset date for asymptomatic cases</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s02">2
                        <figcaption class="mainColor">
                            Analysis</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s02">
                        Analysis</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s02">
                    <!-- 普通段落 -->
                        <p id="3f3d3579-ffd3-4386-afd6-add6fdad137f">
                            For confirmed cases, demographic and clinical characteristics were summarized using descriptive statistics. Age distribution graphs were constructed using patient age at baseline for confirmed cases diagnosed in Wuhan, Hubei Province (including Wuhan), and China (including Hubei Province). Sex ratio (i.e., male:female [M:F] ratio) was also calculated. Case fatality rates were calculated as the total number of deaths (numerator) divided by the total number of cases (denominator), expressed as a percent. Observed time was summarized using person-days (PD) and mortality was calculated as the number of deaths (numerator) divided by the total observed time (denominator), expressed per 10 PD.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="f05a1e04-5871-462c-9eba-112d699491fa">
                            For geo-temporal analysis, the county-level location of each case at time of diagnosis was used to build color-coded maps of China to indicate the numbers of cases in each province on December 31, 2019; January 10, 2020; January 31, 2020; and February 11, 2020. This analysis was performed using ArcGIS Desktop software (version 10.6; Esri; Redlands, California, USA).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="30f74db4-8499-4249-aed7-4e26390fe8af">
                            The epidemiological curve for all cases was constructed by plotting the number of cases (y-axis) versus self-reported date of symptom onset (x-axis). Date of symptom onset for confirmed, suspected, clinically diagnosed, and asymptomatic cases were stacked to show total cases over time. The epidemiological curve for confirmed cases was also overlaid with the number of cases versus date of diagnosis to show the delay between onset of symptoms and diagnosis of disease.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="06ef0567-6954-4b28-a128-e5dea19e2c79">
                            Two subgroups were also analyzed separately using epidemiological curves: confirmed cases diagnosed outside of Hubei Province (with and without Wuhan-related exposure) and all cases diagnosed among health workers (confirmed, suspected, clinically diagnosed, and asymptomatic).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                </ul>
        </figure>
        <figure vid="s05">
            <figcaption class="mainColor navTitle">
                Results</figcaption>
            <ul class="group">
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <!-- 输出章节标题 start -->
                <!-- <figure vid="s05">2
                        <figcaption class="mainColor">
                            Patients</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s05">
                        Patients</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s05">
                    <!-- 普通段落 -->
                        <p id="47099661-afea-4332-a8e1-329bc8bdf71f">
                            A total of 72,314 unique records were extracted and data from all records were included in the analysis. Thus, all 72,314 individuals diagnosed with COVID-19 as of February 11, 2020, were included in the analysis. Among them, 44,672 cases (61.8%) were confirmed, 16,186 cases (22.4%) were suspected, 10,567 cases (14.6%) were clinically diagnosed, and 889 cases (1.2%) were asymptomatic.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="6c67d4f2-e0a1-428b-85e6-c61e11c58560">
                            Baseline characteristics of confirmed cases (n=44,672) are presented in <span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table1">Table 1</a></span>. A majority were aged 30–69 years (77.8%), male (51.4%), farmers or laborers (22.0%), and diagnosed in Hubei Province (74.7%). Most patients reported Wuhan-related exposures (85.8%) and were classified as mild cases (80.9%).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <div class="figure">
                                <div class="table-body">
                                    <input id="basePath" type="hidden" value="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/">
                                        <div class="table-body table_content">
                                    <table>
<thead>  <tr><td class="table_top_border" align="center" valign="middle"><b>Baseline characteristics</b></td><td class="table_top_border" align="center" valign="middle"><b>Confirmed cases,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Deaths,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Case fatality </b><br><b>rate, %</b></td><td class="table_top_border" align="center" valign="middle"><b>Observed time,</b><br><b> PD</b></td><td class="table_top_border" align="center" valign="middle"><b>Mortality,</b><br><b> per 10 PD</b> </td></tr></thead>
<tbody><tr><td class="table_top_border2" align="left" valign="middle">Overall</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:20pt" align="center" valign="middle">  44,672</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:30pt" align="center" valign="middle">1,023</td><td class="table_top_border2" align="center" valign="middle">  2.3</td><td class="table_top_border2" align="center" valign="middle">661,609</td><td class="table_top_border2" align="center" valign="middle">0.015</td></tr><tr><td align="left" valign="middle">Age, years</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　0–9</td><td align="center" valign="middle">416 (0.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">    4,383</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　10–19</td><td align="center" valign="middle">549 (1.2)</td><td align="center" valign="middle">1 (0.1)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">    6,625</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　20–29</td><td align="center" valign="middle">3,619 (8.1)</td><td align="center" valign="middle">7 (0.7)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">  53,953</td><td align="center" valign="middle">0.001</td></tr><tr><td align="left" valign="middle">　30–39</td><td align="center" valign="middle">7,600 (17.0)</td><td align="center" valign="middle">18 (1.8)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">114,550</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　40–49</td><td align="center" valign="middle">8,571 (19.2)</td><td align="center" valign="middle">38 (3.7)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">128,448</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">　50–59</td><td align="center" valign="middle">10,008 (22.4)</td><td align="center" valign="middle">130 (12.7)</td><td align="center" valign="middle">  1.3</td><td align="center" valign="middle">151,059</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　60–69</td><td align="center" valign="middle">8,583 (19.2)</td><td align="center" valign="middle">309 (30.2)</td><td align="center" valign="middle">  3.6</td><td align="center" valign="middle">128,088</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　70–79</td><td align="center" valign="middle">3,918 (8.8)</td><td align="center" valign="middle">312 (30.5)</td><td align="center" valign="middle">  8.0</td><td align="center" valign="middle">  55,832</td><td align="center" valign="middle">0.056</td></tr><tr><td align="left" valign="middle">　≥80</td><td align="center" valign="middle">1,408 (3.2)</td><td align="center" valign="middle">208 (20.3)</td><td align="center" valign="middle">14.8</td><td align="center" valign="middle">  18,671</td><td align="center" valign="middle">0.111</td></tr><tr><td align="left" valign="middle">Sex</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Male</td><td align="center" valign="middle">22,981 (51.4)</td><td align="center" valign="middle">653 (63.8)</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">342,063</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">　Female</td><td align="center" valign="middle">21,691 (48.6)</td><td align="center" valign="middle">370 (36.2)</td><td align="center" valign="middle">  1.7</td><td align="center" valign="middle">319,546</td><td align="center" valign="middle">0.012</td></tr><tr><td align="left" valign="middle">Occupation</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Service industry</td><td align="center" valign="middle">3,449 (7.7)</td><td align="center" valign="middle">23 (2.2)</td><td align="center" valign="middle">  0.7</td><td align="center" valign="middle">  54,484</td><td align="center" valign="middle">0.004</td></tr>   <tr><td align="left" valign="middle">　Farmer/laborer</td><td align="center" valign="middle">9,811 (22.0)</td><td align="center" valign="middle">139 (13.6)</td><td align="center" valign="middle">  1.4</td><td align="center" valign="middle">137,992</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">　Health worker </td><td align="center" valign="middle">1,716 (3.8)</td><td align="center" valign="middle">5 (0.5)</td><td align="center" valign="middle">  0.3</td><td align="center" valign="middle">  28,069</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　Retiree</td><td align="center" valign="middle">9,193 (20.6)</td><td align="center" valign="middle">472 (46.1)</td><td align="center" valign="middle">  5.1</td><td align="center" valign="middle">137,118</td><td align="center" valign="middle">0.034</td></tr><tr><td align="left" valign="middle">　Other/none</td><td align="center" valign="middle">20,503 (45.9)</td><td align="center" valign="middle">384 (37.5)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">303,946</td><td align="center" valign="middle">0.013</td></tr>     <tr><td align="left" valign="middle">Province</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hubei</td><td align="center" valign="middle">33,367 (74.7)</td><td align="center" valign="middle">979 (95.7)</td><td align="center" valign="middle">  2.9</td><td align="center" valign="middle">496,523</td><td align="center" valign="middle">0.020</td></tr><tr><td align="left" valign="middle">　Other</td><td align="center" valign="middle">11,305 (25.3)</td><td align="center" valign="middle">44 (4.3)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">165,086</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">Wuhan-related exposure*</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Yes</td><td align="center" valign="middle">31,974 (85.8)</td><td align="center" valign="middle">853 (92.8)</td><td align="center" valign="middle">  2.7</td><td align="center" valign="middle">486,612</td><td align="center" valign="middle">0.018</td></tr><tr><td align="left" valign="middle">　No</td><td align="center" valign="middle">5,295 (14.2)</td><td align="center" valign="middle">66 (7.2)</td><td align="center" valign="middle">  1.2</td><td align="center" valign="middle">  71,201</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">    7,403</td><td align="center" valign="middle">104</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">103,796</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">Comorbid condition<sup>†</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hypertension</td><td align="center" valign="middle">2,683 (12.8)</td><td align="center" valign="middle">161 (39.7)</td><td align="center" valign="middle">  6.0</td><td align="center" valign="middle">  42,603</td><td align="center" valign="middle">0.038</td></tr><tr><td align="left" valign="middle">　Diabetes</td><td align="center" valign="middle">1,102 (5.3)</td><td align="center" valign="middle">80 (19.7)</td><td align="center" valign="middle">  7.3</td><td align="center" valign="middle">  17,940</td><td align="center" valign="middle">0.045</td></tr><tr><td align="left" valign="middle">　Cardiovascular disease</td><td align="center" valign="middle">873 (4.2)</td><td align="center" valign="middle">92 (22.7)</td><td align="center" valign="middle">10.5</td><td align="center" valign="middle">  13,533</td><td align="center" valign="middle">0.068</td></tr><tr><td align="left" valign="middle">　Chronic respiratory disease</td><td align="center" valign="middle">511 (2.4)</td><td align="center" valign="middle">32 (7.9)</td><td align="center" valign="middle">  6.3</td><td align="center" valign="middle">    8,083</td><td align="center" valign="middle">0.040</td></tr><tr><td align="left" valign="middle">　Cancer (any)</td><td align="center" valign="middle">107 (0.5)</td><td align="center" valign="middle">6 (1.5)</td><td align="center" valign="middle">  5.6</td><td align="center" valign="middle">    1,690</td><td align="center" valign="middle">0.036</td></tr><tr><td align="left" valign="middle">　None</td><td align="center" valign="middle">15,536 (74.0)</td><td align="center" valign="middle">133 (32.8)</td><td align="center" valign="middle">  0.9</td><td align="center" valign="middle">242,948</td><td align="center" valign="middle">0.005</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">23,690 (53.0)</td><td align="center" valign="middle">617 (60.3)</td><td align="center" valign="middle">  2.6</td><td align="center" valign="middle">331,843</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">Case severity<sup>§</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Mild</td><td align="center" valign="middle">36,160 (80.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Severe</td><td align="center" valign="middle">6,168 (13.8)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Critical</td><td align="center" valign="middle">2,087 (4.7)</td><td align="center" valign="middle">1,023 (100)</td><td align="center" valign="middle">49.0</td><td align="center" valign="middle">  31,456</td><td align="center" valign="middle">0.325</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">257 (0.6)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">Period (by date of onset)</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Before Dec 31, 2019</td><td align="center" valign="middle">104 (0.2)</td><td align="center" valign="middle">15 (1.5)</td><td align="center" valign="middle">14.4</td><td align="center" valign="middle">    5,142</td><td align="center" valign="middle">0.029</td></tr><tr><td align="left" valign="middle">　Jan 1–10, 2020</td><td align="center" valign="middle">653 (1.5)</td><td align="center" valign="middle">102 (10.0)</td><td align="center" valign="middle">15.6</td><td align="center" valign="middle">  21,687</td><td align="center" valign="middle">0.047</td></tr><tr><td align="left" valign="middle">　Jan 11–20, 2020</td><td align="center" valign="middle">5,417 (12.1)</td><td align="center" valign="middle">310 (30.3)</td><td align="center" valign="middle">  5.7</td><td align="center" valign="middle">130,972</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　Jan 21–31, 2020</td><td align="center" valign="middle">26,468 (59.2)</td><td align="center" valign="middle">494 (48.3)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">416,009</td><td align="center" valign="middle">0.012</td></tr><tr><td class="table_bottom_border" align="left" valign="middle">　After Feb 1, 2020</td><td class="table_bottom_border" align="center" valign="middle">12,030 (26.9)</td><td class="table_bottom_border" align="center" valign="middle">102 (10.0)</td><td class="table_bottom_border" align="center" valign="middle">  0.8</td><td class="table_bottom_border" align="center" valign="middle">  87,799</td><td class="table_bottom_border" align="center" valign="middle">0.012</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="6">Abreviation: PD, person-days. -, not applicable.<br>* The Wuhan-related exposure variable, only includes a total of 37,269 patients and 919 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>†</sup> The comorbid condition variable, only includes a total of 20,812 patients and 504 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>§</sup> The case severity variable, only includes a total of 44,415 patients and 1,023 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.</td></tr></tfoot>
</table></div>
                                </div>
                                <div class="figTitle">
                                    <!-- 英文表题 -->
                                    <p class="figTitleEn" id="Table1">
                                            <b>Table&nbsp;1.</b>&nbsp;
                                            Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020.</p>
                                    </div>
                            </div>
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s05">2
                        <figcaption class="mainColor">
                            Deaths, Case Fatality Rates, and Mortality</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s05">
                        Deaths, Case Fatality Rates, and Mortality</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s05">
                    <!-- 普通段落 -->
                        <p id="ad0909b4-d417-4b98-86ec-dbf829f96f4d">
                            As shown in <span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table1">Table 1</a></span>, a total of 1,023 deaths have occurred among 44,672 confirmed cases for an overall case fatality rate of 2.3%. Additionally, these 1,023 deaths occurred during 661,609 PD of observed time, for a mortality rate of 0.015/10 PD.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="0b7c3c13-befb-4992-8218-f08a7756d773">
                            The ≥80 age group had the highest case fatality rate of all age groups at 14.8%. Case fatality rate for males was 2.8% and for females was 1.7%. By occupation, patients who reported being retirees had the highest case fatality rate at 5.1%, and patients in Hubei Province had a &gt;7-fold higher case fatality rate at 2.9% compared to patients in other provinces (0.4%). While patients who reported no comorbid conditions had a case fatality rate of 0.9%, patients with comorbid conditions had much higher rates—10.5% for those with cardiovascular disease, 7.3% for diabetes, 6.3% for chronic respiratory disease, 6.0% for hypertension, and 5.6% for cancer. Case fatality rate was also very high for cases categorized as critical at 49.0%.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s05">2
                        <figcaption class="mainColor">
                            Age Distribution and Sex Ratio</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s05">
                        Age Distribution and Sex Ratio</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s05">
                    <!-- 普通段落 -->
                        <p id="c24d0bfe-b222-4a29-81f1-85ddc12ee407">
                            The age distribution of cases in Wuhan only, in Hubei Province overall, and in China overall are presented in <span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure1">Figure 1</a></span>. The proportion of confirmed cases 30–79 years of age at baseline (i.e., date of diagnosis) was 89.8% for cases in Wuhan city versus 88.6% in Hubei overall (which includes Wuhan) and 86.6% in China overall (which includes Hubei Province and all 30 other provincial-level administrative divisions, or PLADs). The male-to-female ratio was 0.99:1 in Wuhan, 1.04:1 in Hubei, and 1.06:1 in China overall.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <div class="_figclass figure">
                                <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg">
                                            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-1.jpg&#39;" style=" border: 1px solid #d9d4d4;float:none; cursor: pointer;height: auto; margin: auto  !important; width: 100% !important;" class="figure_img" id="Fig-Figure1" ref="#Fig-Figure1">
                                        </a>
                                    <div class="figTitle">
                                    <!-- 英文图题 -->
                                    <p class="figTitleEn" id="Figure1">
                                            <b>Figure&nbsp;1.</b>&nbsp;
                                            Age distribution and sex ratio of all confirmed COVID-19 cases in China through February 11, 2020. (A) patients diagnosed in the city of Wuhan only; (B) patients diagnosed in Hubei Province, which includes Wuhan as its capital city; and (C) patients diagnosed in China overall, including Hubei Province and all 30 other provincial-level administrative divisions (PLADs). Dashed red line highlights the proportion of patients in the 30–79 years age range. Sex ratio (i.e. male-to-female [M:F] ratio) is shown below each graph.</p>
                                    <!-- 英文图题 -->
                                    </div>
                            </div>
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s05">2
                        <figcaption class="mainColor">
                            Geo-Temporal Findings</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s05">
                        Geo-Temporal Findings</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s05">
                    <!-- 普通段落 -->
                        <p id="4ccdb8ed-b69f-4b0d-9673-02d1d437f498">
                            On January 19, 2020, National Health Commission of the People’s Republic of China confirmed that Guangdong Provincial CDC reported first imported cases of COVID-19, via the Chinese Infectious Diseases Reporting System. This was the first time COVID-19 had been reported outside of Hubei Province via the System. As of January 22, 2020, a total of 301 confirmed COVID-19 cases were reported from 83 counties in 23 provinces. On January 30, 2020, Xizang Autonomous Region (Tibet) reported its first confirmed COVID-19 case coming from Hubei Province. Thus, COVID-19 cases have been reported from all 31 PLADs (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2</a></span>).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <div class="_figclass figure">
                                <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg">
                                            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-2.jpg&#39;" style=" border: 1px solid #d9d4d4;float:none; cursor: pointer;height: auto; margin: auto  !important; width: 100% !important;" class="figure_img" id="Fig-Figure2" ref="#Fig-Figure2">
                                        </a>
                                    <div class="figTitle">
                                    <!-- 英文图题 -->
                                    <p class="figTitleEn" id="Figure2">
                                            <b>Figure&nbsp;2.</b>&nbsp;
                                            Geo-temporal spread of COVID-19 in China through February 11, 2020. (A) a total of 14 county-level administrative areas (hereafter counties) in Hubei Province only (inset) had reported cases as of December 31, 2019; (B) by January 10, 2020, 113 counties in 20 PLADs had reported cases with the highest prevalence still in Hubei Province; (C) nine days later, on January 20, 627 counties in 30 PLADs had reported cases and PLADs neighboring Hubei Province observed increasing prevalence; (D) by the end of January 31, 1,310 counties across all 31 PLADs were affected and prevalence in the central, south, and south-central regions had risen dramatically; (E) by the end of February 11, 1,386 counties nationwide were affected and prevalence in the south-central PLADs had risen to the level of Hubei.</p>
                                    <!-- 英文图题 -->
                                    </div>
                            </div>
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="12a67433-2eb2-4548-81a4-62b0ea09a211">
                            As of February 11, 2020, a total 44,672 confirmed cases were reported from 1,386 counties of 31 provinces, autonomous regions, and municipalities and Hubei Province accounted for 74.7% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2E</a></span>). Among them, 0.2% of cases had onset of illness before December 31, 2019 and all were from Hubei Province (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2A</a></span>); 1.7% had onset of illness during January 1–10, 2020, distributed in 113 counties of 22 PLADs and Hubei Province accounted for 88.5% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2B</a></span>); 13.8% had onset of illness during January 11–20, 2020, distributed in 627 counties of 30 PLADs and Hubei Province accounted for 77.6% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2C</a></span>); 73.1% had onset of illness during January 21–31, 2020, distributed in 1310 counties of 31 PLADs and Hubei Province accounted for 74.7% (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure2">Figure 2D</a></span>).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s05">2
                        <figcaption class="mainColor">
                            Epidemiological Curve</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s05">
                        Epidemiological Curve</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s05">
                    <!-- 普通段落 -->
                        <p id="8649763b-f4b9-472e-a53a-bf1be10dd4c7">
                            <span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure3">Figure 3A</a></span> shows the COVID-19 epidemic curve with number of cases plotted by date of patient onset of symptoms from December 8, 2019 to February 11, 2020. Confirmed, suspected, clinically diagnosed, and asymptomatic cases are stacked to show total daily cases by date of symptom onset. The inset shows that in December 2019 only 0–22 cases/day began to experience symptoms. The peak onset of symptoms for all cases overall occurred on February 1, 2020. Since then, onset of illness has declined.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <div class="_figclass figure">
                                <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg">
                                            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-3.jpg&#39;" style=" border: 1px solid #d9d4d4;float:none; cursor: pointer;height: auto; margin: auto  !important; width: 100% !important;" class="figure_img" id="Fig-Figure3" ref="#Fig-Figure3">
                                        </a>
                                    <div class="figTitle">
                                    <!-- 英文图题 -->
                                    <p class="figTitleEn" id="Figure3">
                                            <b>Figure&nbsp;3.</b>&nbsp;
                                            Epidemiological curves of COVID-19 in China through February 11, 2020. (A) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020. A total of 72,314 cases are shown and confirmed cases (blue) are compared to suspected cases (green), clinically diagnosed cases (yellow), and asymptomatic cases (red). The inset shows a zoomed-in view of all days in December, when total daily count remained below 24 cases; (B) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020 for confirmed cases only (blue). The number of cases diagnosed each day is also shown for confirmed cases only (orange). The inset shows a zoomed-in view of all days in December, when total daily count remained below 15 cases.</p>
                                    <!-- 英文图题 -->
                                    </div>
                            </div>
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="fa705e88-ab79-45dd-bbd0-7b4d55b73db2">
                            <span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure3">Figure 3B</a></span> shows the same COVID-19 epidemic curve for confirmed cases only with number of cases plotted by date of patients’ onset of symptoms from December 8, 2019 to February 11, 2020. These data are overlaid with confirmed cases plotted by date of diagnosis to show the lag between the time patients fall ill and the time they actually are diagnosed and are reported to the Infectious Disease Information System. Although for confirmed cases onset of illness peaked around January 23–27, diagnosis of infection by nucleic acid testing of throat swabs did not peak until February 4.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                <!-- <figure vid="s05">2
                        <figcaption class="mainColor">
                            Subgroup Findings</figcaption>
                    </figure> -->

                    <h4 class="mainColor navTitle" vid="s05">
                        Subgroup Findings</h4>
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s05">
                    <!-- 普通段落 -->
                        <p id="6bc22324-ed72-413f-8f8f-174144e22944">
                            <span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure4">Figure 4</a></span> shows the COVID-19 epidemic curve with the number of cases plotted by date of onset of symptoms from December 18, 2019 to February 11, 2020 for two subgroups—confirmed cases found outside of Hubei Province (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure4">Figure 4A</a></span>) and all cases among health workers nationwide (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure4">Figure 4B</a></span>). Peak timing of onset of symptoms among cases outside of Hubei Province occurred on January 27. Most of these cases (85.8%) reported having recently resided in or visited Wuhan or having had close contact with an infected individual from Wuhan. Peak timing of onset of symptoms among health worker cases occurred on February 1. In the 422 medical facilities serving COVID-19 patients, a total of 3,019 health workers have been infected (1,716 confirmed cases), and 5 have died.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <div class="_figclass figure">
                                <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg">
                                            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-4.jpg&#39;" style=" border: 1px solid #d9d4d4;float:none; cursor: pointer;height: auto; margin: auto  !important; width: 100% !important;" class="figure_img" id="Fig-Figure4" ref="#Fig-Figure4">
                                        </a>
                                    <div class="figTitle">
                                    <!-- 英文图题 -->
                                    <p class="figTitleEn" id="Figure4">
                                            <b>Figure&nbsp;4.</b>&nbsp;
                                            Subgroup epidemiological curves of COVID-19 in China through February 11, 2020. (A) subgroup analysis of confirmed cases discovered outside of Hubei Province only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first case outside Hubei Province on December 18, 2019 through the end of February 11, 2020. Total confirmed cases outside Hubei Province, and Wuhan-related exposure (dark purple) versus Wuhan-unrelated exposure (light purple), are shown; (B) subgroup analysis of all cases among health workers only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first health worker case on December 27, 2019 through the end of February 11, 2020. Total cases among health workers and confirmed (blue) versus suspected (green), clinically diagnosed (yellow), and asymptomatic (red) cases are shown.</p>
                                    <!-- 英文图题 -->
                                    </div>
                            </div>
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="d6e8f169-460a-416c-bdb4-57cd30b31974">
                            Confirmed cases, case severity, and case fatality rates among health workers in different areas of China and different time periods are presented in <span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table2">Table 2</a></span>. A total of 1,080 confirmed cases among health workers have been found in Wuhan, accounting for 64.0% of national total. An additional 394 health worker cases (23.3%) were found in Hubei Province (excluding Wuhan), and 214 cases (12.7%) were found in the other 30 PLADs. The proportion of health worker cases that were severe or critical was 17.7% in Wuhan, 10.4% in Hubei Province, 7.0% in the remaining 30 PLADs, and 14.6% overall. The proportion of health worker cases in Wuhan classified as severe or critical declined from 38.9% in early January to 12.7% in early February. In China overall, the severe or critical cases among health workers also declined—from 45.0% in early January to 8.7% in early February.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <div class="figure">
                                <div class="table-body">
                                    <input id="basePath" type="hidden" value="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/">
                                        <div class="table-body table_content">
                                    <table>
<thead><tr><td rowspan="2" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Period </b><br><b>(by date of onset)</b></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Wuhan</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Hubei (outside Wuhan)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (outside Hubei)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (overall)</b></td></tr><tr><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td></tr></thead>
<tbody><tr><td class="table_top_border2" style="font-size:7pt" align="left" valign="middle">Before Dec 31, 2019</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 1–10, 2020</td><td align="center" valign="middle" style="font-size:7pt">     18</td><td align="center" valign="middle" style="font-size:7pt">7 (38.9)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     20</td><td align="center" valign="middle" style="font-size:7pt">9 (45.0)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.0)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 11–20, 2020</td><td align="center" valign="middle" style="font-size:7pt">   233</td><td align="center" valign="middle" style="font-size:7pt">52 (22.3)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.4)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     48</td><td align="center" valign="middle" style="font-size:7pt">8 (16.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     29</td><td align="center" valign="middle" style="font-size:7pt">1 (3.4)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   310</td><td align="center" valign="middle" style="font-size:7pt">61 (19.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 21–31, 2020</td><td align="center" valign="middle" style="font-size:7pt">   656</td><td align="center" valign="middle" style="font-size:7pt">110 (16.8)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   250</td><td align="center" valign="middle" style="font-size:7pt">29 (11.6)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.8)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   130</td><td align="center" valign="middle" style="font-size:7pt">10 (7.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">1,036</td><td align="center" valign="middle" style="font-size:7pt">149 (14.4)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.2)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">After Feb 1, 2020</td><td align="center" valign="middle" style="font-size:7pt">   173</td><td align="center" valign="middle" style="font-size:7pt">22 (12.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     95</td><td align="center" valign="middle" style="font-size:7pt">3 (3.2)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     54</td><td align="center" valign="middle" style="font-size:7pt">3 (5.6)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   322</td><td align="center" valign="middle" style="font-size:7pt">28 (8.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr>  <tr><td class="table_bottom_border" style="font-size:7pt" align="left" valign="middle">Total</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,080</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">191 (17.7)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">3 (0.3)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   394</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">41 (10.4)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">2 (0.5)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   214</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">15 (7.0)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,688</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">247 (14.6)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">5 (0.3)</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="16">Abreviation: CFR, case-fatality rate.<br>* CFR presented here was calculated as number of deaths (numerator) divided by total number of confirmed cases in the row (denominator), expressed as a percent.</td></tr></tfoot>
</table></div>
                                </div>
                                <div class="figTitle">
                                    <!-- 英文表题 -->
                                    <p class="figTitleEn" id="Table2">
                                            <b>Table&nbsp;2.</b>&nbsp;
                                            Confirmed cases, case severity, and case fatality rates among health workers in different areas of China by time period.</p>
                                    </div>
                            </div>
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                </ul>
        </figure>
        <figure vid="s06">
            <figcaption class="mainColor navTitle">
                Discussion</figcaption>
            <ul class="group">
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s06">
                    <!-- 普通段落 -->
                        <p id="ec91a14c-d80f-45ee-9176-e32e5ecb7c89">
                            A main finding of this characterization and exploratory analysis of the first 72,314 cases of COVID-19 found in China in the 40 days between first recognition of the outbreak of pneumonia with unknown etiology on December 31, 2019 to the end of the study period on February 11, 2020 is that this novel coronavirus is highly contagious. It has spread extremely rapidly from a single city to the entire country within only about 30 days. Moreover, it has achieved such far-reaching effects even in the face of extreme response measures including the complete shutdown and isolation of whole cities, cancellation of Chinese New Year celebrations, prohibition of attendance at school and work, massive mobilization of health and public health personnel as well as military medical units, and rapid construction of entire hospitals.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="0fc8cac6-2a48-4d83-869b-da0d50084bcf">
                            In light of this rapid spread, it is fortunate that COVID-19 has been mild for 81% of patients and has a very low overall case fatality rate of 2.3%. Among the 1,023 deaths, a majority have been ≥60 years of age and/or have had pre-existing, comorbid conditions such as hypertension, cardiovascular disease, and diabetes. Moreover, the case fatality rate is unsurprisingly highest among critical cases at 49%, and no deaths have occurred among those with mild or even severe symptoms (<span class="xref"><a href="javascript:;" ref-type="table" data-href="#Table1">Table 1</a></span>).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="f0cd995a-7a11-4091-a0e3-c412f651d7d3">
                            A major contribution of our study is a first description of the COVID-19 epidemic curves. We interpret the overall curve (<span class="xref"><a href="javascript:;" ref-type="fig" data-href="#Figure3">Figure 3A</a></span>) as having a mixed outbreak pattern—the data appear to indicate a continuous common source pattern of spread in December and then from early January through February 11, 2020, the data appear to have a propagated source pattern. This mixed outbreak time trend is consistent with the working theory that perhaps several zoonotic events occurred at Huanan Seafood Wholesale Market in Wuhan allowed 2019-nCoV to be transmitted from a still-unknown animal into humans and, due to its high mutation and recombination rates, it adapted to become capable of and then increasingly efficient at human-to-human transmission (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>).</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="b6e31f56-5e0c-4bcf-a584-35daa92c1a0c">
                            The early days of the outbreak have been reminiscent of SARS and MERS, and indeed, the discovery that the causative agent was a closely-related, never-before-described coronavirus predicted potential for nosocomial transmission and so-called “super-spreader” events (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>). Unfortunately, 2019-nCoV did indeed infect health workers in China via nosocomial transmission. Here we offer a first description of the 1,716 confirmed cases among health workers. Overall, they also display a likely mixed outbreak pattern—perhaps the data are characterized by a point source curve beginning in late December 2019, which was eclipsed by a higher magnitude continuous source curve beginning on January 20, 2020. To date, there is no evidence of a super-spreader event occurring in any of the Chinese health facilities serving COVID-19 patients. However, we do not know whether this is due to the nature of the virus itself or whether these events have been successfully prevented.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="81b3a955-a722-4a07-b226-0b7eb3077019">
                            It is these authors’ sincere hope and intent that this new analysis, on what has become a “public health emergency of international concern,” (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b12">12</a></span>) helps to inform health and public health workers preparing for or perhaps already experiencing COVID-19 in their populations. This study provides important insight into several crucial open questions on this epidemic and how to design strategies to effectively control it (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>). For instance, the downward trend in the overall epidemic curve suggests that perhaps isolation of whole cities, broadcast of critical information (e.g., promoting hand washing, mask wearing, and care seeking) with high frequency through multiple channels, and mobilization of a multi-sector rapid response teams is helping to curb the epidemic.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="7a5421f4-6289-4617-bbcb-29a99f65a8c5">
                            China’s response is certainly an echo of lessons learned during SARS and is a tribute to the work China and other low- and middle-income countries have been doing, with the much-needed help of international partners, over the past few decades to build infectious disease surveillance systems and public health infrastructure capable of catching outbreaks early and responding swiftly using evidence-based best practices. The 2019-nCoV and other coronaviruses may continue to adapt over time to become more virulent (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>), and zoonosis is not going to stop. We must remain vigilant, hone our skills, fund our defenses, and practice our responses, and we must help our neighbors to do the same.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="1d6d9bb3-7e78-4287-b58c-332e1acfeab4">
                            The very large number of cases included in our study was a major strength. Nevertheless, our study did have some important limitations. Firstly, a large proportion of cases included in our analysis (37%) were not confirmed by nucleic acid testing since this process is slow, labor intensive, and requires specialized equipment and skilled technicians. Yet all 72,314 cases were at least diagnosed clinically and investigated by trained epidemiologists. Secondly, some records did have missing data for a few important variables of interest—Wuhan-related exposure, comorbid conditions, and case severity—which limits our ability to draw conclusions from the data.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="568ad511-04d1-401c-bb08-9ddc914e5474">
                            In conclusion, the present descriptive, exploratory analysis of the first 72,314 cases of COVID-19 reported through February 11, 2020 offers important new information to the international community on the epidemic in China. In particular, this analysis chronicles the extremely rapid spread of the novel coronavirus despite extreme efforts to contain it. However, important questions remain including identification of the animal reservoir, determination of infectiousness period, identification of transmission routes, and effective treatment and prevention methods including further test development, drug development, and vaccine development (<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b3">3</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b4">4</a></span>,<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b8">8</a></span>–<span class="xref"><a href="javascript:;" ref-type="bibr" data-href="#b9">9</a></span>). As an international community, we must all be responsible partners in surveillance, communication, response, research, and implementation of evidence-based public health and clinical practice. The massive vigorous actions taken by the Chinese government have slowed down the epidemic in China and curbed spread to the rest of the world. Although the epidemic appears to be in decline in the lead up to February 11, 2020, we may yet face more challenges. Huge numbers of people will soon be returning to work and school after the extended New Year holiday. We need to prepare for a possible rebound of the COVID-19 epidemic in the coming weeks and months.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    <!-- 输出章节标题 start -->
                </ul>
        </figure>
        <figure vid="s12">
            <figcaption class="mainColor navTitle">
                Acknowledgements</figcaption>
            <ul class="group">
                <!-- 输出章节标题 end -->
                <!-- 输出章节下的段落内容start -->
                <li vid="s12">
                    <!-- 普通段落 -->
                        <p id="8b04e711-4d44-4a12-a6f5-57e025cf8db3">
                            This work was supported by National Science and Technology Foundation of China (2018ZX10201002-008-002), and by National Nature Science Foundation of China (NSFC, 71934002). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="4a7d70c9-7c68-42cc-ad88-8e7a14232aca">
                            The team thanks all local health workers for their contributions in providing testing, treatment, and care to COVID-19 patients in China.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="fc68e203-a575-4937-9545-b2c1d756c9df">
                            <b>Disclaimer: </b> The opinions expressed herein reflect the collective views of the co-authors and do not necessarily represent the official position of the National Center for AIDS/STD Control and Prevention of the Chinese Center for Disease Control and Prevention.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="d9431f33-430f-4cc1-9eda-2731e458a29e">
                            In order to share the results of epidemiological characteristics of COVID-19 domestically and internationally, the Chinese Versionis jointly published on the <i>Chinese Journal of Epidemiology</i>.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        <!-- 普通段落 -->
                        <p id="26aa36f9-abb6-4cf8-ac4c-8543cb0bf77c">
                            <b>Author Group &amp; Contributions:</b> The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team includes Zijian Feng, Qun Li, Yanping Zhang<sup>#</sup>, Zunyou Wu, Xiaoping Dong, Huilai Ma, Dapeng Yin, Ke Lyu, Dayan Wang, Lei Zhou, Ruiqi Ren, Chao Li, Yali Wang, Dan Ni, Jing Zhao, Bin Li, Rui Wang, Yan Niu, Xiaohua Wang, Lijie Zhang, Jingfang Sun, Boxi Liu, Zhiqiang Deng, Zhitao Ma, Yang Yang, Hui Liu, Ge Shao, Huan Li, Yuan Liu, Hangjie Zhang, Shuquan Qu, Wei Lou, Dou Shan, Yuehua Hu, Lei Hou, Zhenping Zhao, Jiangmei Liu, Hongyuan Wang, Yuanjie Pang, Yuting Han, Qiuyue Ma, Yujia Ma, Shi Chen, Wei Li, Routong Yang, Zhewu Li, Yingnan Guo, Xinran Liu, Bahabaike Jiangtulu, Zhaoxue Yin, Juan Xu, Shuo Wang, Lin Xiao, Tao Xu, Limin Wang, Xiao Qi, Guoqing Shi, Wenxiao Tu, Xiaomin Shi, Xuemei Su, Zhongjie Li, Huiming Luo, Jiaqi Ma, Jennifer M. McGoogan. All Team members jointly conceptualized the study, analyzed and interpreted the data, wrote and revised the manuscript, and decided to submit for publication.</p>
                        <!-- 公式段落 -->
                        <!-- 图段落 -->
                        <!-- 表段落 -->
                        <!-- box段落 -->
                        </li>
                    </ul></figure>
        </ul>
        <!-- Reported by: -->
                <!-- Reported by: -->
                   <a class="tabJump" href="http://weekly.chinacdc.cn/en/article/app/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51/reference">Reference <num>(12)</num></a>
        <div class="References-wrap" style="display:none;">
            <table class="reference-tab reference-tab-app">
                <tbody><tr id="b1">
                        <td class="mainColor td1" valign="top">[1]</td>
                        <td class="article-ref td2">Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan, China: Wuhan Municipal Health Commission. <a href="http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989" target="_blank">http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989</a>. [2019-12-31]. (In Chinese).</td>
                                </tr>
                <tr id="b2">
                        <td class="mainColor td1" valign="top">[2]</td>
                        <td class="article-ref td2">World Health Organization. Novel coronavirus – China. Geneva, Switzerland: World Health Organization. <a href="https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/" target="_blank">https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/</a>. [2020-01-12].</td>
                                </tr>
                <tr id="b3">
                        <td class="mainColor td1" valign="top">[3]</td>
                        <td class="article-ref td2">Wang C, Hornby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. <a href="http://dx.doi.org/10.1016/S0140-6736(20)30185-9" target="_blank">http://dx.doi.org/10.1016/S0140-6736(20)30185-9</a>. [2020-01-24].</td>
                                </tr>
                <tr id="b4">
                        <td class="mainColor td1" valign="top">[4]</td>
                        <td class="article-ref td2">Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91(2020):264 − 6. http://dx.doi.org/10.1016/j.ijid.2020.01.009.</td>
                                                </tr>
                <tr id="b5">
                        <td class="mainColor td1" valign="top">[5]</td>
                        <td class="article-ref td2">Zhu N, Zhang D, Wang W, Li XW, Yang B, Song JD, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. <a href="http://dx.doi.org/10.1056/NEJMoa2001017" target="_blank">http://dx.doi.org/10.1056/NEJMoa2001017</a>. [2020-01-24].</td>
                                </tr>
                <tr id="b6">
                        <td class="mainColor td1" valign="top">[6]</td>
                        <td class="article-ref td2">Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan SF, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbs Infect. <a href="http://dx.doi.org/10.1080/22221751.2020.1719902" target="_blank">http://dx.doi.org/10.1080/22221751.2020.1719902</a>. [2020-01-24].</td>
                                </tr>
                <tr id="b7">
                        <td class="mainColor td1" valign="top">[7]</td>
                        <td class="article-ref td2">Tan WJ, Zhao X, Ma XJ, Wang WL, Niu PH, Xu WB, et al. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019−2020. China CDC Weekly 2020;2(4): 61-2. <a href="http://weekly.chinacdc.cn/en/article/ccdcw/2020/4/61" target="_blank">http://weekly.chinacdc.cn/en/article/ccdcw/2020/4/61</a>.</td>
                                </tr>
                <tr id="b8">
                        <td class="mainColor td1" valign="top">[8]</td>
                        <td class="article-ref td2">Paules CI, Marston HD, Fauci AS. Coronavirus infection—more than just the common cold. JAMA. <a href="http://dx.doi.org/10.1001/jama.2020.0757" target="_blank">http://dx.doi.org/10.1001/jama.2020.0757</a>. [2020-01-23].</td>
                                </tr>
                <tr id="b9">
                        <td class="mainColor td1" valign="top">[9]</td>
                        <td class="article-ref td2">Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China – key questions for impact assessment. N Engl J Med. <a href="http://dx.doi.org/10.1056/NEJMp2000929" target="_blank">http://dx.doi.org/10.1056/NEJMp2000929</a>.[2020-01-24].</td>
                                </tr>
                <tr id="b10">
                        <td class="mainColor td1" valign="top">[10]</td>
                        <td class="article-ref td2">Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. <a href="http://dx.doi.org/10.1016/S0140-6736(20)30183-5" target="_blank">http://dx.doi.org/10.1016/S0140-6736(20)30183-5</a>. [2020-01-24]</td>
                                </tr>
                <tr id="b11">
                        <td class="mainColor td1" valign="top">[11]</td>
                        <td class="article-ref td2">Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. <a href="http://dx.doi.org/10.1016/S0140-6736(20)30154-9" target="_blank">http://dx.doi.org/10.1016/S0140-6736(20)30154-9</a>. [2020-01-24].</td>
                                </tr>
                <tr id="b12">
                        <td class="mainColor td1" valign="top">[12]</td>
                        <td class="article-ref td2">World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, Switzerland: World Health Organization. <a href="https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)" target="_blank">https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</a>. [2020-01-30].</td>
                                </tr>
                </tbody></table>
        </div>

    </section>
    <!--footer START-->
    <footer>
       <a href="http://weekly.chinacdc.cn/fileCCDCW/journal/article/ccdcw/2020/8/PDF/COVID-19.pdf">
                        <div class="pdfView">
                            <div class="in-bl">
                                <i class="fa fa-file-pdf-o"></i>
                                <span>PDF &nbsp;view</span>
                            </div>
                        </div>
                    </a>
                <div class="Matrix-code WeChatView">
				<img style="display:block;" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/wechat_en_e53946e2-c6c4-41e9-9a9b-fea8db1a8f51.jpg" alt="WeChat">
					<span>follow<i></i>share</span>
			</div>
        <input id="qrcode" type="hidden" value="/fileCCDCW/journal/article/ccdcw/2020/8/PIC/wechat_en_e53946e2-c6c4-41e9-9a9b-fea8db1a8f51.jpg">
            <div class="toTop">
            <p><b>Top</b></p>
            <span class="fa fa-angle-up"></span>
        </div>
    </footer>
    <!--footer END-->
</div>
<div class="article-btn ac">
    <div class="_table">
        <div class="_cell">
            <span></span>
            <span></span>
            <span></span>
        </div>
    </div>
</div>
<div class="article-menu">
    <h3>Catalog</h3>
    <div class="article-menu-bot" style="height: 937px;">
    	<ul class="iphone-wrapper"><li><h6 class="navTitle" id="about-articletit-app" style="padding-top:15px;"><b>Author Affiliation</b></h6></li><li><h3 class="full-text navTitle">HTML</h3></li><li><figcaption class="mainColor navTitle">
                                    Abstract</figcaption></li><li><figcaption class="mainColor navTitle">
                Introduction</figcaption></li><li><figcaption class="mainColor navTitle">
                Method</figcaption></li><li><h4 class="mainColor navTitle" vid="s02">
                        Study Design</h4></li><li><h4 class="mainColor navTitle" vid="s02">
                        Data Source</h4></li><li><h4 class="mainColor navTitle" vid="s02">
                        Variables</h4></li><li><h4 class="mainColor navTitle" vid="s02">
                        Analysis</h4></li><li><figcaption class="mainColor navTitle">
                Results</figcaption></li><li><h4 class="mainColor navTitle" vid="s05">
                        Patients</h4></li><li><h4 class="mainColor navTitle" vid="s05">
                        Deaths, Case Fatality Rates, and Mortality</h4></li><li><h4 class="mainColor navTitle" vid="s05">
                        Age Distribution and Sex Ratio</h4></li><li><h4 class="mainColor navTitle" vid="s05">
                        Geo-Temporal Findings</h4></li><li><h4 class="mainColor navTitle" vid="s05">
                        Epidemiological Curve</h4></li><li><h4 class="mainColor navTitle" vid="s05">
                        Subgroup Findings</h4></li><li><figcaption class="mainColor navTitle">
                Discussion</figcaption></li><li><figcaption class="mainColor navTitle">
                Acknowledgements</figcaption></li></ul>
    </div>
</div>
















</div>
<!--手机端 结束-->
<!--底部  开始-->
<div id="common-bottom">
    	
<input type="hidden" id="language" value="en">
<input type="hidden" id="fileurls" value="/fileCCDCW/">
<input type="hidden" id="isShowImg" value="1">
<input type="hidden" value="中国疾病预防控制中心周报（英文）" id="journalTitleCn">
<input type="hidden" value="China CDC Weekly" id="journalTitleEn">
<input type="hidden" value="CCDCW" id="journalAbbr">
<div class="bottom-fixed" style="display: block;"></div>
<div class="footer">
	<div class="btmt">Copyright© 2019 Chinese Center for Disease Control and Prevention(China CDC) </div>
    <div class="bottom">
		<p>No.155 Changbai Road, Changping District, Beijing, China </p>
		<p><span>Tel：+86-10-63150501, 63150701</span>  <!--<span>Fax：+86-10-58900240</span>-->  </p>
		<p><a href="http://www.beian.miit.gov.cn/" target="_blank">京ICP备11024750号-1</a></p>
		<p>Supported by:
		<a target="_blank" href="http://www.rhhz.net/"> Beijing Renhe Information Technology Co. Ltd</a>
		 <span class="btmb-span">
		</span>
		</p>
	</div>
</div>

<script src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/sowise-plugin.js.download" custom-options="{&#39;citedby&#39;:false,&#39;suggest&#39;:false,&#39;ipRecord&#39;:true,&#39;journalId&#39;:234}"></script></div>
<!--导出引用  开始-->
<div class="modal fade" id="exportCitationModal">
    <div class="modal-dialog">
        <div class="modal-content">
            <div class="modal-header">
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
                <h2 class="modal-title mainColor" id="myModalLabel"><b>Export File</b></h2>
            </div>
            <div class="modal-body">
                <div class="panel panel-primary">
                    <div class="panel-heading">
                        <h4 class="panel-title">Citation</h4>
                    </div>
                    <div class="panel-body">
                        <p class="quot">
                            <!--<span class="mainColor">Citation:</span>-->
                            </p><div class="copyCitationInfo" style="width: 0px;height: 0px;opacity:0;overflow: hidden;">The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020[J]. China CDC Weekly, 2020, 2(8): 113-122.</div>
                            <span class="info citationEn" id="">										The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020[J]. <i>China CDC Weekly</i>, 2020, 2(8): 113-122. 								</span>
                            <div class="modal-footer modal-footer-copy">
								<span class="copy-citation" onclick="copyArticle(this)" title="copy to clipboard">
									<img class="shu" src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/shu.png" alt="shu">
								</span>
                            </div>
                        <p></p>
                    </div>
                </div>
                <div class="panel panel-success">
                    <div class="panel-heading">
                        <h4 class="panel-title">Format</h4>
                    </div>
                    <div class="panel-body">
                        <div class="radio">
                            <label>
                                <input type="radio" value="ris" name="format" checked="">
                                RIS(for EndNote,Reference Manager,ProCite)
                            </label>
                        </div>
                        <div class="radio">
                            <label>
                                <input type="radio" value="bib" name="format">
                                BibTex
                            </label>
                        </div>
                        <div class="radio">
                            <label>
                                <input type="radio" value="txt" name="format">
                                Txt
                            </label>
                        </div>
                    </div>
                </div>
                <div class="panel panel-success">
                    <div class="panel-heading">
                        <h4 class="panel-title">Content</h4>
                    </div>
                    <div class="panel-body">
                        <div class="radio">
                            <label>
                                <input type="radio" value="0" name="content" checked="">
                                Citation Only
                            </label>
                        </div>
                        <div class="radio">
                            <label>
                                <input type="radio" value="1" name="content">
                                Citation and Abstract
                            </label>
                        </div>
                    </div>
                </div>
            </div>
            <div class="modal-footer">
                <button type="button" class="btn btn-primary" data-dismiss="modal" onclick="toExportCitation(this,&#39;en&#39;)" article_id="e53946e2-c6c4-41e9-9a9b-fea8db1a8f51" id="exportArticleId">Export</button>
                <button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
            </div>
        </div>
    </div>
</div>
<!--导出引用  结束-->

<!--图示功能-->
<div id="imgShow">
    <!--大图-->
    <div id="originalImgs-wrapper" style="width: 900px;">
        <div class="originalImgs-wrapper">
            <img id="originalImgs" src="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51" alt="">
        </div>
        <!--图题-->
        <div id="imgTitle" title="鼠标滚动">
            <div>
                <p class="titleEn"></p>
            </div>
        </div>
        <!--页码-->
        <p id="imgsPageNum">
            <span id="nowImgIndex" class="underHigh"></span>/<span id="allImgNum"></span>
        </p>
        <!--下载-->
        <div id="downloadImgs">
            <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad:&nbsp;
            <a id="originalImgDownload" class="underHigh" href="javascript:void(0);">Full-Size Img</a>&nbsp;
            <a id="originalPPTDownload" class="underHigh" href="javascript:void(0);" style="border-left: 1px solid #ccc;padding-left: 5px;">PowerPoint</a>
        </div>
    </div>
    <!--小图-->
    <div id="miniImgs-wrapper">
        <div id="imgPrev">
            <a href="javascript:void(0);"><span class="imgShowIcon imgShowIcon-prev"></span> </a>
        </div>
        <div id="miniImgs">
            <ul>
                <li class="" data-img="downloadImg(&#39;ce156d55-4c32-44ba-82fa-81c56589ee58&#39;,&#39;figure&#39;)" data-ppt="downloadPPT(&#39;ce156d55-4c32-44ba-82fa-81c56589ee58&#39;,&#39;figure&#39;)">
                        <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg">
                                    <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-1.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-1.jpg&#39;">
                                </a>
                            </li>
                <li class="" data-img="downloadImg(&#39;dbe4612b-45f3-4a3a-93a3-223ba653d2bd&#39;,&#39;figure&#39;)" data-ppt="downloadPPT(&#39;dbe4612b-45f3-4a3a-93a3-223ba653d2bd&#39;,&#39;figure&#39;)">
                        <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg">
                                    <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-2.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-2.jpg&#39;">
                                </a>
                            </li>
                <li class="" data-img="downloadImg(&#39;6f1f49a5-7d61-4d1e-a234-8e1fe1434e55&#39;,&#39;figure&#39;)" data-ppt="downloadPPT(&#39;6f1f49a5-7d61-4d1e-a234-8e1fe1434e55&#39;,&#39;figure&#39;)">
                        <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg">
                                    <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-3.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-3.jpg&#39;">
                                </a>
                            </li>
                <li class="" data-img="downloadImg(&#39;0a807ce1-3669-445d-ba1a-f8c62d7622ee&#39;,&#39;figure&#39;)" data-ppt="downloadPPT(&#39;0a807ce1-3669-445d-ba1a-f8c62d7622ee&#39;,&#39;figure&#39;)">
                        <a href="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg">
                                    <img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/COVID-19-4.jpg" onerror="this.onerror=null;this.src=&#39;/fileCCDCW/journal/article/ccdcw/2020/8/PIC/COVID-19-4.jpg&#39;">
                                </a>
                            </li>
                </ul>
        </div>
        <div id="imgNext">
            <a href="javascript:void(0);"><span class="imgShowIcon imgShowIcon-next"></span> </a>
        </div>
    </div>
    <!--返回-->
    <div id="imgBack">
        <a href="javascript:void(0);"> Return<span class="triangle"></span>
        </a>
    </div>
</div>
<!-- 右侧缩略图表 -->
<div class="show-table">
	<div class="new-back">
		<a href="javascript:;"> Return<span class="triangle"></span></a>
	</div>
    <div class="picbox">
        <ul class="piclist" style="height: 937px;">
            
        <li style="height: 937px;"><div class="figure table_new" style="">
				<span id="44719c7b-c83a-4fe4-885b-6c40859b15ec" level="2" sort="9" class="sec-title">&nbsp;</span>
					<div class="article_table_fullText clearfix" ref="Table1">
																		<!--<a class="group4" href="#Table1_content" title="TABLE&nbsp;1.&nbsp;Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020." id="Table1">
							<img src="http://weekly.chinacdc.cn:80/style/web/images/table-icon.gif"/>
						</a> -->
						<div class="table_caption">
						 	<!-- 英文图题 -->
						 									<div>
									<span class="TableText">
										<b>TABLE&nbsp;1.</b>&nbsp;
									</span>
					    			Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020.
					       		</div>
				       								</div>
						<div id="Table1_content" class="table table_content">
							<div class="table-body 									                       table_type2	                        						    ">
								<table>
<thead>  <tr><td class="table_top_border" align="center" valign="middle"><b>Baseline characteristics</b></td><td class="table_top_border" align="center" valign="middle"><b>Confirmed cases,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Deaths,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Case fatality </b><br><b>rate, %</b></td><td class="table_top_border" align="center" valign="middle"><b>Observed time,</b><br><b> PD</b></td><td class="table_top_border" align="center" valign="middle"><b>Mortality,</b><br><b> per 10 PD</b> </td></tr></thead>
<tbody><tr><td class="table_top_border2" align="left" valign="middle">Overall</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:20pt" align="center" valign="middle">  44,672</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:30pt" align="center" valign="middle">1,023</td><td class="table_top_border2" align="center" valign="middle">  2.3</td><td class="table_top_border2" align="center" valign="middle">661,609</td><td class="table_top_border2" align="center" valign="middle">0.015</td></tr><tr><td align="left" valign="middle">Age, years</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　0–9</td><td align="center" valign="middle">416 (0.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">    4,383</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　10–19</td><td align="center" valign="middle">549 (1.2)</td><td align="center" valign="middle">1 (0.1)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">    6,625</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　20–29</td><td align="center" valign="middle">3,619 (8.1)</td><td align="center" valign="middle">7 (0.7)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">  53,953</td><td align="center" valign="middle">0.001</td></tr><tr><td align="left" valign="middle">　30–39</td><td align="center" valign="middle">7,600 (17.0)</td><td align="center" valign="middle">18 (1.8)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">114,550</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　40–49</td><td align="center" valign="middle">8,571 (19.2)</td><td align="center" valign="middle">38 (3.7)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">128,448</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">　50–59</td><td align="center" valign="middle">10,008 (22.4)</td><td align="center" valign="middle">130 (12.7)</td><td align="center" valign="middle">  1.3</td><td align="center" valign="middle">151,059</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　60–69</td><td align="center" valign="middle">8,583 (19.2)</td><td align="center" valign="middle">309 (30.2)</td><td align="center" valign="middle">  3.6</td><td align="center" valign="middle">128,088</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　70–79</td><td align="center" valign="middle">3,918 (8.8)</td><td align="center" valign="middle">312 (30.5)</td><td align="center" valign="middle">  8.0</td><td align="center" valign="middle">  55,832</td><td align="center" valign="middle">0.056</td></tr><tr><td align="left" valign="middle">　≥80</td><td align="center" valign="middle">1,408 (3.2)</td><td align="center" valign="middle">208 (20.3)</td><td align="center" valign="middle">14.8</td><td align="center" valign="middle">  18,671</td><td align="center" valign="middle">0.111</td></tr><tr><td align="left" valign="middle">Sex</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Male</td><td align="center" valign="middle">22,981 (51.4)</td><td align="center" valign="middle">653 (63.8)</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">342,063</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">　Female</td><td align="center" valign="middle">21,691 (48.6)</td><td align="center" valign="middle">370 (36.2)</td><td align="center" valign="middle">  1.7</td><td align="center" valign="middle">319,546</td><td align="center" valign="middle">0.012</td></tr><tr><td align="left" valign="middle">Occupation</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Service industry</td><td align="center" valign="middle">3,449 (7.7)</td><td align="center" valign="middle">23 (2.2)</td><td align="center" valign="middle">  0.7</td><td align="center" valign="middle">  54,484</td><td align="center" valign="middle">0.004</td></tr>   <tr><td align="left" valign="middle">　Farmer/laborer</td><td align="center" valign="middle">9,811 (22.0)</td><td align="center" valign="middle">139 (13.6)</td><td align="center" valign="middle">  1.4</td><td align="center" valign="middle">137,992</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">　Health worker </td><td align="center" valign="middle">1,716 (3.8)</td><td align="center" valign="middle">5 (0.5)</td><td align="center" valign="middle">  0.3</td><td align="center" valign="middle">  28,069</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　Retiree</td><td align="center" valign="middle">9,193 (20.6)</td><td align="center" valign="middle">472 (46.1)</td><td align="center" valign="middle">  5.1</td><td align="center" valign="middle">137,118</td><td align="center" valign="middle">0.034</td></tr><tr><td align="left" valign="middle">　Other/none</td><td align="center" valign="middle">20,503 (45.9)</td><td align="center" valign="middle">384 (37.5)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">303,946</td><td align="center" valign="middle">0.013</td></tr>     <tr><td align="left" valign="middle">Province</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hubei</td><td align="center" valign="middle">33,367 (74.7)</td><td align="center" valign="middle">979 (95.7)</td><td align="center" valign="middle">  2.9</td><td align="center" valign="middle">496,523</td><td align="center" valign="middle">0.020</td></tr><tr><td align="left" valign="middle">　Other</td><td align="center" valign="middle">11,305 (25.3)</td><td align="center" valign="middle">44 (4.3)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">165,086</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">Wuhan-related exposure*</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Yes</td><td align="center" valign="middle">31,974 (85.8)</td><td align="center" valign="middle">853 (92.8)</td><td align="center" valign="middle">  2.7</td><td align="center" valign="middle">486,612</td><td align="center" valign="middle">0.018</td></tr><tr><td align="left" valign="middle">　No</td><td align="center" valign="middle">5,295 (14.2)</td><td align="center" valign="middle">66 (7.2)</td><td align="center" valign="middle">  1.2</td><td align="center" valign="middle">  71,201</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">    7,403</td><td align="center" valign="middle">104</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">103,796</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">Comorbid condition<sup>†</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hypertension</td><td align="center" valign="middle">2,683 (12.8)</td><td align="center" valign="middle">161 (39.7)</td><td align="center" valign="middle">  6.0</td><td align="center" valign="middle">  42,603</td><td align="center" valign="middle">0.038</td></tr><tr><td align="left" valign="middle">　Diabetes</td><td align="center" valign="middle">1,102 (5.3)</td><td align="center" valign="middle">80 (19.7)</td><td align="center" valign="middle">  7.3</td><td align="center" valign="middle">  17,940</td><td align="center" valign="middle">0.045</td></tr><tr><td align="left" valign="middle">　Cardiovascular disease</td><td align="center" valign="middle">873 (4.2)</td><td align="center" valign="middle">92 (22.7)</td><td align="center" valign="middle">10.5</td><td align="center" valign="middle">  13,533</td><td align="center" valign="middle">0.068</td></tr><tr><td align="left" valign="middle">　Chronic respiratory disease</td><td align="center" valign="middle">511 (2.4)</td><td align="center" valign="middle">32 (7.9)</td><td align="center" valign="middle">  6.3</td><td align="center" valign="middle">    8,083</td><td align="center" valign="middle">0.040</td></tr><tr><td align="left" valign="middle">　Cancer (any)</td><td align="center" valign="middle">107 (0.5)</td><td align="center" valign="middle">6 (1.5)</td><td align="center" valign="middle">  5.6</td><td align="center" valign="middle">    1,690</td><td align="center" valign="middle">0.036</td></tr><tr><td align="left" valign="middle">　None</td><td align="center" valign="middle">15,536 (74.0)</td><td align="center" valign="middle">133 (32.8)</td><td align="center" valign="middle">  0.9</td><td align="center" valign="middle">242,948</td><td align="center" valign="middle">0.005</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">23,690 (53.0)</td><td align="center" valign="middle">617 (60.3)</td><td align="center" valign="middle">  2.6</td><td align="center" valign="middle">331,843</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">Case severity<sup>§</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Mild</td><td align="center" valign="middle">36,160 (80.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Severe</td><td align="center" valign="middle">6,168 (13.8)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Critical</td><td align="center" valign="middle">2,087 (4.7)</td><td align="center" valign="middle">1,023 (100)</td><td align="center" valign="middle">49.0</td><td align="center" valign="middle">  31,456</td><td align="center" valign="middle">0.325</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">257 (0.6)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">Period (by date of onset)</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Before Dec 31, 2019</td><td align="center" valign="middle">104 (0.2)</td><td align="center" valign="middle">15 (1.5)</td><td align="center" valign="middle">14.4</td><td align="center" valign="middle">    5,142</td><td align="center" valign="middle">0.029</td></tr><tr><td align="left" valign="middle">　Jan 1–10, 2020</td><td align="center" valign="middle">653 (1.5)</td><td align="center" valign="middle">102 (10.0)</td><td align="center" valign="middle">15.6</td><td align="center" valign="middle">  21,687</td><td align="center" valign="middle">0.047</td></tr><tr><td align="left" valign="middle">　Jan 11–20, 2020</td><td align="center" valign="middle">5,417 (12.1)</td><td align="center" valign="middle">310 (30.3)</td><td align="center" valign="middle">  5.7</td><td align="center" valign="middle">130,972</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　Jan 21–31, 2020</td><td align="center" valign="middle">26,468 (59.2)</td><td align="center" valign="middle">494 (48.3)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">416,009</td><td align="center" valign="middle">0.012</td></tr><tr><td class="table_bottom_border" align="left" valign="middle">　After Feb 1, 2020</td><td class="table_bottom_border" align="center" valign="middle">12,030 (26.9)</td><td class="table_bottom_border" align="center" valign="middle">102 (10.0)</td><td class="table_bottom_border" align="center" valign="middle">  0.8</td><td class="table_bottom_border" align="center" valign="middle">  87,799</td><td class="table_bottom_border" align="center" valign="middle">0.012</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="6">Abreviation: PD, person-days. -, not applicable.<br>* The Wuhan-related exposure variable, only includes a total of 37,269 patients and 919 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>†</sup> The comorbid condition variable, only includes a total of 20,812 patients and 504 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>§</sup> The case severity variable, only includes a total of 44,415 patients and 1,023 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.</td></tr></tfoot>
</table>
							</div>
						</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button clear">
						<div class="table-csv-right fr">&nbsp;|&nbsp;Show Table</div>
						<div class="table-csv-left fr">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
							<a href="javascript:void(0);" onclick="downloadCsv(&#39;929d84bd-d6a0-42dd-b1ca-2fd716173a30&#39;,&#39;para&#39;)">CSV</a>
						</div>
					</div>
				</div></li><li style="height: 937px;"><div class="figure table_new" style="">
				<span id="08c69da6-cf6d-4f6d-a693-799b231ab229" level="2" sort="14" class="sec-title">&nbsp;</span>
					<div class="article_table_fullText clearfix" ref="Table2">
																		<!--<a class="group4" href="#Table2_content" title="TABLE&nbsp;2.&nbsp;Confirmed cases, case severity, and case fatality rates among health workers in different areas of China by time period." id="Table2">
							<img src="http://weekly.chinacdc.cn:80/style/web/images/table-icon.gif"/>
						</a> -->
						<div class="table_caption">
						 	<!-- 英文图题 -->
						 									<div>
									<span class="TableText">
										<b>TABLE&nbsp;2.</b>&nbsp;
									</span>
					    			Confirmed cases, case severity, and case fatality rates among health workers in different areas of China by time period.
					       		</div>
				       								</div>
						<div id="Table2_content" class="table table_content">
							<div class="table-body 									                       table_type2	                        						    ">
								<table>
<thead><tr><td rowspan="2" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Period </b><br><b>(by date of onset)</b></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Wuhan</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Hubei (outside Wuhan)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (outside Hubei)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (overall)</b></td></tr><tr><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td></tr></thead>
<tbody><tr><td class="table_top_border2" style="font-size:7pt" align="left" valign="middle">Before Dec 31, 2019</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 1–10, 2020</td><td align="center" valign="middle" style="font-size:7pt">     18</td><td align="center" valign="middle" style="font-size:7pt">7 (38.9)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     20</td><td align="center" valign="middle" style="font-size:7pt">9 (45.0)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.0)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 11–20, 2020</td><td align="center" valign="middle" style="font-size:7pt">   233</td><td align="center" valign="middle" style="font-size:7pt">52 (22.3)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.4)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     48</td><td align="center" valign="middle" style="font-size:7pt">8 (16.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     29</td><td align="center" valign="middle" style="font-size:7pt">1 (3.4)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   310</td><td align="center" valign="middle" style="font-size:7pt">61 (19.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 21–31, 2020</td><td align="center" valign="middle" style="font-size:7pt">   656</td><td align="center" valign="middle" style="font-size:7pt">110 (16.8)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   250</td><td align="center" valign="middle" style="font-size:7pt">29 (11.6)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.8)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   130</td><td align="center" valign="middle" style="font-size:7pt">10 (7.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">1,036</td><td align="center" valign="middle" style="font-size:7pt">149 (14.4)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.2)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">After Feb 1, 2020</td><td align="center" valign="middle" style="font-size:7pt">   173</td><td align="center" valign="middle" style="font-size:7pt">22 (12.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     95</td><td align="center" valign="middle" style="font-size:7pt">3 (3.2)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     54</td><td align="center" valign="middle" style="font-size:7pt">3 (5.6)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   322</td><td align="center" valign="middle" style="font-size:7pt">28 (8.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr>  <tr><td class="table_bottom_border" style="font-size:7pt" align="left" valign="middle">Total</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,080</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">191 (17.7)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">3 (0.3)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   394</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">41 (10.4)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">2 (0.5)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   214</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">15 (7.0)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,688</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">247 (14.6)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">5 (0.3)</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="16">Abreviation: CFR, case-fatality rate.<br>* CFR presented here was calculated as number of deaths (numerator) divided by total number of confirmed cases in the row (denominator), expressed as a percent.</td></tr></tfoot>
</table>
							</div>
						</div>
					</div>
					<!-- 下拉显示 -->
					<div class="figure_button clear">
						<div class="table-csv-right fr">&nbsp;|&nbsp;Show Table</div>
						<div class="table-csv-left fr">
							<img src="./The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020_files/download.png">DownLoad: 
							<a href="javascript:void(0);" onclick="downloadCsv(&#39;1e2a6c9c-4405-4fe6-9c73-8644b984f555&#39;,&#39;para&#39;)">CSV</a>
						</div>
					</div>
				</div></li></ul>
        <div id="big_play_prev" class="home-picprev thePrev"></div>
        <div id="big_play_next" class="home-picnext theNext"></div>
		
    </div>
    <div class="picsmallbox">
		<a href="javascript:;" id="play_prev" class="play_prev">
			<span class="imgShowIcon imgShowIcon-prev"></span>
		</a>
        <div class="picboxpic">
            <ul id="picsmall" class="picsmall clear" style="height: 122px;">
                
            <li><a href="javascript:;"><div class="table-body 									                       table_type2	                        						    ">
								<table>
<thead>  <tr><td class="table_top_border" align="center" valign="middle"><b>Baseline characteristics</b></td><td class="table_top_border" align="center" valign="middle"><b>Confirmed cases,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Deaths,</b><br><b> N (%)</b></td><td class="table_top_border" align="center" valign="middle"><b>Case fatality </b><br><b>rate, %</b></td><td class="table_top_border" align="center" valign="middle"><b>Observed time,</b><br><b> PD</b></td><td class="table_top_border" align="center" valign="middle"><b>Mortality,</b><br><b> per 10 PD</b> </td></tr></thead>
<tbody><tr><td class="table_top_border2" align="left" valign="middle">Overall</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:20pt" align="center" valign="middle">  44,672</td><td class="table_top_border2" style="align-point:35pt (;eft;padding-left:30pt" align="center" valign="middle">1,023</td><td class="table_top_border2" align="center" valign="middle">  2.3</td><td class="table_top_border2" align="center" valign="middle">661,609</td><td class="table_top_border2" align="center" valign="middle">0.015</td></tr><tr><td align="left" valign="middle">Age, years</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　0–9</td><td align="center" valign="middle">416 (0.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">    4,383</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　10–19</td><td align="center" valign="middle">549 (1.2)</td><td align="center" valign="middle">1 (0.1)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">    6,625</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　20–29</td><td align="center" valign="middle">3,619 (8.1)</td><td align="center" valign="middle">7 (0.7)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">  53,953</td><td align="center" valign="middle">0.001</td></tr><tr><td align="left" valign="middle">　30–39</td><td align="center" valign="middle">7,600 (17.0)</td><td align="center" valign="middle">18 (1.8)</td><td align="center" valign="middle">  0.2</td><td align="center" valign="middle">114,550</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　40–49</td><td align="center" valign="middle">8,571 (19.2)</td><td align="center" valign="middle">38 (3.7)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">128,448</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">　50–59</td><td align="center" valign="middle">10,008 (22.4)</td><td align="center" valign="middle">130 (12.7)</td><td align="center" valign="middle">  1.3</td><td align="center" valign="middle">151,059</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　60–69</td><td align="center" valign="middle">8,583 (19.2)</td><td align="center" valign="middle">309 (30.2)</td><td align="center" valign="middle">  3.6</td><td align="center" valign="middle">128,088</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　70–79</td><td align="center" valign="middle">3,918 (8.8)</td><td align="center" valign="middle">312 (30.5)</td><td align="center" valign="middle">  8.0</td><td align="center" valign="middle">  55,832</td><td align="center" valign="middle">0.056</td></tr><tr><td align="left" valign="middle">　≥80</td><td align="center" valign="middle">1,408 (3.2)</td><td align="center" valign="middle">208 (20.3)</td><td align="center" valign="middle">14.8</td><td align="center" valign="middle">  18,671</td><td align="center" valign="middle">0.111</td></tr><tr><td align="left" valign="middle">Sex</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Male</td><td align="center" valign="middle">22,981 (51.4)</td><td align="center" valign="middle">653 (63.8)</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">342,063</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">　Female</td><td align="center" valign="middle">21,691 (48.6)</td><td align="center" valign="middle">370 (36.2)</td><td align="center" valign="middle">  1.7</td><td align="center" valign="middle">319,546</td><td align="center" valign="middle">0.012</td></tr><tr><td align="left" valign="middle">Occupation</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Service industry</td><td align="center" valign="middle">3,449 (7.7)</td><td align="center" valign="middle">23 (2.2)</td><td align="center" valign="middle">  0.7</td><td align="center" valign="middle">  54,484</td><td align="center" valign="middle">0.004</td></tr>   <tr><td align="left" valign="middle">　Farmer/laborer</td><td align="center" valign="middle">9,811 (22.0)</td><td align="center" valign="middle">139 (13.6)</td><td align="center" valign="middle">  1.4</td><td align="center" valign="middle">137,992</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">　Health worker </td><td align="center" valign="middle">1,716 (3.8)</td><td align="center" valign="middle">5 (0.5)</td><td align="center" valign="middle">  0.3</td><td align="center" valign="middle">  28,069</td><td align="center" valign="middle">0.002</td></tr><tr><td align="left" valign="middle">　Retiree</td><td align="center" valign="middle">9,193 (20.6)</td><td align="center" valign="middle">472 (46.1)</td><td align="center" valign="middle">  5.1</td><td align="center" valign="middle">137,118</td><td align="center" valign="middle">0.034</td></tr><tr><td align="left" valign="middle">　Other/none</td><td align="center" valign="middle">20,503 (45.9)</td><td align="center" valign="middle">384 (37.5)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">303,946</td><td align="center" valign="middle">0.013</td></tr>     <tr><td align="left" valign="middle">Province</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hubei</td><td align="center" valign="middle">33,367 (74.7)</td><td align="center" valign="middle">979 (95.7)</td><td align="center" valign="middle">  2.9</td><td align="center" valign="middle">496,523</td><td align="center" valign="middle">0.020</td></tr><tr><td align="left" valign="middle">　Other</td><td align="center" valign="middle">11,305 (25.3)</td><td align="center" valign="middle">44 (4.3)</td><td align="center" valign="middle">  0.4</td><td align="center" valign="middle">165,086</td><td align="center" valign="middle">0.003</td></tr><tr><td align="left" valign="middle">Wuhan-related exposure*</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Yes</td><td align="center" valign="middle">31,974 (85.8)</td><td align="center" valign="middle">853 (92.8)</td><td align="center" valign="middle">  2.7</td><td align="center" valign="middle">486,612</td><td align="center" valign="middle">0.018</td></tr><tr><td align="left" valign="middle">　No</td><td align="center" valign="middle">5,295 (14.2)</td><td align="center" valign="middle">66 (7.2)</td><td align="center" valign="middle">  1.2</td><td align="center" valign="middle">  71,201</td><td align="center" valign="middle">0.009</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">    7,403</td><td align="center" valign="middle">104</td><td align="center" valign="middle">  2.8</td><td align="center" valign="middle">103,796</td><td align="center" valign="middle">0.010</td></tr><tr><td align="left" valign="middle">Comorbid condition<sup>†</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Hypertension</td><td align="center" valign="middle">2,683 (12.8)</td><td align="center" valign="middle">161 (39.7)</td><td align="center" valign="middle">  6.0</td><td align="center" valign="middle">  42,603</td><td align="center" valign="middle">0.038</td></tr><tr><td align="left" valign="middle">　Diabetes</td><td align="center" valign="middle">1,102 (5.3)</td><td align="center" valign="middle">80 (19.7)</td><td align="center" valign="middle">  7.3</td><td align="center" valign="middle">  17,940</td><td align="center" valign="middle">0.045</td></tr><tr><td align="left" valign="middle">　Cardiovascular disease</td><td align="center" valign="middle">873 (4.2)</td><td align="center" valign="middle">92 (22.7)</td><td align="center" valign="middle">10.5</td><td align="center" valign="middle">  13,533</td><td align="center" valign="middle">0.068</td></tr><tr><td align="left" valign="middle">　Chronic respiratory disease</td><td align="center" valign="middle">511 (2.4)</td><td align="center" valign="middle">32 (7.9)</td><td align="center" valign="middle">  6.3</td><td align="center" valign="middle">    8,083</td><td align="center" valign="middle">0.040</td></tr><tr><td align="left" valign="middle">　Cancer (any)</td><td align="center" valign="middle">107 (0.5)</td><td align="center" valign="middle">6 (1.5)</td><td align="center" valign="middle">  5.6</td><td align="center" valign="middle">    1,690</td><td align="center" valign="middle">0.036</td></tr><tr><td align="left" valign="middle">　None</td><td align="center" valign="middle">15,536 (74.0)</td><td align="center" valign="middle">133 (32.8)</td><td align="center" valign="middle">  0.9</td><td align="center" valign="middle">242,948</td><td align="center" valign="middle">0.005</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">23,690 (53.0)</td><td align="center" valign="middle">617 (60.3)</td><td align="center" valign="middle">  2.6</td><td align="center" valign="middle">331,843</td><td align="center" valign="middle">0.019</td></tr><tr><td align="left" valign="middle">Case severity<sup>§</sup></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Mild</td><td align="center" valign="middle">36,160 (80.9)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Severe</td><td align="center" valign="middle">6,168 (13.8)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">　Critical</td><td align="center" valign="middle">2,087 (4.7)</td><td align="center" valign="middle">1,023 (100)</td><td align="center" valign="middle">49.0</td><td align="center" valign="middle">  31,456</td><td align="center" valign="middle">0.325</td></tr><tr><td align="left" valign="middle">　Missing</td><td align="center" valign="middle">257 (0.6)</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td><td align="center" valign="middle">−</td></tr><tr><td align="left" valign="middle">Period (by date of onset)</td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td><td align="center" valign="middle"></td></tr><tr><td align="left" valign="middle">　Before Dec 31, 2019</td><td align="center" valign="middle">104 (0.2)</td><td align="center" valign="middle">15 (1.5)</td><td align="center" valign="middle">14.4</td><td align="center" valign="middle">    5,142</td><td align="center" valign="middle">0.029</td></tr><tr><td align="left" valign="middle">　Jan 1–10, 2020</td><td align="center" valign="middle">653 (1.5)</td><td align="center" valign="middle">102 (10.0)</td><td align="center" valign="middle">15.6</td><td align="center" valign="middle">  21,687</td><td align="center" valign="middle">0.047</td></tr><tr><td align="left" valign="middle">　Jan 11–20, 2020</td><td align="center" valign="middle">5,417 (12.1)</td><td align="center" valign="middle">310 (30.3)</td><td align="center" valign="middle">  5.7</td><td align="center" valign="middle">130,972</td><td align="center" valign="middle">0.024</td></tr><tr><td align="left" valign="middle">　Jan 21–31, 2020</td><td align="center" valign="middle">26,468 (59.2)</td><td align="center" valign="middle">494 (48.3)</td><td align="center" valign="middle">  1.9</td><td align="center" valign="middle">416,009</td><td align="center" valign="middle">0.012</td></tr><tr><td class="table_bottom_border" align="left" valign="middle">　After Feb 1, 2020</td><td class="table_bottom_border" align="center" valign="middle">12,030 (26.9)</td><td class="table_bottom_border" align="center" valign="middle">102 (10.0)</td><td class="table_bottom_border" align="center" valign="middle">  0.8</td><td class="table_bottom_border" align="center" valign="middle">  87,799</td><td class="table_bottom_border" align="center" valign="middle">0.012</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="6">Abreviation: PD, person-days. -, not applicable.<br>* The Wuhan-related exposure variable, only includes a total of 37,269 patients and 919 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>†</sup> The comorbid condition variable, only includes a total of 20,812 patients and 504 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.<br><sup>§</sup> The case severity variable, only includes a total of 44,415 patients and 1,023 deaths and these values were used to calculate percentages in the confirmed cases and deaths columns.</td></tr></tfoot>
</table>
							</div></a></li><li><a href="javascript:;"><div class="table-body 									                       table_type2	                        						    ">
								<table>
<thead><tr><td rowspan="2" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Period </b><br><b>(by date of onset)</b></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Wuhan</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>Hubei (outside Wuhan)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (outside Hubei)</b></td><td class="table_top_border" style="width:0.5%" align="center" valign="middle"></td><td colspan="3" class="table_top_border" style="font-size:7pt" align="center" valign="middle"><b>China (overall)</b></td></tr><tr><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td><td style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Confirmed cases, </b><br><b>N</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Severe + critical, </b><br><b>N (%)</b></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle"><b>Deaths, N (CFR<sup>*</sup>, %)</b></td></tr></thead>
<tbody><tr><td class="table_top_border2" style="font-size:7pt" align="left" valign="middle">Before Dec 31, 2019</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_top_border2" style="width:0.5%" align="center" valign="middle"></td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">       0</td><td class="table_top_border2" style="font-size:7pt;align-point:15pt (;eft;padding-left:19pt" align="center" valign="middle">0</td><td class="table_top_border2" style="font-size:7pt" align="center" valign="middle">0</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 1–10, 2020</td><td align="center" valign="middle" style="font-size:7pt">     18</td><td align="center" valign="middle" style="font-size:7pt">7 (38.9)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">       1</td><td align="center" valign="middle" style="font-size:7pt">1 (100)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     20</td><td align="center" valign="middle" style="font-size:7pt">9 (45.0)</td><td align="center" valign="middle" style="font-size:7pt">1 (5.0)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 11–20, 2020</td><td align="center" valign="middle" style="font-size:7pt">   233</td><td align="center" valign="middle" style="font-size:7pt">52 (22.3)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.4)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     48</td><td align="center" valign="middle" style="font-size:7pt">8 (16.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     29</td><td align="center" valign="middle" style="font-size:7pt">1 (3.4)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   310</td><td align="center" valign="middle" style="font-size:7pt">61 (19.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">Jan 21–31, 2020</td><td align="center" valign="middle" style="font-size:7pt">   656</td><td align="center" valign="middle" style="font-size:7pt">110 (16.8)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   250</td><td align="center" valign="middle" style="font-size:7pt">29 (11.6)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.8)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   130</td><td align="center" valign="middle" style="font-size:7pt">10 (7.7)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">1,036</td><td align="center" valign="middle" style="font-size:7pt">149 (14.4)</td><td align="center" valign="middle" style="font-size:7pt">2 (0.2)</td></tr><tr><td align="left" valign="middle" style="font-size:7pt">After Feb 1, 2020</td><td align="center" valign="middle" style="font-size:7pt">   173</td><td align="center" valign="middle" style="font-size:7pt">22 (12.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.6)</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     95</td><td align="center" valign="middle" style="font-size:7pt">3 (3.2)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">     54</td><td align="center" valign="middle" style="font-size:7pt">3 (5.6)</td><td align="center" valign="middle" style="font-size:7pt">0</td><td style="width:0.5%" align="center" valign="middle"></td><td align="center" valign="middle" style="font-size:7pt">   322</td><td align="center" valign="middle" style="font-size:7pt">28 (8.7)</td><td align="center" valign="middle" style="font-size:7pt">1 (0.3)</td></tr>  <tr><td class="table_bottom_border" style="font-size:7pt" align="left" valign="middle">Total</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,080</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">191 (17.7)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">3 (0.3)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   394</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">41 (10.4)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">2 (0.5)</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">   214</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">15 (7.0)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">0</td><td class="table_bottom_border" style="width:0.5%" align="center" valign="middle"></td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">1,688</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">247 (14.6)</td><td class="table_bottom_border" style="font-size:7pt" align="center" valign="middle">5 (0.3)</td></tr></tbody>
<tfoot><tr><td align="justify" valign="middle" colspan="16">Abreviation: CFR, case-fatality rate.<br>* CFR presented here was calculated as number of deaths (numerator) divided by total number of confirmed cases in the row (denominator), expressed as a percent.</td></tr></tfoot>
</table>
							</div></a></li></ul>
        </div>
        <a href="javascript:;" id="play_next" class="play_next">
			<span class="imgShowIcon imgShowIcon-next"></span>
		</a>
    </div>
</div>
<ul id="miniImgs_title" hidden="">
    <li>
            Figure&nbsp;1.&nbsp;Age distribution and sex ratio of all confirmed COVID-19 cases in China through February 11, 2020. (A) patients diagnosed in the city of Wuhan only; (B) patients diagnosed in Hubei Province, which includes Wuhan as its capital city; and (C) patients diagnosed in China overall, including Hubei Province and all 30 other provincial-level administrative divisions (PLADs). Dashed red line highlights the proportion of patients in the 30–79 years age range. Sex ratio (i.e. male-to-female [M:F] ratio) is shown below each graph.</li>
    <li>
            Figure&nbsp;2.&nbsp;Geo-temporal spread of COVID-19 in China through February 11, 2020. (A) a total of 14 county-level administrative areas (hereafter counties) in Hubei Province only (inset) had reported cases as of December 31, 2019; (B) by January 10, 2020, 113 counties in 20 PLADs had reported cases with the highest prevalence still in Hubei Province; (C) nine days later, on January 20, 627 counties in 30 PLADs had reported cases and PLADs neighboring Hubei Province observed increasing prevalence; (D) by the end of January 31, 1,310 counties across all 31 PLADs were affected and prevalence in the central, south, and south-central regions had risen dramatically; (E) by the end of February 11, 1,386 counties nationwide were affected and prevalence in the south-central PLADs had risen to the level of Hubei.</li>
    <li>
            Figure&nbsp;3.&nbsp;Epidemiological curves of COVID-19 in China through February 11, 2020. (A) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020. A total of 72,314 cases are shown and confirmed cases (blue) are compared to suspected cases (green), clinically diagnosed cases (yellow), and asymptomatic cases (red). The inset shows a zoomed-in view of all days in December, when total daily count remained below 24 cases; (B) the epidemiological curve shows the progression of illness in the outbreak over time from December 8, 2019 to February 11, 2020 for confirmed cases only (blue). The number of cases diagnosed each day is also shown for confirmed cases only (orange). The inset shows a zoomed-in view of all days in December, when total daily count remained below 15 cases.</li>
    <li>
            Figure&nbsp;4.&nbsp;Subgroup epidemiological curves of COVID-19 in China through February 11, 2020. (A) subgroup analysis of confirmed cases discovered outside of Hubei Province only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first case outside Hubei Province on December 18, 2019 through the end of February 11, 2020. Total confirmed cases outside Hubei Province, and Wuhan-related exposure (dark purple) versus Wuhan-unrelated exposure (light purple), are shown; (B) subgroup analysis of all cases among health workers only. The epidemiological curve shows the progression of illness in the outbreak over time from the onset of symptoms of the first health worker case on December 27, 2019 through the end of February 11, 2020. Total cases among health workers and confirmed (blue) versus suspected (green), clinically diagnosed (yellow), and asymptomatic (red) cases are shown.</li>
    </ul>
<script type="text/javascript">
	$(document).ready(function () {
		 //访问文章记录
	    var articleId =  $("#articleId").val();
	    if(!isNull(articleId)){
		    var nowUrl = window.location.href;
			var number = nowUrl.indexOf("viewType=HTML");
			getVisitInfo(articleId,3);
	    }
	});
	</script>

<div id="cboxOverlay" style="display: none;"></div><div id="colorbox" class="" role="dialog" tabindex="-1" style="display: none;"><div id="cboxWrapper"><div><div id="cboxTopLeft" style="float: left;"></div><div id="cboxTopCenter" style="float: left;"></div><div id="cboxTopRight" style="float: left;"></div></div><div style="clear: left;"><div id="cboxMiddleLeft" style="float: left;"></div><div id="cboxContent" style="float: left;"><div id="cboxTitle" style="float: left;"></div><div id="cboxCurrent" style="float: left;"></div><button type="button" id="cboxPrevious"></button><button type="button" id="cboxNext"></button><button id="cboxSlideshow"></button><div id="cboxLoadingOverlay" style="float: left;"></div><div id="cboxLoadingGraphic" style="float: left;"></div></div><div id="cboxMiddleRight" style="float: left;"></div></div><div style="clear: left;"><div id="cboxBottomLeft" style="float: left;"></div><div id="cboxBottomCenter" style="float: left;"></div><div id="cboxBottomRight" style="float: left;"></div></div></div><div style="position: absolute; width: 9999px; visibility: hidden; display: none; max-width: none;"></div></div><form style="display:none" target="" method="post" action="http://weekly.chinacdc.cn/article/exportPdf"><input type="hidden" name="id" value="e53946e2-c6c4-41e9-9a9b-fea8db1a8f51"></form></body></html>